The impact of framing on policy passage: the case of assisted reproductive technology by Smith, Heather K.
THE IMPACT OF FRAMING ON POLICY PASSAGE: THE CASE 



























In Partial Fulfillment 
of the Requirements for the Degree 
MSPP in the 













THE IMPACT OF FRAMING ON POLICY PASSAGE: THE CASE 

























Dr. Roberta Berry, Advisor 
School of Public Policy 
Georgia Institute of Technology 
 
Dr. Richard Barke 
School of Public Policy 
Georgia Institute of Technology 
 
Dr. Juan Rogers 
School of Public Policy 










 I wish to thank the School of Public Policy faculty for answering my many 
questions that I had while working on this paper. I also wish to thank my committee and 
my advisor for helping bring this paper to completion despite the logistics and many 
challenges of this summer. I would like to thank Dr. Elizabeth Berliner for her insightful 
comments on earlier drafts, and my colleagues for listening to my many revisions to the 
concepts. I would especially like to thank Dr. Roberta Berry for the extensive amount of 
time and work she has put into guiding this paper to its final form. And finally, I would 
like to thank my mother and father for being patient with me in this journey to a final 


















TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS  
LIST OF TABLES vi 
LIST OF FIGURES vii 
LIST OF SYMBOLS AND ABBREVIATIONS ix 
SUMMARY ix 
CHAPTER 
1 CHAPTER 1: BRIEF INTRODUCTION TO ASSISTED REPRODUCTIVE 
TECHNOLOGIES AND THE POLICY REGULATORY ISSUES 1 
1.1 A general overview of the technologies and the approach of this study 2 
1.2 The History of ARTs in the U.S.: Inconsistency and Challenges to 
Underlying 9 
1.3 Policy, regulatory and other critiques 19 
1.4 A Short History of Medicine and Reproductive Rights 30 
1.5 Summary of research questions and orientations 42 
2 CHAPTER 2: UNDERLYING THEORIES AND FRAMEWORKS 43 
2.1 General Overview of the frameworks and theories 43 
2.2 Social Movement Theory 44 
2.3 Social Constructions, Problem definitions and Policy Frames 49 
3 CHAPTER 3: METHODOLOGY 54 
3.1Study data and research questions 54 
3.2 Data Collection 57 
3.3 Summary of Sources 59 
4 CHAPTER 4: CLASSIFICATION AND FRAME ANALYSIS 107 
 v 
4.1 Classification Analysis 61 
4.2 Frame Analysis 66 
5 CHAPTER 5: CONCLUSIONS CHAPTER 5107 
5.1 Contribution to theory 107 
5.2 Limitations and contribution to ART policy literature 108 
5.3 Policy implications 109 
 
APPENDIX A: TABLES OF REPORTS 110 
APPENDIX B: LIST OF SEARCH TERMS 116 
APPENDIX C: FRAMES & SOCIAL CONSTRUCTIONS 117 
APPENDIX D: BILLS 123 
REFERENCES 129 
 vi 
LIST OF TABLES 
Page 
Table 1: The data for the frame analysis 59 
Table 2: The breakdown of data collected for the frame analysis 66 
Table 3: Organization of data 80 
Table 4: FCSRCA frame 81 
Table 5: Examples of frames for two federally failed bills 87 
Table 6: EAB Report Recommendations 110 
Table 7: OTA 1988 Report Recommendations 111 
Table 8: PCB Report Recommendations (specifically regarding ARTs) 114 
Table 9: Frames 117 
Table 10: List of actors distilled from all bills 120 
Table 11: Nvivo stop terms 122 
Table 12: The bills, ordered by level and date Error! Bookmark not defined. 




LIST OF FIGURES 
Page 
Figure 1: Figure 1:A general overview of the history of ARTs 10 
Figure 2: A timeline of ART from 1970-1984 11 
Figure 3: A timeline from 1982-1995 16 
Figure 5: Identified target groups in the ART policy arena 64 
Figure 6: Actors identified to be key in the solution action 65 
Figure 7: Overall framework for Hypothesis 1, for the purpose of explaining the cases in 
which a frame will or will not result in passage. Modification of the political 
context model found in Blackwell's Companion to Social Movement, p. 70 
(Kriesi, 2004) 69 
Figure 8: The case in which an alternative actor is identified as the beneficiary of the 
problem frame or a traditional actor the cause of it. Modification of the 
political context model found in Blackwell's Companion to Social Movement, 
p. 70 (Kriesi, 2004) 69 
Figure 9: The case in which a bill identifies a solution that removes the option for 
primarily self-management on the part of dominant actors. Modification of the 
political context model found in Blackwell's Companion to Social Movement, 
p. 70 (Kriesi, 2004) 70 
Figure 10: The case in which a bill excludes traditional actors, particularly historically 
powerful traditional actors, for participation in the development and 
implementation of the solution. Modification of the political context model 
found in Blackwell's Companion to Social Movement, p. 70 (Kriesi, 2004) 71 
Figure 11: The overall case of frames over time. It is expected that there should be some 
appearance of feedback. Modification of the political context model found in 
Blackwell's Companion to Social Movement, p. 70 (Kriesi, 2004) 72 
Figure 12: Federal 'Failed' Bills: An example of the word count comparison between 
those words that were encountered frequently between all individual bills 
counts and those that were encountered frequently in a cumulative word count 
across all bills 74 
Figure 13: Federal Failed Bills word count distribution 75 
Figure 14: Set of actors contained within a word count of Federal level bills that failed to 
be passed 76 
 vii
Figure 15: An actors x bills matrix, for federal level failed bills. The purpose of this 
matrix was to identify which bill utilized which actors. 78 
Figure 16: Federal timeline of bills. The blue highlighted bill is the only passed bill at this 
level. 79 
Figure 17: A time line of California bills. The blue highlighted bills are passed bills 94 
Figure 18: Time line of Georgia Bills. The passed bills are highlighted in blue. 101 
Figure 19: Social constructions of actors from frames. Modified from Ingram & 










LIST OF ABBREVIATIONS 
 
AFA American Fertility Association (formerly, American Infertility Association 
[AIA]) 
AID  artificial insemination by donor 
AMA  American Medical Association 
ART  assisted reproductive technology 
ASRM  American Society for Reproductive Medicine 
AATB  American Association of Tissue Banks 
CDC  Centers for Disease Control 
CMMS  Centers for Medicaid and Medicare Services 
CPDF  comparative policy design framework 
DHHS  Department of Health and Human Services 
EAB  Ethics Advisory Board 
FCSRCA  Fertility Clinic Success Rate and Certification Act 
FDA  Food and Drug Administration 
GIFT  gamete intrafallopian transfer 
HEW  Department of Health Education and Welfare 
ICSI  intercytoplasmic sperm injection 
IVF  in vitro fertilization 
NICHHD  National Institute of Child Health and Human Development 
NCOART National Coalition for the Oversight of Assisted Reproductive Technologies 
NRC  National Research Council 
OTA  Office of Technology Assessment 
PCB  The Presidential Commission for the Study of Bioethical Issues 
 x 
SART  Society for Assisted Reproductive Technology 
ZIFT  zygote intrafallopian transfer 









In the last 30 years, in vitro fertilization (IVF) has created a significant amount of 
controversy around the world. Within the U.S., policy movement has been limited, 
occurring primarily at the state level, which has created a fragmented system of rules to 
manage the technology. However, there appear to be indications that how the issue is 
presented, and which actors are chosen to be represented in legislation, may impact the 
passage of policy, thereby also providing a reason for why little policy movement has 
occurred. In this study, pieces of federal, California and Georgia legislation were 
examined for the occurrence of differing frames, as identified by the actors presented, in 
order to determine whether different frames occurred in passed legislation than those 
found in failed legislation. It was determined that, while actors did not differ significantly 
between passed and failed legislation, there were some slight differences between actors 
used at the federal level, as well between the different state levels. Even further, the 








BRIEF INTRODUCTION TO ASSISTED REPRODUCTIVE 
TECHNOLOGIES AND THE POLICY REGULATORY ISSUES 
 
 In the United States, the clinical application of assisted reproductive technology 
(ART) has been understood to enjoy freedom from governmental intervention, 
particularly in contrast to many other developed countries. Although the research aspects 
of the technology (embryo research, cloning, etc.) have undergone extensive scrutiny and 
been subject to a number of policy restrictions, the clinical aspects have largely remained 
free of government policy constraints (Bleiklie, et al., 2004, p.83 ). In fact, the clinical 
application and use of ARTs have widely been observed to be largely exempt from 
governmental oversight, data collection and regulation, particularly at the federal level 
(Goggin & Orth, 2004, p. 83; DeMelo-Martin, 1999, p.65 ). In Bleiklie, Goggin and 
Rothmayer's Comparative Biomedical Policy, Goggin's chapter on the U.S. ART policy 
observes that the U.S. has little in policy with relation to access to ARTs. Even further, 
both the chapter by Goggin and a white paper by Rebecca Harris recognize the emphasis 
upon professional self-regulation as the primary rule type related to ARTs  (Goggin & 
Orth, 2004, p.92; Harris, 2010). Harris also points out that the traditional means of 
managing medicine seems to be the dominant model of managing ARTs in the U.S., 
stating that “[t]he model for medical regulation has been professional self-regulation, 
with licensing and liability torts as the primary tools of compliance. This places power 
squarely in the professional societies and medical practitioners (as well as medical 
malpractice insurance companies).” (Harris, 2010). 
 The few policy studies of the ARTs, such as those using Bleiklie, et al.' s 
Comparative Policy Design Framework (CPDF) and the white paper by Harris, make 
attempts to explain facets of the policy problems of the ART arena. Neither one, 
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however, appears to capture the full story of the lack of policy change within the U.S. 
policy context. The CPDF's particularly extensive study of institutional structure, actor 
coalitions, and policy designs (p. 5-13), informed the approach of this study, particularly 
the understanding of the coalition groups in existence. The Harris study provided some 
insight into the power situation of the arena. However, these earlier studies tend to appear 
highly static in nature, particularly ignoring the dynamics and history of the interactions 
they are studying. This study is an attempt to understand the policy arena as a dynamic 
system with strong policy currents that maintain the political policy structures. 
 This study views the policy making in a given arena as a dynamic, iterative 
process and focuses on how problem definition and policy framing affect the 
development and successful passage of ART policies on the federal and state levels. 
Some barriers to policy creation that have been pinpointed are due to the fragmentation of 
opposition groups (Rothmayr, et al., 2004, p.228 ), but this study proposes that additional 
constraints are due to the problem constructions (and solutions) found within the policies 
themselves and are influenced by the historical institutional structures of medical 
governance. 
1.1 A general overview of the technologies and the approach of this study 
 ARTs have held a relatively unique position in the U.S. policy world. Since their 
debut on the world medical stage in the late 1970s, they have been hailed as the solution 
to infertility problems faced by numerous 'traditional' couples each year. With the birth of 
Elizabeth Carr in 1981, the first 'test-tube baby' born in the U.S., hundreds of infertile 
couples in the U.S. found that they would now have the opportunity to have children to 
whom they were genetically related, just as other more fertile couples had been doing for 
generations. Further, numerous 'non-traditional' couples/parents would also be able to 
have children of their own. Through the years, ARTs have not escaped scientific scrutiny 
and appear to be both safe and effective. 
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 Despite this, these technologies as a treatment for infertility have not been free of 
criticism from other scholarly disciplines. Many of these critiques have stemmed from 
the fields of ethics and law, since many of these technologies either interfere with 
previously accepted ethical norms and beliefs, or because many of the controversies 
relate to complex, interrelated rights issues of the parents, their expected children, the 
practicing professionals, or other impacted groups, such as surrogates. For example, 
consider the argument outlined by Robert Blank and Janna Merrick in their book Human 
Reproduction, Emerging Technologies and Conflicting Rights (1995), about the lenses 
through which one can view reproductive rights: (1) the right not to have children, (2) the 
right to have children and (3) the right to determine the quality or characteristics of said 
children (1995, p. 5). Alternative bodies of critique also have developed in parallel to 
these mainstream arguments, such as in feminist law, in the sociology of medicine, in 
feminist ethics, and from the religious and pro-life communities. 
 These critiques often focused upon the impact of ART on the 'pillars' of society, 
such as family, health, and the research possibilities created through the use of these 
technologies (de Melo-Martin, 1999). Even further, questions have arisen regarding the 
ethical and economic incentives that arise due to the availability of such technology, such 
as embryo sex-selection and the transfer of excess embryos (Schonfeld, 2003; Collopy, 
2004). Moreover, some doubt has been cast on the effectiveness of evaluation methods 
such as health technology assessments, due to possible applications of socially 
constructed biases embedded in the assumptions of these methods (de Melo-Martin, 
1999). Examples of arguments over the impact of ART use include the altered role of 
women in society (Wilker, 1986; Kerian, 1997), the long-term effects of fertility drugs 
used in conception (Rutnam, 1991), the incentive to postpone conception (Heitman, 
1995), and the advent of gamete donation and surrogacy (Robertson, 1996; Kierien, 
1997). It has also been noted by scholars that there has been little federal policy 
development, despite the number of critiques. The sole exception to this is the Fertility 
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Clinic Success Rate and Certification Act of 1992 (FCSRCA), which publishes whether 
fertility clinics have a standardized process for transfer that falls within professional 
standards, and their success in accomplishing live births through their transfer process 
(Goggin & Orth, 2004, p.90). 
 Despite the fact that critiques of this technology are far from scarce, federal policy 
regarding their management has been limited in the last twenty-plus years that it has been 
in use (Eggen, 1991; de Melo-Martin, 1999). In fact, the management and regulation of 
ART practice has often appeared to gain saliency in public and political discourse only in 
the case of high-profile developments, such as the controversy surrounding 'octomom', or 
in cases of ethical conundrums, such as the price of egg donation. (Kolata, 1999; Kolata, 
1998; Naik, 2009). Even during these developments, passage of policy has not 
necessarily occurred. The reasons for the saliency of these issues have not always been 
clear. For example, the saliency of the 'octomom' event may have been derived from the 
fact that she relied upon public assistance to support her family, almost as much as the 
fact that she was the first to give birth to surviving octuplets (Bowe, 2009).  
Alternatively, the saliency of egg donation in New York appears to have been more 
focused on the ethics of economic incentives (Kolata, 1999; Kolata, 1998). While major 
reports such as 2004's Reproduction and Responsibility by the President's Commission on 
Bioethics pinpointed several areas of ethical concern and provided subsequent policy 
recommendations, little policy appears to have materialized (PCB, 2004). 
 In part, the lack of policy at the federal level has been argued to be a false 
indicator of policy movement and that a majority of regulatory action occurs at the state 
level (Adamson, 2002). It is important to note that this position of deferring to federalist 
principles is not unusual in the U.S., particularly with regard to medical policy (OTA, 
1988; PCB, 2004). According to Goggin & Orth, the states have been far more proactive 
in establishing oversight of ARTs than what is found at the federal level (2004, p. 92). An 
additional facet of regulation is the role of professional organizations, which are argued 
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to provide a number of self-imposed rules and which collect a significant amount of data. 
They are also recognized to play a significant role in the engagement of non-medical 
members of the community in oversight (Adamson, 2005; Aronson, 2000). This system 
of rules has largely been argued to suffer from significant fragmentation, which 
exemplifies how much the U.S. regulatory structure still differs from its counterparts and 
how little comprehensive oversight occurs (Rothmayr, et al., 2004, p.231). 
 With regard to public scrutiny, some highly publicized cases have reached 
mainstream media attention (Kolata, 1999; NYT, Feb. 12, 2009), but the issue of 
additional ART oversight appears to be pursued more heavily in scholarly and legal 
forums rather than public forums. There has been little exploration as to why this is the 
case, but it has been proposed that social construction within the policy arena may have a 
significant impact on how policy plays out (Rothmayr, et al., 2003, p.251). This may also 
be the case for the public forums. However, the intersection of ethics, law and policy on 
this topic has proven to be fertile ground for discussion, and has instigated a number of 
debates, including the role of ethics in policy analysis (Amy, 1984; Kenny & Giacomini, 
2005), and the extent to which policy may intervene in the lives of private citizens 
(Kenny & Giacomini, 2005). 
 To some extent, this debate between scholarly communities can be traced to the 
dispute over whether ART use is a private, health-related decision or a public and social 
health concern. In the sight of many, particularly medical professionals and consumers, it 
has been argued that ART applications are a matter of couples exercising their 
reproductive rights (Robertson, 1996). Key to this argument is the establishment of 
negative reproductive rights through the federal courts, examples of which include Roe v. 
Wade, among others (Roe v. Wade, 410 U.S. 113 (1973)). At points, there have even been 
attempts to extend this argument towards the positive right to reproduce, as evidenced by 
the disputes regarding coverage of procedures by employers, private insurance and 
publicly funded healthcare plans (Gordon, 2005). This concept of a right to reproduce has 
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been heavily relied on to trump many arguments for additional oversight, as additional 
oversight, data collection or monitoring could have the potential of interfering with 
privacy (Robertson, 1996). 
 In contrast to the reproductive rights argument, there is a diverse number of 
arguments against the open policies currently governing ART use, including 
considerations of the long-term impact upon women, the rights of the children produced, 
and cost to society overall. Examples of oppositional positions include the impact of 
health history knowledge on the part of children produced via donors (Daniels, 2000), the 
long term repercussions of drugs used in fertility treatments on the women using them 
(Jennings & Callahan, 2001), and the longitudinal data on children produced via IVF 
(Green, 2004). Beyond the argument about the need to institute policies to protect 
potentially vulnerable actors (such as women, children, or the infertile couple) and 
society, questions have also arisen regarding the effectiveness of internal, professional 
oversight in an industry that clearly benefits from the continuance of limited external 
oversight (Charo, 2002). Given the findings that infertile 'couples' may have altered 
perceptions of risk and that the physician holds some 'self-interest' within the transaction, 
questions regarding the clarity and objectivity of decision-making in these transactions 
have arisen also (Grobman, et al., 2001). 
 Social constructions have also been argued to play a role in the debate, both in 
how actors are targeted through policy and which actors are able to gain political 
legitimacy and access to the political arena (Goggin & Orth, 2004, p.93-96). The effects 
of actor social construction in this arena, as well as knowledge social construction, have 
not been heavily researched previously and therefore, the implications for policy have 
been unclear. As proposed by Helen Ingram and Anne Schneider, social constructions 
can play a role in policy power dynamics (Ingram & Schneider, 1997, p. 192-3), but can 
also potentially restrict policy solutions and even which problems are considered (Ingram 
& Schneider, 1997, p. 106). For example, the social construction of doctors as 'experts', 
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'uninfluenced by market forces', 'ethically above self-interest', have been argued to not 
only contribute to the ways through which they are targeted in policy, but also the 
historical means through which they can wield power politically (Stevens, 2002, Varone, 
Rothmayr & Monpetit 2006). As such, the role of social constructions is not minor in the 
study of this policy arena. 
 The purpose of this study is to understand the role and effects of frames in this 
policy arena, with frames here referring to the wording and rhetoric used to refer to the 
wording and structure of problems and solutions in a particular policy area. The 
institutional arena has been somewhat defined by previous studies (Bleiklie, et al., 2004; 
Varone, Rothmayr & Monpetit 2006), as have some of the power balances that may 
define the boundaries of the arena (Harris, 2010, Varone, Rothmayr & Monpetit 2006). 
This study hopes to shed further light on the role of frames in explaining the persistence 
of actor social constructions. A more tangential focus of this study is the historical 
constructions of actors, such as medical professionals, the historical development of 
reproductive rights and how the relationship between these two things yielded certain 
policy frames that gained traction early in the establishment of the ART policy arena1.  
Therefore, the initial focus of analysis will be on the history of specific actors of 
medicine and reproduction in ART. The following chapter will contain a breakdown of 
relevant groups and organizations for the purpose of finding frames and the final portion 
will consist of an examination of federal and state level legislation pertaining to the use 
of ARTs. The remainder of this chapter focuses on the state of the technology, an outline 
of past and current policies, the critiques of both the technology and its management, and 
will address the historical structures present. The subsequent chapters will address the 
                                                 
1
 Feedback is an important aspect of the effects of historical constructions on policy creation, but is 
outside of the scope of this current study. Even so, the author does acknowledge that history can be viewed 
as constraining the available views on a particular policy problem through factors such as power balances, 
status quo bias and institutional availability. 
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theoretical and methodological approaches of this study, followed by the results and 
conclusions. 
1.1.1 What ARTs are and How They Work 
 As defined by the Centers for Disease Control (CDC), assisted reproductive 
technologies are “all fertility treatments in which both eggs and sperm are handled” 
(CDC, 2009). This definition does refer to many of the technologies often utilized for 
treatment of infertility/involuntary childlessness, and it also neglects several treatments or 
technologies often included in the broader classification of 'reproductive technologies', 
such as artificial insemination (by donor [AID] or by husband [AIH], hereafter referred to 
solely as AID) and fertility-enhancing drugs (Blank & Merrick, 1995, p. 96-98). While 
IVF and its associated techniques are the only technologies managed by the CDC through 
FCSRCA legislation, it is important to note that the other two forms of reproductive 
enhancement also are controversial and closely related in nature. 
 Currently, the most common technologies used in assisting reproduction, as 
reported in the 2007 Assisted Reproductive Technology report published by the CDC, are 
IVF, with or without intracytoplasmic sperm injection (ICSI), gamete intrafallopian 
transfer (GIFT) and zygote intrafallopian transfer (ZIFT). Developed in 1978, IVF is the 
oldest of the three techniques mentioned above, with ZIFT and GIFT being developed in 
1984 as a means of improving the success rates of ARTs (Asch, 1994, p.75-76). IVF and 
ZIFT are the most similar to each other, both involving the creation of an embryo outside 
of the body prior to implantation, whereas GIFT involves the implantation of individual 
gametes into the fallopian tubes, at which point fertilization is expected to occur (Asch, 
1994, p. 75). ICSI, in contrast with the other three techniques mentioned, only acts as a 
mechanism to assure fertilization, through the injection of sperm into the ovum rather 
than incubating the gametes together within a culture medium (Asch, 1994, p. 76; CDC 
ART Report, 2007, Appendix B). 
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1.1.2 Drawing the line & limiting the scope 
 While IVF with or without ICSI, GIFT, ZIFT, AID and fertility-enhancing drugs 
all have ethical issues associated with them, their management is largely separate. The 
U.S. Food and Drug Administration (FDA) has clear jurisdiction over the management of 
fertility-enhancing drugs. It has some control over aspects of AID and ART through the 
regulation of use and testing of human tissue (Adamson, 2005; Adamson, 2002). The 
CDC however, monitors ART data in ways that AID are not managed, for example, 
tracking of success rates. Little evidence of AID management outside of the FDA's 
management of human tissues exists. For the purpose of maintaining clarity and 
consistency, this study will accept the limits of the CDC's definition of ARTs. While 
sources will not be excluded based on the inclusion of AID management, legislation 
solely directed at AID will not be considered. As a result, it is acknowledged that this 
may bias the study as a means of understanding policy frames in this area. However, it 
will also provide the necessary exploratory boundaries to assure a clear explanation of 
how frames affect policy direction in technology. It is also important to note that the 
examination of policy frames will be limited to legislation; while public media may play 
a role in ART political development, they will not be considered a primary source of data 
in this study. 
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Figure 1:A general overview of the history of ARTs 
1.2.1 What ARTs are and How They Work 
 Policy movement targeting ARTs was limited prior to the birth of Elizabeth Carr 
in 1981 (Cohen, et al. 2005). In fact, the 1978 Ethical Advisory Board's (EAB) evaluation 
of the ethical acceptability of ART is one of the few public policy actions of the 1970s 
(deMelo-Martin, 1998, p. 65-66). Other examples include the National Research 
Council's Committee on Life Sciences and Social Policy's technology assessment (HEW, 
1979) and a 1975 regulation issued by the Department of Health, Education and Welfare 
(HEW), under which funding for IVF was banned until the EAB had reached some 
conclusions on the ethical acceptability of the technology (Grobstein, 1983). Much of the 
scrutiny of ART did not occur until after the birth of the first IVF baby (Grobstein, 1983). 
Even with the advent of ethical approval, however, which was included in EAB's 1979 
report to the HEW (de Melo-Martin, 1999; EAB, 1979), public funding was not released 
due to the expiration of the EAB prior to giving approval of funding. Following the 
expiration of the board's charter in 1980, little policy action appeared to be taken based 
upon the report's recommendations, and further federal examination of ART did not 
occur until the Office of Technology Assessment's (OTA) reports on it in the 1980s 
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(Bonnicksen, 1986). The segment of the time line of in which the above policy action 
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Figure 2: A timeline of ART from 1970-1984 
As acknowledged above, there are a number of technologies that play a role in treating 
infertility, such as AID. Many of these technologies are not currently regulated under the 
same standards as ARTs. AID, as a means of treatment for infertility, was a technique 
utilized since early in the twentieth century to assist some infertile couples in 
reproduction (Smith, 1968). While this technology predates and provides the scientific 
foundation of many of the techniques now generally referred to as ARTs, it is governed 
by laws based upon the handling of materials, and is not covered by FCSRCA. It is not 
clear as to why AID is distinguished from other ARTs because, as can be seen throughout 
the literature (Beller & Weir, 1994; Walters & Singer, 1982), many of the ethical and 
social issues that arise from IVF (or GIFT) also occur with AID, with the exception of 
embryo experimentation (Asch, 1994). 
 ARTs were introduced for commercial use in the U.S. in the early 1980s, with the 
birth of Elizabeth Carr, but they debuted on the world stage as a means of treating 
infertility in 1978, with the birth of Louise Brown. The introduction of IVF as a 
technique available within the U.S. would not come for another four years, but its 
introduction as a technique potentially to be used on humans raised a number of questions 
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based on the potential for ethical conflict. In 1979, the EAB released its initial report to 
the HEW (later the Department of Health and Human Services (DHHS)) for the purpose 
of establishing whether IVF was ethically acceptable (EAB, 1979). This early policy 
report provided insight into the potential for ethical and safety issues, and also laid the 
groundwork for the possibility of public funding of the technology. The EAB determined 
several important points with regard to the management of IVF2 and established that 
proceeding with IVF research in the U.S. was an ethically sound and acceptable course of 
action (Studdard, 1981). As a result of this report, doctors and scientists led by Howard 
Jones at Eastern Virginia Medical School, were able to successfully culminate the first 
U.S. IVF baby in Elizabeth Carr in 1981 Studdard, 1981).  
It is important to note that this early report covered an exceptional amount of 
ground on the ethics of new biomedical technologies and provided an interdisciplinary 
perspective on the challenges facing the technology. It managed to include opinions from 
legal, ethical, social science and medical scholars in its attempt to understand the 
multidimensional implications of ART use. From a legal standpoint, the report 
determined that the right to privacy as it relates to reproduction and marital relationships, 
or 'reproductive rights', most closely applied to IVF clinical use (EAB, 1979, p. 65). 
However, legal arguments divided their understanding of ART use between clinical and 
laboratory applications of the technology (EAB, 1979, p. 68). Other ethically based 
arguments on ART also make this distinction. As such, this study addresses only the 
management of clinical aspects of this technology (EAB, 1979, Ch. 4; Studdard, 1981). 
                                                 
2
 The points include (1) risks to mother and potential child were not clearly established and a review 
of additional animal models could improve understanding of the health risks and effects; (2) further 
technology research involving humans was ethically acceptable given that (a) human subjects guidelines 
were followed, (b) research was designed to determine safety that could not otherwise be determined 
through other models, (c) the people involved would be explicitly informed of the use of their gametes, (d) 
the embryos would not be sustained abnormally longer than the normal time of completion for 
implantation, and (e) that the public as well as 'interested parties' would be informed of the outcome if the 
procedures showed evidence of higher than normal abnormalities in offspring; (3) it did not address the 
issue of funding of such research. 
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1.2.2 Policy treatment of ARTs from the advent of commercial use to the 
establishment of FCSRCA 
 By the time the first IVF baby was born in 1981, policy recommendations and 
legislation on clinical use and application of ARTs were limited. However, with the 
availability of ART to treat infertility, scholarly, public and political debate erupted, 
focusing on the use and monitoring of these new technologies (Hyer, 1978; Lee, 1986). 
As ARTs became more available, the reality of social impacts began to reach the 
forefront of the debate. The concepts of property, parenthood, legitimacy and family had 
all shifted, and it became apparent that new rules and definitions would have to be 
developed, as the previous ones no longer clearly applied. (EAB, 1979; Wadlington, 
1983)  
 A primary point of interest during this decade of ARTs was the safety and 
efficacy of the technology (EAB, 1979; Kurinczuk, 2003). As explained in the third 
paragraph of section 2.1, following the ethical approval of IVF by EAB, research 
proceeded that culminated in the birth of Elizabeth Carr in 1981. From this work, a 
number of new IVF and similar techniques were developed, including GIFT, Perionatal 
Oocyte and Sperm Transfer (PROST) and ZIFT. The birth also provided a catalyst for 
policy development in the ART arena (Bonnicksen, 1986). Between 1981 and 1992, the 
management and analysis related to ARTs fell within the domain of OTA. During this 
period, they published one study addressing policy development pertaining specifically to 
infertility and ARTs and several others that addressed the role of new biotechnologies in 
society and medicine. (OTA, 1988a; OTA, 1988b; OTA, 1987). The 1988 infertility 
report provided a number of insights into the ethical3, legal4 and policy5,6 issues 
                                                 
3 The right to reproduce, the moral status of the embryo, the relationship between parents and 
children, the patient's right to know (regarding experimentation), confidentiality and honesty, and the 
responsibility of one generation for the one(s) after it. 
4 Transactions relating to the transfer of gametes, embryos and neonates, as well as what the 
definition of parenthood is within the legal context (as compared to the genetic/scientific context) 
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underlying both clinical and laboratory use of ARTs (OTA, 1988b). Overall, a number of 
policy options were addressed, including additional regulation. However, the report also 
reinforced the idea that much of the power of governance for ARTs lay at the state level, 
through professional licensing and jurisdiction over health issues and family law. (OTA, 
1988a, p.172)  As a result, few federal government options found in the report were 
implemented. Congress also held several hearings on issues of the implications, access, 
and consumer protection related to these technologies, but they too resulted in little 
policy action (Blank & Merrick, 1995). 
 In contrast to the federal level, state level and professional organizational level 
policy movement was not insignificant. On the professional side, the Society for Assisted 
Reproductive Technology (SART) began collecting success rates for member clinics in 
1985, through a system that would later provide the framework for measures 
implemented by the CDC in its oversight capacity (CDC, 2009). Given this action, and 
work done by the American Fertility Society (now known as the American Society for 
Reproductive Medicine [ASRM]), a number of professional measures were put in place 
for practitioners of ARTs (Blank & Merrick, 1995, p. 96;). Since this time, regulation in 
the U.S. has mostly consisted of self-regulatory guidelines established at the professional 
level (Adamson, 2005). These professional organizations, along with consumer 
organizations such as RESOLVE and the American Fertility Association (AFA, formerly 
the American Infertility Association) also dominated much of the discourse on ART, 
through coalitions such as National Coalition for Oversight of Assisted Reproductive 
                                                                                                                                                 
5 This section clearly articulates costs (of infertility as well as infertility treatment), issues related to 
quality of product, and the breakdown of the affected population(s). It also, briefly addresses the state of 
management of that technology as it related to policy product at that time, which was largely considered to 
be an issue to be dealt with at the state level (with regard to clinical practice), given that it was considered a 
'medical issue' and a consideration for family law, both state level matters.(OTA, 1988, p.10) 
6 The OTA report on IVF also identified nine areas in which potential policy options existed, 
including: (1) data collection, (2) infertility prevention measures, (3) consumer information/ awareness, (4) 
infertility treatment access, (5) assessing the reproductive health and well-being of veterans, (6) gamete and 




Technologies (NCOART) and legislative advocacy (Adamson, 2005; SART, 2010). They 
also played significant roles in the management and implementation of FCSRCA through 
both provision of oversight and acting as a facilitator for the collection of additional 
clinic data. 
 With regard to state policy action during this period, some states were quite active 
in creating legislation related to ARTs. At least 11 states created policy mandating either 
insurance coverage or the offer of coverage for infertility treatment. Two of these states, 
California and New York, specifically excluded the coverage of IVF (NCSL, 2009). Even 
further, several states instituted restrictions on insemination, ranging from a ban on self-
insemination to a requirement that insemination be conducted by a physician 
(Blankenship 1993). Overall, while state policy action was not stagnant during this period 
of time, it also was fragmented, creating a number of different types of policies. 
 The key policy move of the decade at the federal level, however, was the 
development and enactment of the FCSRCA of 1992. In the late 1980's and early 1990's, 
a few clinics were cited for false advertisement of success rates, a term often used to refer 
to live-birth rates, by the Federal Trade Commission (FTC) (FTC, 1990, p. 26). As a 
result, Congress moved to implement legislation to 'protect' the ART consumer from false 
advertisement. Once during the second session of the 101st Congress (1989-1990), and 
twice during the first session and once during the second session of the 102nd Congress 
(1991-1992), a bill was introduced with the intent for providing a system of certification 
for fertility clinics and a reporting/tracking system for their success rates (H.R. 756; H.R. 
3490; H.R. 5110; Pub.L. 102-493). The final introduction of the bill in 1992 passed both 
houses of Congress and was enacted. This piece of legislation is the single example of 
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Figure 3: A timeline from 1982-1995 
1.2.3 Policy treatment of ARTs from FCSRCA to present 
 After the passage of FCSRCA in 1992, one might expect that this represented a 
change in attitude towards centralized ART policy. However, much of the successful 
policy change since FCSRCA has been in areas of access more so than oversight. As 
acknowledged in the fifth paragraph of the last section, part of the reason behind the 
implementation of FCSRCA was a response to an FTC violation on advertisement of 
success rates (Adamson, 2005). Whether FCSRCA has been successful at correcting for 
this issue is less clear and evaluative study of its effectiveness appears to be limited. With 
regard to other aspects of ART policy, however, the CDC has published the results of 
their current oversight activities publicly since 1997 (CDC, 2005). Further, the PCB 
revisited the issues facing ARTs in 2004 (PCB, 2004). The report states many of the 
points made by earlier reports from the EAB and OTA regarding potential means of 
managing ARTs, such as a need for additional data from which to draw conclusions and 
the need to create additional infertility prevention measures (EAB, 1978; OTA, 1988a). 
With regard to changes in management strategy, a few high profile cases have created 
short-lived turmoil in the policy arena and, yet again, little has morphed into public 
policy change. Changes in professional self-regulatory guidelines, on the other hand, 
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have been far more dynamic, often responding to public outcry (Adamson, 2005; 
Adamson, 2008). However, not all of this change has been transparent, with guideline 
access largely being restricted to members of ASRM (ASRM, 2010). Overall, policy 
change within the last 18 years has largely been limited to state regulation and 
professional self-regulation. 
 At the state level, the legislative action has been varied. Some states, such as 
Louisiana, Pennsylvania and New Hampshire, have been very active in creating laws to 
govern ART use within their states (PCB, 2004; Adamson, 2005). Some states have 
implemented rules not only on the status of the embryo (Havins, 1999), but also the 
requirements, rights and responsibilities of all parties that are directly involved, including 
establishing an owner or guardian of embryos once they are created (Havins, 1999). 
Moreover, states have taken some action regarding informed consent and other measures 
to improve the outcomes for the consumer, on top of those provided by FCSRCA 
(Rosato, 2003). Even given this policy action, however, a number of gaps are still 
acknowledged to exist, one of which has been the lack of uniformity of policy across 
states. However, this lack of uniformity has generally been explained by the structure of 
the U.S. government, which creates fragmentation through its separation of powers and 
federalist structure (Blank & Merrick, 1995). 
1. The state of the law and legal structures in ARTs 
 The judicial regulatory history impacting ARTs begins with judicial decisions 
made about the right to reproduce or not reproduce. Griswold v. Connecticut established 
a right to reproductive choice about contraception within the context of marriage 
(Griswold v. Connecticut, 381 U.S. 489, 1965; de Melo-Martin, 1999, p. 64). Roe v. 
Wade established the right to privacy in reproductive choice about abortion (Roe v. Wade, 
410 U.S. 113 (1973)). Skinner v. Oklahoma guaranteed the right to reproduce without 
interference (Skinner v. Oklahoma, 316 U.S. 535 (1942)). While all of these cases were 
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key in establishing what are known as negative reproductive rights, the rights of 
individuals to be free of governmental interference in their reproductive choices, many 
argue that a more essential right in the assisted reproductive world is a positive right to 
reproduce, which would guarantee not only the right to be free from government 
intervention in one's reproductive choices, but also that it is the responsibility of the 
government to provide infertile couples with the means to reproduce, including the 
provision of services like ART. (de Melo-Martin, 1999, p. 65) 
 Beyond the judicial decisions regarding one's right to use ART for the purpose of 
reproduction, there have also been some rulings regarding the outcomes of the procedure 
or steps within the procedure. These include cases establishing familial and property 
rights and concerning physicians' discretion to provide treatment (Ekstut, 2008). For 
example, several rulings have been made regarding establishment of parentage of a 
resultant embryo, in the case of surrogacy or gestation and gamete donation, and 
establishment of parenthood by parties (Eckstut, 2008; K.M. v. E.G., Cal. 2005; UPA, 
2002) or in the case of changes in the relationship between gamete donors (or 'parents') 
(Eckstut, 2008; UPA, 2002), and the ability of the embryo/child to inherit with 
postmortem implantation (Eckstut, 2008; UPA, 2002). In the case of surrogacy contracts, 
gamete donation and establishing parentage, it can clearly be seen that the norms defining 
parenthood that formerly informed family law have changed, not only due to a division of 
genetic and physical parenthood, but also because of the potential financial incentives 
offered to surrogates and donors (Levine, 2010). A number of ethical concerns arise due 
to these new incentives, such as the commodification of women's bodies and human 
gametes, coercion, and risk discounting (Collopy, 2004; Redshaw, Hockley & Davidson, 
2007; Levine, 2010). There is also great potential for discrimination in the provision of 
services, particularly against non-traditional couples and single parents, based on the 
wording of some judicial rulings and statutes (Eckstut, 2008). Yet another emerging area 
is embryo status. Ownership/property status, adoption status and postmortem birth all are 
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examples of situations in which the norms that underlay family and property law, no 
longer clearly apply. Ideas of consent, parentage, and legitimacy for the purposes of 
inheritance are now confused due to the shift in when activities can temporally take 
place, as in the case of a pregnancy achieved after the death of one of the parents, or 
adoption of an embryo though it often lacks the legal status of a post-natal child (OTA, 
1988, p. 224). 
 However, a number of states also have made attempts to clarify statutory 
confusion due to ART practice, ranging from establishing ownership or guardianship of 
embryos at insemination, creating legislation to determine the parentage of the child 
produced, and establishing the timetable for legitimacy in the case of inheritance (Moses, 
2006, p. 33). As such, many have argued that ARTs are not 'free' from regulation 
(Adamson, 2005). The counter argument to this point however has often been that since 
regulatory statutes and judicial rulings are not consistent across states, the industry 
remains effectively unregulated (Valverde, 2007; Moses, 2006). 
 These cases reveal the legal challenges posed by ARTs, as they render the prior 
regulatory structures irrelevant or unclear. The norms governing previous rulings have 
now been altered by the new possibilities in reproduction and parenting, as well as access 
to services (Moses, 2007). What is clear is that the consequences of using ART are much 
broader than just the positive or negative right to reproduce and the decisions made 
regarding them are likely to be far reaching. 
1.3 Policy, regulatory and other critiques 
 The issue with ARTs is not only that regulatory oversight is insufficient but also 
that there are a number of ethical, scientific, and social implications of these 
technologies. According to physicians and consumer groups for the infertile, ARTs 
provide a way to ease the suffering associated with the inability to produce children in the 
traditional manner (Adamson, 2005). Even further, these technologies provide new 
 
 20
avenues of research to cure diseases suffered by thousands of people every day, such as 
diabetes and Parkinson's, through cell-based therapies (NIH, 2009). However, the 
critiques of the use and management of these technologies also are significant. The U.S. 
policy development on this issue has been limited, resulting in a permissive regulatory 
structure in the industry. At the federal level, this manifests as a structure that is limited 
in both oversight and rule development (Bleiklie, et al., 2003). Even further, as discussed 
in section 2.4, much of the decision making power exists at the state and professional 
levels (Moses, 2005). This structure has been one of the targets of critique, given that it is 
relatively unique amongst the developed countries that utilize ARTs (Bleiklie, et al., 
2003). But regulatory structure is not the only source of critique of ARTs. There have 
also been questions on the scientific safety of these technologies, as well as their social 
impact. This section will briefly address some of the science critiques that question the 
safety of ARTs, and social critiques, which object to the use of ART for reasons beyond 
science. The final part of this section will address the regulatory critiques, or those 
critiques that propose means to address the problems pinpointed by these social and/or 
science critiques. 
1.3.1 The state of the law and legal structures in ARTs 
 Within the science of ARTs, there is a limited amount of questioning of the safety 
and outcomes of the technology as it is currently used. Often these critiques do not argue 
that use of IVF be banned, but often they do point out the problems with how it is applied 
and how well the implications are understood. The latter is often expressed in terms of 
the long and short term health impacts. For example, it has long been acknowledged that 
pregnancies achieved through ART show an increased risk of multiple births (Doyle, 
1996; CDC: Assisted Reproductive Technology, 2010) and ovarian hyperstimulation 
syndrome (OHSS) (Keith & Oleszczuk, 1999). There have also been indications that 
there is an increased risk of morbidity for both mother and resultant child through the 
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ART process (Grobstein, et al., 1983; CDC, 2010). A number of health complications for 
singleton children of ART have also been reported. For example, low birth weight has 
been reported for both singletons and multiples, and previous studies have linked it to a 
number of long term health issues for children conceived through ART (Omblet, et al., 
2006; McDonald, et al., 2009). The issues relating to health impacts on children 
conceived via ART appear to be confirmed through the CDC's ten year surveillance 
program of ART outcomes (CDC website, 2009). However, it has also been pointed out 
that the conditions suffered by IVF children cannot be conclusively linked to ART usage 
because of the possibility that the result may be due to the subfertility of the parents 
(McDonald, et al., 2009). 
 There are also the psychological aspects of ART to consider. Foremost is the 
indication of greater acceptance of risk by couples undergoing ART in order to reach 
their optimal number of children (Collopy, 2004). There have also been questions 
regarding the long term health, development and welfare of children produced from ART. 
Specific examples include the bonding process between parent and child when donor 
gametes are used for conception and the valuation of children due to the economic and 
physical costs associated with achieving conception (Little, et al., 2006). 
 Alternatively, even in light of the questions, it is also unfair to characterize the use 
of this technology as being without merit. Responses to some of the critiques include the 
argument that these technologies ameliorate some of the psychological suffering caused 
by infertility (Jordan, 1999; Schmidt, 2006), making it possible for non-traditional 
couples and individuals to build families (Liu, 2009), and create new avenues for 
research and disease treatment (citation). Moreover, it is pointed out that many of the 
early issues that plagued ARTs, such as high percentages of multiple births and low live-
birth success rates, have steadily decreased in prevalence as the technology has matured 
(Toner, 2002). Therefore, it is postulated that many of these issues will be resolved given 
time, without government intervention or oversight (Adamson, 2002). Even further, this 
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line of argumentation proposes that proposed solutions would in fact hamper the 
development of the technology (Gleicher, 2005; Moses, 2005). For example, the 
proposition to limit the number of embryos transferred, in order to minimize the 
occurrence of multiple births, (1) would be a one-size-fits-all solution for a problem that 
requires case-by-case evaluation; and (2) would increase the cost of treatment to achieve 
a single birth because it could increase the number of cycles involved (Little, et al., 
2006). 
1.3.2 Social/social science critiques 
 Regarding the social impacts of ART, beyond those impacted by current law, as 
discussed in this chapter there are also a number of ethical and sociological issues to be 
addressed regarding ARTs. For example, there are questions not only about the health of 
the mother and child during and after the procedure, but also about the impact of the 
technology itself on the valuation of these individuals in society (Schonfeld, 2003). It has 
been argued by a number of feminist writers that these technologies change the role of 
the woman from 'person' to 'womb', and this change in social norms thereby devalues the 
position of women in society that they have worked so hard to redefine (Kerian, 1997). 
This section will be split into three parts, and although some aspects of these parts 
overlap in discipline, the arguments presented are distinct. 
1.3.2.1 Sociological & Political Science Critiques of ARTs 
 Within the sociological scholarly community, ARTs have received a wealth of 
attention, particularly within the study of the sociology of medicine. Given the role of 
ARTs in changing social and physiological norms that have previously existed, as 
addressed in section 1.4 of this chapter, it is clear that there is a social component to the 
practice and outcomes of ART. Much of the motivation for this study stems from the 
arguments regarding 'medicalization' within this field. As defined by Peter Conrad, 
medicalization is the process through which a problem becomes defined by medical 
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terms, utilizes a medical frame for its understanding, or involves a medical intervening 
force for the purpose of 'correction' (Conrad, 1992). His definition provides one 
perspective from which to view the critiques that will be presented here. 
 Medicalization, particularly of childbirth and reproduction, has been a prominent 
lens through which critiques of ARTs have developed. A primary point of interest in this 
set of critiques is the development of 'involuntary childlessness', a socially constructed 
status expressing want, into 'infertility,' a disease or disability requiring treatment 
(Finkelstein, 1990). The medicalization process as a lens through which to view ARTs 
and their use has featured heavily in feminist critique, as will be addressed in section 
1.3.2c. However, more general medicalization critiques also play a role in the 
understanding of ART, such as Conrad and Leitner's examination of the role of  
'infertility as a disease' in the debate over insurance reimbursement, coverage and 
litigation regarding coverage (Conrad & Leitner, 2004). Even further, this critique 
extends into the effects of medicalization on people's decision-making, primarily it's role 
in their pursuit of some technologies, such as IVF or surrogacy (Richard, 1990). Overall, 
the medicalization critique focuses not only upon the role of medicine in defining 
expertise as it relates to concepts such as infertility, but also its role in the pursuit of 
certain treatments such as ARTs. 
 Another prominent point that has been made about ARTs is its creation of new 
families by expanding the option to reproduce not only to the 'biologically infertile', but 
also the 'socially infertile'. Groups included in this definition of socially infertile are those 
who could not reproduce due to choices regarding sexual and interpersonal relations and 
those who choose not to reproduce by traditional means, for example, because of 
lifestyles or potentially devastating genetic problems they would prefer not to risk 
passing onto their offspring (Shultz, 1990). While not objectionable on face value, these 
new reproductive options have often been pointed out to create new areas of concern 
because of the involvement of external partners such as surrogates and gamete donors. 
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This has not only complicated previous legal understandings of parenthood, as addressed 
in section 1.2.4, but also the cognitive and social perceptions of 'parenthood', 'family', and 
the fundamental understanding of relationships (Robertson, 1996). Therefore, the division 
of previously indivisible 'stages' of parenthood (genetic, gestational, and social), has 
created a loss of information for both the individual and society as a whole that has not 
been successfully reacquired. 
 The additional sociological considerations on ARTs to be addressed in this paper 
fall within the following two categories of ethical critiques and feminist critiques. While 
it is acknowledged that this current outline only touches upon a fraction of the critiques 
associated with ARTs, it was determined that these were of the most importance to this 
study. Other critiques, such as the impacts of social construction on non-traditional 
couple access, while important in the larger study of ART, are not among the subjects of 
interest in this study. 
1.3.2.2 Ethical Critiques of ARTs 
 By far the largest body of critique and support for ARTs appears in the ethics 
literature. A number of ethical arguments have been made in favor of minimal 
government intervention in ART practice, based upon the implications of these 
technologies for the well-being of both biologically and socially infertile couples (Shultz, 
1990) as well as the protection of procreative liberty (Robertson, 1996). However, others 
have pointed out important countervailing ethical considerations, including the rights of 
the embryo and the resultant child (Clements, 2009), how well informed the party 
undergoing the procedure is with respect to the risks and long term implications 
(Grobman, et al., 2001), and the utilization of multifetal reduction to address the transfer 
of multiple embryos (Coleman & DeBuono, 1999).  Further considerations involve the 
right of children to know the means of their conception and, if necessary, access their 
genetic information. The former issue of understanding the means of one's conception, in 
 
 25
part conflicts with the rights of the parents' privacy regarding their own reproductive 
choices (Robertson, 2004). However, it also relates to the argument in favor of the 
collection of longitudinal health data on children conceived by IVF, which has been 
suggested as a means to gain a better understanding of the potential health and health 
policy issues that may arise due to IVF (Fastoulis, 1999). 
 Beyond the ethical implications related to the embryo however, are the issues 
related to social pressures upon couples to have a child, thereby forcing a less than 
optimal choice selection, and the implications of the reduced risk perception and 
increased risk discounting of infertile couples (Collopy, 2004). While it has often been 
noted that physicians have guidelines relating to the provision of clear information to the 
prospective patients, it has often been suggested that ARTs, like experimental techniques, 
should require informed consent. In part, this has been argued for the reasons related to 
their perception of risk, and the social pressures associated with their 'infertile status' 
(Schmidt, 2006). However, there has also been the suggestion that the implementation of 
informed consent or some similar documentation would assure the prevention of self-
interested parties taking advantage of parties for the purpose of gain, be it the physician 
of a couple for the purpose of financial gain or the couple of a surrogate for the social 
gain (Houmard & Seifer, 1999). 
 Overall, it can be seen that ARTs are not without a number of ethical 
considerations, not all of which are easily handled by policy. However, as it pertains to 
our study, the existence of these ethical conflicts provides some insight into the diversity 
of frames potentially held by the public. It is also important to note that this is not an 
exhaustive list of all ethical considerations related to ART use or research, but those that 
relate most closely to our study's interest in public values regarding the clinical 
application of ARTs. Other tangential considerations not mentioned above include those 
risks and incentives of surrogates and gamete donors, particularly egg donors, because of 
the invasiveness of the techniques involved in creating and maintaining pregnancy 
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through IVF, as well as what incentives are created by allowing for compensation in 
these cases. 
1.3.2.3 Feminist Critiques of ARTs 
 A number of critiques of ARTs exist under the general umbrella of 'feminism'. 
Some of these critiques oppose the use of ARTs, based on previous power relations both 
within and outside the medical establishment, as well as the psycho-social implications 
(Ettore, 2000). These studies often take the form of historical analyses of the 
medicalization of childbirth or critiques of the patient-doctor relationship, in which one 
party is dependent upon the other due to perceived expertise (Birenbaum-Carmeli, 2003). 
Other critiques focus on the potential consequences for women within society because 
gestation still remains an aspect of reproduction in which the burden falls upon the 
woman. This critique often focuses upon the potential for exploitation and 
commoditization of women as 'incubators' (Kerian, 1997). Alternatively, critiques have 
also focused upon the likelihood of women bearing most of the burden of ART 
procedures in the short and long term, through things like hormone injections to increase 
the likelihood of implantation, the impact of gestation, and other unknown, long-term 
implications (Luke, et al., 2007). However, additional feminist arguments advocate for 
use of the technology, as well as expansion of access, since they create the ability of 
women to procreate independent of men, thereby providing yet another form of 
procreative freedom for women. Even further, some arguments also cite the psychosocial 
impact of infertility upon women, not from the perspective of medicalization or social 
pressures surrounding childlessness, but instead from a perspective of procreative 
freedom. While the arguments both for and against the use of this technology are 
expansive, it is more important to acknowledge the existence of the debate than to 
expound upon the specific arguments at this point. Some of these arguments are 
addressed within the case studies, as they pertain to the frame analysis. 
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1.3.3 Regulatory/Policy proposed alternative approaches 
 The focus of this paper is both the critiques presented above and also the lack of 
oversight and regulation found within the policy arena, the latter of which has often been 
the motivation behind a number of the critiques above. A number of regulatory 
suggestions have been proposed to solve the issues addressed by the critiques listed 
above. Some minimal regulatory or oversight frameworks have been proposed in the U.S. 
to date, such as those proposed in the EAB report of 1979, the OTA report of 1988, and 
the PCB report of 2004 (EAB, 1979, p. 104-108; OTA, 1988, p. 15-31; PCB, 2004, 
p.183-204). There have also been a number of scholarly regulatory frameworks proposed, 
many of which overlap with those of the official reports. The primary reason for the 
interest in these proposed regulative approaches is that they represent alternative lenses 
through which ART policy frames may be constructed. In this section, the regulatory and 
oversight approaches proposed in formal reports will be addressed first, followed by 
those covered in the scholarly literature. 
 When EAB first confirmed the ethical acceptability of ARTs in 1979, specifically 
IVF, they included a number of caveats and suggestions for potential oversight regarding 
ARTs, largely because ARTs involved a number of health risks and other unknowns. One 
point that they emphasized in their summary was that their approval was based upon the 
argument that the use of IVF was “defensible but...legitimately controverted” (p. 100). In 
effect, they established that, while it would be ethically acceptable to move forward with 
additional IVF research, the ethical arguments against it were neither unfounded nor 
unwarranted. They advocated for additional animal model research to improve efficacy 
and provide better data about the risks (p. 104). They also concluded that research 
involving humans would be ethically acceptable given a number of caveats, as addressed 
in footnote 1 of section 1.2.1 (p. 106) and that support by HEW would be ethically 
acceptable within the bounds of those caveats of research involving humans, though they 
specifically did not address whether this should include federal funding of such research 
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(p. 108). They also concluded that additional data should be collected by multiple 
organizations, including the National Institute of Child Health and Human Development 
(NICHHD), in conjunction with private and international organizations (p. 112), and that 
the establishment of a 'uniform or model law' should be created for the purpose of further 
clarifying the legal status of children born of ARTs (p. 113).  
 Following from this, given that the EAB was not renewed in 1980, the OTA 
became the primary body for assessment of ARTs. They produced a report focusing 
specifically upon the ethics and policy options related to the use of ARTs in 1988 (OTA, 
1988). They also produced two reports related to AID and the implications of new 
biomedical technologies on 'rights' around the same time, which provided further context 
for how politically salient biomedical technologies had become. The issues that they 
identified in their 1988 report, were as follows: (1) the right to reproduce, (2) the moral 
status of the embryo, (3) the bonding between parent and child, (4) research involving 
patients, (5) the confidential aspects of ART use and the extent of 'truth-telling', and (6) 
inter-generational responsibility (p. 11). The report touched on many aspects of ARTs, 
including feminist and religious perspectives on ARTs, the legal perspectives associated 
with it at the time, how it was addressed with regards to federally provided benefits, such 
as veterans benefits, and how other countries have addressed issues with ARTs. Their 
conclusions with regard to policy options for ARTs, particularly which aspects of ART 
were open for congressional action, were data collection on reproductive health, research 
on preventing infertility, consumer information and awareness, consumer access, veteran 
reproductive health, gamete and embryo transfer, recordkeeping, surrogacy, and research 
(p. 15). They further elaborated that there was interest for the federal government in each 
of these areas, including7:  
1. extension of federal bills to enhance education regarding reproductive health, 
                                                 




2. enacting comprehensive and less localized, longitudinal studies related to ART 
use, 
3. expansion of healthcare benefits provided by the federal government to include 
ART procedures, 
4. institution of national standards for gamete donation, and 
5. expansion of infertility research. 
While the list presented here is not a comprehensive list of considerations, the 
overarching story found in these recommendations is that a number of regulatory and 
oversight policy options were proposed in response to the issues posed by ART use. 
 The final major report regarding ART use is that of the PCB, which was released 
in 2004. They also identified a number of ethical issues to be addressed, including more 
common considerations such as the implications for potential biological intervention into 
human procreation and the impacts upon the participants of the procedure, as well as 
more tangential issues for our study such as disposal, and research on and post-
production use of embryos (p. 36). More important than the ethical issues presented in 
this report, are the direct and indirect ways through which ART were outlined to be 
regulated by government, in which direct forms of governance include physician 
licensing for ART procedure performance and location and indirect forms of governance 
including Investigational New Drugs (IND) restrictions by the FDA at this point in time. 
Moreover, even with the expansive list of federal, state and non-governmental regulations 
in place, it was determined that the 'patchwork' regulatory system was inadequate to 
properly provide sufficient protections for those involved (p. 78). Several policy options 
were provided, both as alternatives to or augmentations of the current system (Part II, p. 
181). Some of these included the creation of a new regulatory agency, additional 
legislative action and increased monitoring (p. 186, 189, 194). However, this report also 
recognized the increased costs associated with both its institutional and substantive policy 
options, as well as uncertainty regarding the implications and decreasing incentives to 
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alter the current structure (p. 183). With regard to recommendations, the council offered 
three broad recommendations8: Increased federal data collection, reporting, and 
monitoring regarding use and effects (p. 208), increased oversight by professionals and 
professional societies (p. 215), and additional, targeted legislation (p. 218). 
 A number of scholars have also raised additional important regulatory 
considerations, going beyond these expansive reports. While many of them have mainly 
emphasized the need for additional oversight (Grobstein, et al. 1983; Cohen, 1997; Islat, 
1998), some have also questioned the proposed means of regulation because they are 
insufficiently reinforced by current mechanisms, such as informed consent for patients 
(Cohen, 1997). What has also been pointed out is the emphasis within the current system 
on costs and benefits, which, while important, have largely overwhelmed other concerns 
(Andrews & Elster, 2000). 
 Therefore, the overall conclusion beyond those measures proposed by much of the 
larger reports and further emphasized by many of the scholarly publications is that, 
regardless of what regulation were to be put in place, a large barrier beyond the cost, 
which exists for most legislative action, is the breadth of concerns additional regulation 
would need to address. For example, informed consent would be expected to have 
minimal impact without additional data collection and publication. Even further, the 
conflict of social versus economic values is also a consideration which impacts the 
passage or consideration of new regulation. 
1.4 A Short History of Medicine and Reproductive Rights 
                                                 
8 The full list of recommendations and subheadings can be found in  of Appendix 1 
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 In order to flesh out the socio-political relationships of how the frames that are 
hypothesized to exist in the bills, it is necessary to provide some history on medicine9 in 
the United States, as well as reproductive medicine. Not only has this means of 
governance been suggested to play a role in the understanding of how these technologies 
may be governed and by who, it may have had some impact on the composition of 
interest groups and who is considered a legitimate participant in the development of 
policy. 
 In the US, the intertwining of the abortion debate and the ARTs debate have often 
resulted in them being cast as flip sides of the same coin. As such, the mobilization of 
resources and interest groups therefore is strongly impacted the development of the 
frames and therefore it is important to introduce how reproductive has been framed and 
how the actors have behaved. 
1.4.1 A General Overview of American Medicine 
 Medicine, in the modern U.S. context, has a unique history, with the institution of 
medicine emerging during the early twentieth century (Starr, 1982). The establishment of 
American medicine as an institution and the implications of it are important to this study; 
it will be argued that these were key in shaping the legislation related to ARTs practice. 
In order to contextualize this argument, a brief history of American medicine since the 
beginning of the 20th century will be the starting point of this analysis. Women's health 
and reproduction in America as a medical practice is a second important topic that will be 
                                                 
9
 As has been pointed out by numerous scholars, part of the reason that the regulatory structures in 
areas like assisted reproductive technologies differ so drastically from other developed countries is due to 




proceeded to. From there, a brief overview of the legal aspects of government 
intervention in the institution of medicine will be given. 
1.4.2 American medicine in the 20th century: A brief history of the development of 
the 'institution of medicine' in the U.S. 
 The present day system of medicine, with medical doctors occupying the 
organized and influential positions that they do today, is an artifact of the last century, 
rather than American history (Starr, 1982). In fact, according to Paul Starr, the 
development of the current system of medicine was more of the development of an 
institution rather than the development of medical practice (p. 8). Starr's analysis 
indicates that a key part of the American medical system is scientific and technological 
advancement (Starr, 1982 p. 10-12; Wilsford, 15). Moreover, standardization paired with 
a cultural shift towards health and a reliance upon the professional as an expert in the 
application of medical care (Starr, p.20; Wilsford, 1991, p. 8). 
 An early development in the history of 'modern medicine', was the increased 
standardization of the profession, and its connection with state licensure. Often argued as 
the key turning point in American medicine, the increased standardization of medicine 
created the ability for M.D.s to create barriers to entry to their field and effectively an 
economic monopoly upon the field of medicine (Starr, 1982, p.20). According to a 
centennial article on the founding and development of the American Medical Association 
(AMA), it was in 1905 that this organization created a 'Council on Medical Education', 
with a headquarters, for the specific purpose of providing oversight and a minimum 
standard of medical education (Fishbein, 1947). In 1906, state licensure boards began to 
require graduation from a medical school designated by the AMA as meeting minimum 
requirements (Walker, 1929). The establishment of being an entity responsible to a 
'greater good' than the market also provided not only justification for the market barriers, 
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but also provided an air of distinction to the profession that, in turn, increased its 
legitimacy and its authority (Starr, 1982, p.20). 
 Also important to the development of 'modern medicine', was the advancement of 
science. The advent of pharmaceuticals and devices to treat people's ailments allowed the 
medical profession to gain acceptance and legitimacy in two ways: (1) it allowed the 
profession to distinguish itself from competitors within the health market and (2) it 
provided further justification for monopolization of the market because of the increased 
complexity of information for the consumer (Starr, 1982, p. 24; Law & Kim, 2005).  
 Beyond the ground work laid in the 'early' history of medicine in the U.S. 
providing for physician professional dominance, later actions within medicine also 
contributed to the current politics of medicine in the U.S. The role of state and federal 
governments in the management of medicine is distinct in the U.S., with the state holding 
a majority of the power to regulate. However, early 20th century health related 
legislation, including the Federal Food, Drug and Cosmetic Act and the Federal 
Occupational Safety and Health Act, allowed for greater federal intervention. Both of 
these were enacted under the auspices of “commerce law" over which the federal 
government has jurisdiction (Starr, 1982, p. 51-54). An alternative example of health 
policy that was established in the 1960s are the Medicaid and Medicare programs, 
established under the Social Security Act. While Medicaid involves a joint effort between 
the state and federal governments both are examples of how the federal government is not 
absent in historical health policy-making. 
 The structural limits and domains of medical policy, coupled with early 20th 
century development of 'professionalization,' have resulted in particularly strong 
professional autonomy.  The organizational/structural changes that have occurred also 
have contributed a unique facet to the policy-making process, resulting in the 
development of a powerful interest group with regards to health-related policies. 
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1.4.3 American medicine in the 20th century: Reproduction in American Medicine 
1.4.3.1 Perceptions of Women and Medicine 
 Another important historical aspect of medical practice, particularly regarding the 
issue of ART, is the relationship between women and doctors. A number of perspectives 
have been generated about how the traditions of medicine have impacted the 
development of medical practice, particularly as it relates to women, womanhood, 
reproduction and childbearing. The early thoughts on female sexuality and evolution of 
medicalized child birth play an important role in the understanding of ARTs as well as 
the opposition to it (Strickler, 1992). The medicalization critique also plays a strong role 
in the discussion, particularly with regard to infertility and the female body overall. 
Relatedly, the pro-status quo ART argument hinges on the idea that childbirth and 
infertility are medical issues to be handled by medical professionals. The historical 
development of these arguments is key to understanding how 'medical autonomy' matters 
to the ART debate, and also bridges the gap between medical autonomy and reproductive 
rights. I argue that the disconnect between these two perspectives on the childbearing 
process is part of what hinders the development of ART policy. 
 The starting point of this argument is the mid-nineteenth century, which was the 
point in time that physicians began to exact more control over the medical market. 
According to Charlotte Borst, obstetrics as an area of specialty in medicine was initially 
plagued with licensing issues (Borst, 1992, p. 201), competition from midwives (Borst, 
1992, p. 207-208), and a general lack of respect from the wider physician community 
(Borst, 1992, p. 204). However, obstetrics did develop into a specialty, approximately 
around the 1930s (p. 201), after altering its focus from surgery to general practice. The 
impact of this was two-fold. First, it resulted in the expulsion of women-doctors from the 
practice, largely due to the thought that obstetrics was 'a man's work'. Second, it resulted 
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in a movement away from (and, at points, an elimination of) midwifery, which had 
previously dominated the area of childbearing (Borst, 1995, p. 118). In effect, women 
were largely removed from the act of childbirth, except as the patient. 
 The relationship between medicine and feminism also has a history dating back to 
the early 20th century. While some facets of this relationship will be addressed in the 
next section, it is important to at least preface it as a segment of the relationship between 
women and medicine. 
1.4.3.2 Issues in women's reproductive medicine in the U.S. 
 Regarding perceptions of reproductive medicine, the development of obstetrics as 
a 'well respected field' was a long journey. In the early years of its establishment in the 
U.S., obstetrics was still viewed as a 'surgical science' and it was not until its joining with 
the association of gynecologists and a shift from surgery to general practice as its base of 
knowledge that it established itself as a 'legitimate' specialty of medicine (Zetka, 2008). 
The development of reproductive medicine with respect to women has been an ongoing 
example of those 'with power' and those 'with less'. 
 The primary perspective through which the progress of 'reproductive medicine' 
can be seen is through the change in perspectives on (1) access to contraception and 
abortion, and (2) pregnancy. The latter has been addressed above, through the 
examination of the rise of obstetrics and the stances on women as both practitioners and 
as patients. The former can be seen through the movements to ban contraception access 
independent of a physician in the early 20th century (Lester & Blakely, 1918). With 
regard to abortion, it was distinguished from contraception early on (Lester & Blakely, 
1918; Ruppenthal, 1919). Whereas a number of states banned both equally, a few 
distinguished between abortion in the case of a pregnancy posing a threat to the life of the 
mother and other forms of contraception and abortion (Ruppenthal, 1919). With regard to 
statutes on birth control in Georgia and California, the two states selected for the case 
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studies of this paper, Georgia seemingly had no laws on the books regarding birth 
control.  In contrast, California had laws that made it illegal to distribute, sell, compose, 
publish, print, give or loan [an] 'obscene or indecent writing, paper or book', a concept 
which included literature on birth control (Ruppenthal, 1919). This was later revised to 
omit '“or any notice or advertisement for producing or facilitating miscarriage.”' (p. 53). 
1.4.4 American medicine in the 20th century: ART, the state and the State 
1.4.4.1 Federalism: the role of the State and the state in the management of medical 
practice 
 According to Wilsford's comparative analysis between the U.S. and France, a key 
part of the American medical institution's development was its relationship with the state 
(p.3). From this perspective, the 'statelessness' of the U.S., paired with many of its 
traditions, such as a strong sense of individuality and a commitment to the concept of 
pluralism, contributed to the development of a stronger medical institution in the U.S. 
than in France (p. 62-72). As Leyerle points out, the development of the American 
healthcare system and the medical institution that drives it was a structural process. As 
such, any changes to this institution would also have to be structural (1984, p. 7). 
Examples such as those given above (the establishment of rules regulating medical 
education, determination of alternative licensing structures (BMJ, 1891), and other forms 
of professional standardization), show the effectiveness of the structural development of  
medicine and its process. It also shows the role of the state in the establishment of these 
rules and the importance of state power in the development of medicine. 
 For example, early in the process of the establishment of medical professionals as 
the preeminent experts in the maintenance of health, it was state boards that demanded 
adherence to AMA standards and created licensing (BMJ, 1891; Fishbein, 1947) and that 
began administering licensing exams for the medical profession (Walker, 1929). Given 
that the general consensus is that the U.S. Constitution grants to the states the power to 
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manage and govern with respect to health issues and, therefore, medical practice, the 
federal government has little jurisdiction (Christoffel, 1982, p. 49). While it has managed 
to circumvent this through the application of law within areas in which it does hold 
jurisdiction (such as interstate commerce or funding through grants), the constitutionality 
of such applications has not always been clear (p. 52-55). The takeaway point from this, 
however, is the importance of structure in the development of medicine and its current 
management. 
1.4.4.2 Medical autonomy 
  A slightly less prominent but still salient issue in the ART debate is the issue of 
medical autonomy. While there is evidence to suggest that this autonomy from 
'government', particularly federal and other entities, may date back to early in the 
establishment of the medicine as an American institution, whether this is the case was 
first argued by authors using the professional dominance model in analysis of the field. 
Under this model, it was proposed that professionals (such as physicians) manage to exist 
autonomously through embedding members within bureaucracy, which allows them to 
maintain control over entry into their field and the appearance of specialized knowledge 
(Prechel & Gupman, 1995). However, it has also been argued that this autonomy has 
been slowly eroded away by new organizations within the field of healthcare and by the 
increased awareness and interest of patients in participating in their own care (Prechel & 
Gupman, 1995). 
1.4.5 Reproductive Rights and politics in the U.S. 
 The development of rights and law in the U.S. has been a critical part of the 
assisted reproductive technology debate. A large part of this could be argued to be 
culturally specific to the U.S., particularly the relationship between what have been 
termed 'reproductive' rights and the management of ART technologies. In addition to the 
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rights of the physicians to practice medicine unhindered, the role of reproductive rights 
also has weighed heavily in the ART policy arena. The ability of the infertile couple to 
exercise a negative right10 has been a compelling reason for a lack of policy intervention. 
However, the contention about whether this right should be extended to a 'positive right'11 
has been less clear. As a result, contractual and family law have also become deeply 
embroiled in this debate. The following section will provide the key institutions, 
landmark cases, timeline and major groups that have shaped the reproductive rights 
debate. 
1.4.6 A Brief History of Reproductive 'Rights' in the U.S. 
 First of all, it is necessary to establish what institutions are instrumental in 
enforcing and driving these rights--the courts. Rulings such as Roe v. Wade and Griswold 
v. Connecticut altered the previous structures regarding both childbirth and reproductive 
medicine (Starr, 1982, p.391). However, state legislatures have also been very formative 
in this debate. Moreover, the medical field has also contributed to the discussion, given 
its role as the 'experts' within this area.  Given the possible evidence of a decline in 
physician autonomy due to third party health organizations, it is important to 
acknowledge the role of insurance companies and managed healthcare organizations in 
the development of and access to the products involved in utilizing one's rights to make 
reproductive decisions. As such, the role of federal level administrative bodies such as 
the Federal Drug Administration (FDA) and National Institutes of Health (NIH) and other 
federal level health care bodies have also impacted the ability of individuals to exercise 
this right (Noah, 2004). 
                                                 
10
 The right by which the government is obligated to refrain from interfering in reproductive choices. 
11
 The right to government assistance in the pursuit of their goals. 
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 A key conceptual institution in this debate has been the U.S. Constitution. Often, 
it has been interpreted to guarantee individuals the right to decisional privacy--through 
the 14th Amendment prohibition on state deprivation of liberty without due process of 
law--of which the ability to reproduce without interference from the law and the state is 
an example (Havins, 1999). Alternatively, through the 14th Amendment, the right to 
reproduce can be constructed as a 'positive' right, at least with regard to insurance 
coverage. However, the application of this interpretation has been less widespread, as can 
be seen by the levels of access for infertility/fertility treatment across states and federal 
legislation regarding the application of federal dollars towards such treatments (Goggin 
& Orth, 2004, p.83-84). 
1.4.7 The relationship between reproductive rights, medical practice and ART 
management 
 Reproductive rights, early structural aspects of the development of the medical 
profession, and the structure of the healthcare system overall, have all played a role in the 
development of ART management. Given the monopoly on reproductive medicine 
derived from the rise of obstetrics in the early 20th century and the close relationship 
between the medical institution and science, the IVF developments in science during the 
1940s and 50s and its 1980s applications in medicine should be less than surprising. Even 
further, given the role of 'specialized knowledge' in the exclusivity of the profession, the 
monopoly of obstetrics on knowledge relating to reproduction has also been a key part of 
the development of the construction of 'involuntary childlessness' as 'infertility'. 
 The structural arrangements within the medical profession, particularly the 
arrangements of organizations related to specialties, the role of organizations such as the 
American College of Obstetrics and Gynecology (ACOG), ASRM and SART also have 
played a role in how ART policy management has developed. Beyond the simple 
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explanation of the 'power' of the medical institution itself, the role of the 'professional 
organization' in policy development directly ties back to social movement theory and the 
issue of the mobilization of bias. Given the creation of ASRM and SART in the 1980s, 
the development of alternative and oppositional movements could arguably be said to 
have been hindered in part by the fact that the rules of the 'game' had already been 
previously established and the bias towards the status quo institution within the arena, 
primarily the institution of medicine. While the organization and economic resources of 
ASRM and SART, as compared to other organizations such as right-to-life organizations 
(RTL) and feminist organizations, undoubtedly play a part in the successful creation of an 
oppositional movement in this area, the structural aspects of access to discourse and 
development of legitimacy in that discourse cannot be ignored. 
 The monopolization of the American medical institution on reproduction (and 
therefore the constructions of knowledge relating to reproduction), also may explain how 
this particular issue has been played out in the policy arena. The tie to previous 
reproductive rights issues clearly has also affected the development of the management of 
the technology, primarily with regard to (1) the legitimacy of some oppositional groups 
and (2) the ability to mobilize others. The former can be argued by examining some of 
the available hearings in Congress and the parties invited to testify. For example, in the 
case of  the hearing before the House Committee on Children, Youth and Families, the 
testimony consisted of three doctors and a representative from the office of pro-life 
activities of the National Conference of Catholic Bishops (Alternative Reproductive 
Technologies: Implications for Children and Families, 1987). The latter has been shown 
somewhat in previous literature, such as Bleiklie's comparative study and the existence of 
'fragmentation' within the action coalitions (2003). While there is less clear historical 
evidence of barriers to mobilization of groups, it provides a potentially interesting area 
for future research. 
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1.4.8 The defining cases & 'historical events' 
1.4.8.1 Medical autonomy 
 In the development of the ART policy arena, there have been particularly 
poignant cases that have been cited with regard to ART reproductive rights. The primary 
cases of interest have obviously been Roe v. Wade and Griswold v. Connecticut, which 
relate directly to the 'reproductive rights' ties to ART. The basic argument derived from 
Roe v. Wade has been the negative right to reproduction, as stated previously. Griswold v. 
Connecticut, on the other hand, preceded Roe v. Wade in establishing the guarantee of the 
U.S. Constitution to the right to privacy with regard to reproduction. Its landmark 
decision established the right of couples to access contraception and prevent the 
establishment of other laws that would infringe upon a couple's right to privacy relating 
to reproduction. Another often cited reproductive rights case is Skinner v. Oklahoma, 
which abolished the ability of the state to institute compulsory sterilization as part of 
criminal punishment. This case provides much of the groundwork for later barriers to 
state intervention in reproductive activities. 
 More recent examples of key ART legal rulings include the case of 'Baby M' and 
Davis v. Davis, which provided the framework for many states to enact statutes regarding 
surrogacy and custody/use of embryos in the event of circumstance changes since their 
development (Davis v. Davis, 842 S.W.2d 588 (1992); In re Baby M, 537 A.2d 1227, 109 
N.J. 396 (1988)). These cases have resulted in the breaking of new ground in the areas of 
both family law and property law, and have even forced some jurisdictions to establish 
the legal standing of embryos. While most of the recent rulings apply more at the state 
level than the national level, they still resonate nationally.  
 Overall, the legal system has played a significant role in the development of 
ARTs, creating additional structural constraints to a political system already bound by 
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other structural barriers built by other institutions. In fact, political structures as barriers 
to types of policy developments abound in this area, as evidenced by history. However, 
history does not show definitively whether there are in fact any constraints within the 
legislative policy process. 
1.5 Summary of research questions and orientations 
 The theoretical foundations of this study will include path dependency framework 
and social movement theory, both of which inform the proposed research questions. I 
propose that the policy process related to clinical ART practice, as detailed in the 
preceding sections, has taken the route that it has due to lock-in of policy frames. I 
believe that this lock-in is due not only to the fragmentation of political coalitions, but 
also the history of access in the policy arena and past precedent. Through historical and 
frame analyses, I believe it is possible to 'track' a set of widely used policy frames (held 
by those that benefit from power asymmetries) through proposed and successful policy, 
thereby providing evidence of path dependence of these frames. 
 This is of interest to and contributes to the wider scholarly community in two 
ways. For one, it could provide a means of empirically studying frames. For another, I 





UNDERLYING THEORIES AND FRAMEWORKS 
2.1 General Overview of the frameworks and theories 
  The nature of the debate surrounding this technology has often devolved into one 
of ethics, and therefore one that cannot be resolved through policy. And though a few 
authors have made inroads into the way in which policy has progressed on this topic, both 
in the U.S. and abroad, there are still gaps regarding the political dynamics that have 
contributed to the policy changes and lack thereof, particularly within the U.S. context. 
This study seeks to fill one of these gaps by understanding the nature of the policy 
change, particularly the relationship between this change and the frame of the problem. 
Key to this discussion of the ART policy dynamics is the concept of problem framing. 
While several authors, including Goggin and Orth (2004), Rothmayr and Varone (2002), 
and Montpetit, Rothmayr and Varone (2005) have been very informative in outlining the 
policy arena of ARTs from a comparative perspective, their analyses largely provided a 
potential framework, not an explanation of why policy has failed to be implemented, 
particularly in the U.S. context. This paper argues that problem frames are the drivers and 
maintainers of the current policy state found in the U.S. It is important to note that I am 
not arguing that problem framing and problem definition caused the policy state, only 
that given the political structure, they facilitate it’s maintenance in the current direction. 
 Again, a tangential focus of this study is also the directionality of the process, and 
by this I mean that it is 'path dependent'.12 It may explain why policy hasn't happen, 
presenting an effective 'non-event'. 
                                                 
12
 The concept of path dependency, in short, is that future decision making is severely constrained by 
past decisions. While it cannot be addressed in this study, the path dependence of this particular policy area 
could further shed light on the historical barriers to policy making in this area 
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 As mentioned throughout Chapter 1, little federal policy has been made in the 
U.S. regarding this technology, and it has been hypothesized that this is due in part to the 
social constructions of actors as well as the fragmentation of collective action coalitions 
(Bleiklie, et al., 2003, p. 101). Some work has been done on the role of power within the 
policymaking arena as it impacts the passage of policy, and this work’s acknowledgment 
of the fragmentation within the policy arena has furthered the insight into the power 
dynamics involved (Harris, 2010). 
 In this paper, however, the focus is not on power dynamics or the fragmentation 
found in actual or potential coalition groups, per se. Instead, the focus is on how 
problems are articulated through framing, which may in turn affect the ability of 
coalitions to form. Relying on previous work done on social construction and problem 
definition, I hope to utilize public documents, more specifically legislative bills, to 
exemplify consistency in framing (Verloo, 2004). 
 In this chapter, I will cover a small portion of social movement theory for the 
purpose of explaining how framing plays a role in policy making.  Additionally, the 
elements of policy framing will be discussed. 
2.2 Social Movement Theory 
 In trying to understand the means of both path dependence and problem definition 
in the problem of ARTs, it is also necessary to understand the role of social movements 
in creating change. Admittedly, a key aspect of this discussion, addressed by previous 
scholars looking at the ART arena through both discursive and collective action lenses, is 
that there is a great deal of fragmentation of oppositional collective action. This can be 
seen through Farquhar's examination of the ART discourse (1996) as well as in Bleiklie, 
et al.'s comparative study of ART policy (2003). However, the problem being addressed 
in this paper regarding ART is why NO policy change has been observed in this 
particular policy arena at the federal level, essentially a 'non-event'. This becomes a 
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question of whether the 'non-event' is a case of a problem not addressed or a non-
problem. My premise and this study assumes that there is a 'problem', and social 
movement theory provides some insight into how this could be. For one, the political 
perspectives of social movement theory provide insight into how politics can constrain or 
facilitate policy developments (Kiese, 2004, p. 66-90). It also provides insight into the 
structural aspects of mobilization of bias as a factor in how problems get placed upon the 
policy agenda. 
 Social movement theory's primary importance to this study is its justification of 
the selection of path dependence as the analytic framework. In the political science 
context of social movement theory, path dependence is somewhat justified. Two key 
points of the path dependence framework are the role of institutional density and political 
opacity, which have often been noted to be insufficiently explained. Social movement 
theory from a political perspective provides some insight into how the institutional 
density and opacity of politics may create an opportunity for some arenas to be 'path 
dependent'. 
2.2.1 Social Movements & Political Frames 
 The political 'context' of social movement theory, according to Blackwell's 
Handbook on Social Movement Theory, is based upon two important aspects: cultural 
model and institutional structure (p.69-79). It is this institutional structure that is the 
primary focus of this paper, with the cultural model aspect of political context being 
secondary, but both require some elaboration. The cultural model, as outlined by Kiese, is 
one in which stable cultural artifacts are of primary importance (p. 72). Kiese points out 
that it is the cultural institutions that affect the ability of actors to decide to act 
collectively (p.70-71). Of particular interest is Koopmans and Stathams' discursive 
opportunity, as presented by Kiese (p.72). As elaborated by him, the ability of groups to 
create discourse on their issue and create symbolic legitimacy is very important to 
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successfully mobilize groups within a movement. The ability to create this discursive 
legitimacy, however, is dependent also upon the structural strategies of political actors for 
'dealing with challengers' commonly present in the political system (p.71). This cultural 
model can provide a great deal of insight into the constraints of ART policy making from 
a mobilization and message standpoint, particularly with regard to how 'legitimate' parties 
appear to be. It also has potential in the study of two facets of the debate: (1) 'legitimacy' 
of access and input on Congressional decision-making, such as who testifies before 
Congress or gets placed on commissions for the purpose of investigations, and (2) the 
effects of a fragmented oppositional group on the policy process. As will be addressed in 
the next section, resource mobilization also plays a role in how cultural models play out. 
 The second part of the political context framework is the institutional structures 
aspect. From this perspective, it is argued that the institutional structure strongly 
influences how the policy arena develops. As explained by Kiese, the openness of a 
policy making body can both constrain and facilitate actors from participating. As he 
outlined in his chapter of Blackwell's Handbook on Social Movements, in conjunction 
with cultural models, “opportunity sets” can be developed (p. 72). The institutional 
structure aspect of policy making, as applied here, is derived from historical 
institutionalism, i.e. the perspective that historical actions influence future actions and 
decisions. To summarize, Thelen points out that historical institutionalism looks at the 
development of institutions as a product of process as compared to the rationalist 
perspective of coordinated functions (1999). From this perspective, feedback and 
historical incidences become greater in importance because they determine future 
interactions and 'structures'. However, in this study, the examination is not of the effects 
of a 'social movement' but instead on the inability to generate such a movement. Meyer 
argues that the political context approach is derived from the concept that 'grievances' are 
not chosen “out of a vacuum”, but are the result of political structure (2004). This 
continues along the same lines as the historic constructionists, insisting that 'context' (or 
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'history') matters. His argument continues along the lines of rebutting the common 
critique of political process theory, by arguing that agency can only be understood within 
the confines of the “rules of the games” (2004, p. 128). 
 Nonetheless, political context authors are addressing the mobilization of 
movements, whereas in this study it is the limitedness of mobilization that is of interest. 
Utilizing the 'opportunity sets' expressed by Koopmans and Statham, provides more 
insight (1999). Their model of 'discursive opportunities' and 'institutional opportunities' 
as interacting measures of the ability to mobilize and 'gain legitimacy', shows the 
interaction between discourse, institutions, and political opportunity from a 'non-event' 
standpoint. Their model provides four options for movement outcomes: full response, co-
optation, preemption, and marginalization (p. 248), in which preemption, co-optation and 
marginalization all could represent possible examples of 'non-events'. The selection of 
which, however, cannot be explained fully by the political context theory, but in 
Figure 4: The model of political context, from social movement theory (Kriesi, 2004). 
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conjunction with mobilization of bias. Figure 4, above, shows the political context model 
as designed by Kiese. The portion of the model that is of most interest to this study is the 
structures aspect, which is labeled as segment 1 of the diagram. Within this, I am 
interested in the political institutions and cultural models. 
2.2.2 Social Movements & Mobilization of Bias 
 From the perspectives of power and the policy process, resource mobilization 
from social movement theory also plays a part. While the political structures and process 
are integral to this story, the differential impact of being able to properly mobilize 
resources and 'people' for a particular cause could potentially impact both part 2 and part 
3 of the political context model above. With consideration of the Koopmans and Statham 
model of political opportunity sets, mobilization of bias strengthens the argument for a 
path dependent framework as well, given that their argument essentially defines the 
conditions under which groups become marginalized. Mobilization of bias explains the 
continued lock-in of marginalization in the policy cycle. 
 From a social movements perspective, mobilization of bias derives from EE 
Schattschneider's 1975 seminal work on biases in political movements (Strolovitch, 
2006). Beyond just the immediate implications of his terming 'mobilization of bias' as an 
important concept of the political system, his work has also been used to explain the 
importance of symbols in social movements (Strolovitch, 2006; Cobb, 1998). His work 
has also inspired the development of several theoretical perspectives, including problem 
definition and problem framing, which this paper draws heavily upon. 
 Beyond Schettshneider, however, is the concept that mobilization of bias 
embodies the importance of power in the discourse on policy and policy action (Bachrach 
& Baratz,1963). From the perspective of Bachrach and Baratz, this power distribution as 
the target of research is not based on a 'ruler' model nor a question of whether 'anyone' 
has power, but instead on how the structure provides for actions and who gains or loses 
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due to that structure (1963). From there, status quo bias could be analyzed and only from 
that point could an analysis of participation occur (p. 952). 
2.2.3 Social Movement & ART policy arena development 
 While the question of this paper relates to the 'frames' of policy and how these 
frames affect policy making, social movement theory provides a great deal of explanation 
as to why context is necessary. It has been argued that fragmentation of coalitions and 
power have played significant parts in the development of the ART policy arena 
(Bleiklie, et al., 2003; Harris, 2010). The role that fragmentation and power play in the 
greater policy arena has not been clearly expressed, however. Social movement theory 
provides insight into not only what role fragmentation of oppositional groups plays in the 
development of policy, but also how this fragmentation may be utilized so as to maintain 
a particular policy-making process/arena. The political context of social movement 
theory provides the explanation that structures and history are important, and that politics 
is not just a matter of resources or the ability to mobilize, but must be understood within 
the confines of the rules of the political game in which resources or the ability to mobilize 
are brought to bear. Similarly, the mobilization of bias aspect of social movement theory 
provides an explanation of the role of power and particularly the role of symbols and 
discourse in the management of power. Even further, both of these facets of social 
movement theory tie directly in with the chosen approach: policy frame analysis. 
2.3 Social Constructions, Problem definitions and Policy Frames 
2.3.1 Social Constructions, Problem definitions and Policy Frames 
 Social construction of actors also informs the structure of path dependency, by 
delineating potential group interactions. More specifically, it provides a means of 
understanding and organizing the power relations that are played out through the 
implementation of policy. In the case of ARTs regulation, the social construction 
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framework acts as the object that is being passed down through the path, in the form of a 
policy frame. Helen Ingram, Anne Schneider and Peter DeLeon offer six propositions 
that characterize how policy design and process interact with social values (Ingram, et al., 
2007, p.98-112). The propositions of Schneider, Ingram and DeLeon are as follows: (1) 
policy designs determine who can participate in the policy making process through 
explicit and implicit means, (2) power determines the distribution of benefits and burdens 
to target groups, in a given policy, (3) policy designs differ according to the social 
construction of the target group, (4) social constructions created by policymakers are 
largely dependent upon 'approval or approbation', (5) the shape and structure of public 
policy is a potent, but not the only force for the change of social construction of given 
target groups, and (6) the context of policy design matters when predicting policy change 
(Ingram, et al., 2007, p.98-112). Application of these propositions reveals how social 
values and constructs can become important to future decision-making. In effect, the 
group social construction within a policy and the values of a society or a subset of the 
society interplay through policy feedback loops, as a result of the perceived success of 
previous policy outputs containing those social constructions (p. 112-113).  
 Social construction has been argued and understood to play a central role in the 
ARTs policy arena for a significant amount of time. (Bleiklie, et al., 2003) Although a 
number of social constructions have been argued to be in play, it has not been clearly 
documented how these social constructions may exist in policy or what role they play in 
the policy process. This study is interested in whether early policies can determine the 
outcomes of later policy debates and, therefore, later policy. The social construction 
framework allows this to be measured by focusing on the lock-in mechanism. The social 
constructions of traditional target groups would be expected to be found within 
successfully passed legislation and the social constructions of alternative target groups 
would be expected to be found in less successfully passed legislation. In the frames, 
found in Appendix C, the proposed social constructions of actors can be seen, in 
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conjunction with the proposed relationship they are hypothesized to have within each 
frame. 
2.3.2 Problem definition & Problem Frames 
 One of the problems often attributed to path dependency theory is its inability to 
explain how lock-in occurs. In this study, it will be argued that this is primarily through 
problem definition and problem framing. David Rochefort and Roger Cobb describe a 
number of different ways of defining a problem, such as the social construction of 
conditions, referred to as the 'social construction of reality' (1994, p. 5-6). Problem 
definition can also affect what are 'valid issues' and whether those issues reach the agenda 
in order to be considered (1994, p. 8). On a more basic level, even the understandings 
within society can have an innate problem definition that can color how problems are 
realized (1994, p. 7). Additionally, problem definition is largely a product of discourse 
and rhetoric; in effect, the definition of a problem depends on how it was explained, what 
'facts' are presented, and the relationship that is presented between ideas (1994, p. 9). 
Thus, discourse is imperative in understanding how problem definition affects many 
problems. 
 With regard to path dependency policy, problem definition not only adds to the 
complexity and ambiguity of political arenas mentioned by Pierson, but also heavily 
affects power asymmetries. This interplay among these four concepts of problem 
definition, social construction, policy frames and political structures can thereby be 
expected to create path dependency in policy-making, by virtue of limiting (1) agenda 
access and (2) political arena access, thereby restricting the recognition of potential 
problems and/or solutions. The theoretical perspectives of political context aspects of 
social movement theory and the mobilization of bias, introduce an alternative way of 
thinking about the impact that the introduction of ARTs has had and will be expected to 
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have, specifically, how pre-existing cultural and political structures can constrain future 
policy development. 
 As compared to problem definition, policy frame analysis has slightly more 
substance with regard to operationalization. Frame analysis has its origins in several 
areas. For one, it derives heavily from the frame concepts of social movement theory, 
such as collective action frames (Snow & Benford, 2000; Diani, 1996; Williams, et al., 
2001). It also has connections to public opinion frames (Druckman, 2001). There are also 
connections to discourse analysis. In this context, I have chosen to look at the policy and 
the frames contained within the policy rather than the frames that create movement 
through groups and public opinion. The key difference between policy frame and 
problem definition lies in Snow's paraphrased interpretation of Goffman, in which he 
defines it as a '”schemata of interpretation that enable individuals to locate, perceive, 
identify and label occurrences within their life space and world at large” (1986, p. 464). It 
contains a 'diagnosis' and a 'prognosis' according to Lombardo and Meier (2006). This 
study, while adhering to the general aspects of the Multiple Meanings of Gender Equality 
(MAGEEQ) frame analysis, will use the terms ‘problem definition’ and ‘solution 
definition’ to define the diagnosis and prognosis aspects of the frame (Lombardo & 
Meier, 2006). 
2.3.3 Understanding problem definition and policy frames in the context of ARTs 
 From a discursive perspective, there has been a great deal of controversy 
regarding how ARTs are discussed. The divisions between people in support of freedom 
in ART practice, those in favor of a complete ban and even those in favor of allowance 
but stronger rules are divided often by 'fuzzy' lines. Dion Farquhar, in her book The Other 
Machine, clearly parsed out the main divisions often seen within the realm of ARTs 
(1996). As she points out, the oppositional groups face more than one issue in 
formulating their position, including the fact that they might share an interest in the same 
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outcome as another group in support of a ban on ART, but their underlying reasons 
differ. However, she provides a clear framework from which to work in understanding 
and developing 'frames' through which to examine ART policies. 
 There appears to be very little previous frame analysis regarding ARTs, 
particularly with regard to policy frames and in the U.S. political context. Our approach 
to understanding the policy arena of ART is exploratory and unproven, but not 
unfounded. Given the wealth of literature on perspectives on ART, from 'pro', 'anti' and 
'stringent' directions, it is believed that policy frames not only can be developed for ART, 
but that these frames can provide some insight into stability in the ART policy process. 
2.4 The map for here on out 
 As stated earlier, this study seeks to assess (1) what current policy frames are 
articulated in the legislation produced relating to the clinical use and practice of ARTs 
and (2) how alternative policy frames are treated in the case of legislative passage. In the 
next chapter, the methods will be addressed. It is hoped that these methods will add 
something to the theory of framing. The fourth chapter is the frame analysis of 
legislation, which will act as the core of this study and the means of supporting the 
proposed hypotheses, also to be found within Chapter 3. Finally, the fifth chapter will 
contain the conclusions drawn from the fourth chapter, as well as address the theoretical 





3.1 Study data and research questions 
 While it is acknowledged that a huge part of the ART debate is based upon ethics, 
it is possible to understand the lack of policy change through policy theory, and 
specifically policy analysis. Though it may not be possible to resolve the debate with 
policy, it is possible to better understand the dynamics of the specific arena and how 
these dynamics appear to cause policy inaction. As alluded to in Chapter 1, I propose that 
key aspects of legislative policy movement are dependent upon the frames applied to the 
issue rather than the distributions of power or institutional arrangements alone. While a 
key underlying aspect of these frames may be derived from the values that stakeholders 
hold, I have chosen to examine policy change or lack thereof as explained from the 
perspective of problem definitions and frames. 
 In trying to understand ART policy in the US, not many pieces of legislation 
pertaining to ART are available. FCSRCA and its related policy statements are the 
primary piece of successful legislation at the federal level. In addition there are a few 
scattered pieces of successful legislation that exist at the state level. Given that this 
particular policy problem is very 'ill-structured' from a policy analysis perspective, the 
analysis in this paper shall be three-fold (Dunn, 2008). The first step was performed in 
Chapter 1, in which the different problems being 'perceived' by 'stakeholders' were 
defined through an abbreviated historical analysis, for the purpose of providing 
perspective on the stakeholders and context of the problems. The second step is the 
classification analysis, for the purpose of delineating the perceived groups of common 
problem definition. These two analyses (historical and classification analysis) are 
expected to provide the necessary frames for the third analysis, which will be a frame 
analysis of policies. 
 
 55
 Therefore, historical analysis will be used to provide the 'backdrop' and context of 
the technologies within the political system, as well as to contextualize the origins of 
those frames that are proposed to exist. It will provide some insight into how 'key' 
stakeholders and all other stakeholders are recognized in this particular problem arena. 
This historical analysis will also heavily shape the understanding of the second and third 
segments of the policy context model presented in Chapter 2, figure 4.  
 Classification analysis and frame analysis were used to develop the applicable 
frames and analyze the frame differences between successfully and unsuccessfully passed 
legislation, respectively. For the purpose of the classification analysis, the three main 
reports on the status and use of ARTs were utilized, supplemented by samples of 
scholarly literature. As classification analysis is dependent upon logical consistency in 
order to assess its performance, Dunn outlined five rules to increase the probability of 
meeting that criterion: (1) substantive relevance, (2) exhaustiveness, (3) disjointedness, 
(4) consistency, and (5) hierarchical distinctiveness (Dunn, p. 99-100). Hence, this study 
uses documents that appear to have fully structured the 'problem' of ARTs (the reports), 
along with supplementary documents to satisfy the exhaustiveness requirement. The 
purpose of using classification analysis as opposed to other problem structuring 
methodologies that may reduce the potential for 'solving the wrong problem', is because 
of the lack of clarity of what the 'problem' with ARTs is. As alluded to with the question 
this study is based on, it may be the result of different constructions of what constitutes a 
problem. 
 For the frame analysis, legislation from the federal level and two state level 
congressional bodies were collected for the purpose of coding for policy frames by 
distilling the actors from each piece of legislation and comparing these actors and the 
narrative associated with them, to the idealized frames created through the literature and 
the classification analysis.  The means through which these actors will be distilled is a 
three part process of (1) obtaining a word count, (2) distilling the actors from this word 
 
 56
count, and (3) re-matching the actors within their portion of the narrative of each bill. The 
purpose in performing this action is to (1) separate out the actual wording used to 
describe actors in legislation, as opposed to assuming that the idealized terms are used; 
and (2) to get an idea of what words appear to be a central feature of bills the state and 
federal levels of government bills, overall. 
 The historical analysis is key to my argument. First, the structure of the U.S. 
governmental system is an important aspect of why ARTs are managed in the way that 
they are. The federalist structure in conjunction with the separation of power divides the 
arenas of access and increases the political complexity and opacity of ART policy 
problems. While it has been argued that this structure facilitates the ability of groups to 
access power, by providing multiple arenas of access, it could also be argued that this 
split in arenas increases the probability of fragmentation of oppositional groups because 
the means of altering policy are so varied. While this paper does not aim to argue that 
point, it is hoped that the historical analysis will provide some insight into how the US 
political system may structurally provide for certain outcomes over others. 
 Stemming from separation of powers, federalism and bounded rationality is the 
following argument: Policy arenas in which the primary frames are heavily influenced by 
federalism and the separation of powers tend to be path dependent in their management. 
Therefore, the management of the ART policy arena, given that it is heavily influenced 
by both 'reproductive rights' and 'medical practice' arguments, should be path dependent. 
The hypotheses are therefore as follows: 
H1: Legislative action is dependent upon the frame of the policy problem and the policy 
solution  
H1a: legislative action will be unsuccessful when the diagnostic aspect of the policy 
frame targets benefits to a group outside of the “traditional ART frame” 
H1b: Legislative action will be unsuccessful when the solution definition of the policy 
frame targets burdens to a group inside the “traditional ART frame” via an outside agent 
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H1c: Legislative action will be successful when the prognostic aspect of the policy frame 
targets agency to a group inside the “open ART frame” 
and 
H2: Early problem definitions created a path dependence of policy management in the 
ART policy arena by association of dominant frames with 'reproductive rights' and 
'medical autonomy' 
3.2 Data Collection 
 In this study, all federal level bills from 1989 onward associated with IVF were 
collected from THOMAS, a federal database containing congressional documents, 
hearings and public laws. Associated revisions were also collected. The primary method 
of determining appropriate word searches was to utilize Congressional subject terms 
listed with FCSRCA. Additional search terms were developed from the 'keywords' of a 
diverse number of scholarly writings on ART, including subject words from Fertility and 
Sterility, the main publication of ASRM. While the sample of bills may be biased slightly 
towards a 'pro-ART' frame, much of the literature on ARTs seems to indicate that a 
common set of terms largely seems to be understood to apply to their use. Nonetheless, 
this is acknowledged to be a potential weakness in this bill search technique. The reason 
for the selection of 1989 as the start year although ART practice in the US had begun in 
1982 is that THOMAS only lists full texts of bills from 1989 onward online, and due to 
time and financial constraints, it was not possible to access bills from the central 
depository, for the purpose of collecting bills proposed prior to 1989, for the purpose of 
analysis. 
 Data was also collected at the state level, limited to two state cases. The state of 
Georgia was selected because legislation was recently introduced that would have 
managed ART clinical use and practice in the form of State Bill 169. The second case 
selected was the state of California, in part because it was the location of the most recent 
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controversy related to ART, 'octomom'. This selection was also due in part to the fact that 
it is one of the few states in the U.S. having several pieces of active legislation directly 
relating to the use and availability of ARTs (NCSL, 2011). The search terms used for 
collected bills were the same as those used at the federal level, in order to maintain 
consistency over the two cases for later comparison. As with the sample of federal bills, it 
is acknowledged that this selection has the potential to bias the outcome of the bill search. 
 Of the bills collected, not all were utilized because of the narrowness of the topic, 
focusing on the management of clinical use and implementation of ARTs. While I 
acknowledge that legislation regulating and monitoring IVF research laboratory 
techniques and practices is not inherently independent of legislation attempting to 
regulate and monitor clinical IVF practice, I have attempted to limit the examination of 
bills to those that specifically address the medical/clinical practice of ARTs. Therefore, 
any bills that applied specifically to laboratory research protocols and IVF were discarded 
as they could not be coded within the frames constructed. 
 A minor part of the data collected was information regarding hearings for a 
selection of the bills. The primary purpose of collecting this information was to determine 
the more obvious actors that participated in developing the views related to the policy 
arena. This was primarily done at the federal level, because these hearings were the most 
easily accessible. Also for the historical analysis portion of this project, historical 
writings were used as the primary source of information. Secondary sources, such as 
scholarly works on the history of medicine and medical policy in the U.S. were also 
relied upon to build the story of how the history of medical autonomy and 'reproductive 
rights' influenced the development of frames and perspectives in the debate. 
 The classification analysis was based on logical divisions as informed primarily 
by the three large government reports created on IVF and other related technologies. This 
was supplemented by scholarly articles in discourse analysis, which has done some work 
on the division of different stakeholder groups in the ART arena; published medical 
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opinions; feminist critiques; religious critiques; legal writings; and other secular critiques. 
While this is acknowledged to have its limitations, particularly with respect to whether it 
successfully addresses the 'right question', per Dunn, it was believed that the main issue 
to be addressed before any analysis of frames in policy, was a 'clarification of concepts', 
which does not appear to have occurred in previous policy analyses of ART issues 
(Dunn, 2008, p. 96). 
3.3 Summary of Sources 
 In total, 105 bills were collected. At the federal level, this included 52 bills of 
which 44 failed to be passed and one was passed into law. Originally, 52 bills had been 
collected at the federal level, but due to the use of the computer-assisted qualitative data 
analysis software (CAQDAS), NVivo (QSR, International, 2009), it was not possible to 
import all of the bills into the program, therefore the eight federal bills that were not 
imported were not used. At the state of California level, there were 43 bills collected, of 
which 18 failed to be passed. At the state of Georgia level, 17 bills were collected of 
which 13 failed to be passed. Given that we have collected bills as the primary set of data 
and a limited amount of related hearing information, the primary means of indicating 
'failed' bills will just be whether or not they managed to be passed through both the house 
and senate bodies at the federal and state levels of government. A more detailed 
description of the legislation collected for this study can be seen in Appendix D. Even 
further, in Table 13 of Appendix D, the legislation along with the publications on ART 
by federal level organizations can be seen. Both of these items are organized by year of 
the final version of the bill. The green shading indicates the years where a Congressional 
hearing on the topic of ‘ART’ occurred. 











Table 1: The data for the frame analysis 
Federal 44 (52) 1 1989-Present 1989-2010 
[2009-2010 
legislative year] 
Georgia 17 4 1995-Present 1995-2010 
[2009-2010 
legislative year] 








CLASSIFICATION AND FRAME ANALYSIS 
4.1 Classification Analysis 
 The cleavages of this analysis were challenging, primarily because I have chosen 
to adhere to the principles of classification analysis outlined by Dunn. Given that he 
outlined 5 principles of classification analysis: (1) substantive relevance, (2) 
exhaustiveness, (3) disjointedness, (4) consistency, and (5) hierarchical distinctiveness 
(Dunn, p. 99-100), it was found that adhering to disjointedness and consistency became 
problematic because of the possibility of multiple frames existing within a single 
document. However, I chose to interpret the need for consistency to apply to the unit of 
measure (in this case, individual word/phrases/concepts) without the whole bills having 
to consist of a single frame. 
 The classification analysis can be seen in the figures below. The primary division 
between groups was one of those who favored 'more stringent' rules for ART use and 
those that favored 'less stringent' or 'status quo' rules for ART use (hereby, referred to as 
'status quo'). In Dion's The Other Machine, similar distinctions were classified as liberal 
discourses and other discourses, of which other included fundamentalist and radical 
discourses (1996, p.18-25). As can be seen from the diagram in figure 5, the 'status quo' 
group is divided only between 'couple' and 'practitioner' foci. This division is resultant of 
two papers by David Adamson, in which he outlines the 'hierarchy of interests' in the 
ART policy arena to be primarily patients, in which he included gametic materials and 
future children, and secondarily 'physicians and embryologists', followed by all other 
interests, including professional organizations (Adamson, 2002; Adamson, 2005). 
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 The divisions found within the 'more stringent rules' group, were initially based 
upon whether these groups were in favor of the technology within a spectrum of rules to 
be applied, or in favor of a complete ban. The reason for placing both 'rules' based and 
'ban' based groups under the same umbrella of 'more rules' is primarily because 
prohibition can be seen as yet another form of greater stringency. Within this division, the 
Catholic Church and secular objectors are those that support no use of ART. Within 
Dion's analysis scheme, these groups could be considered analogous to religious 
fundamentalist, secular fundamentalist and feminist radicals (p.95-127). 
 The division of 'increased rules' groups between women, child/embryo/fetus and 
society/public health, was through a number of arguments in the scholarly literature. 
Regarding the 'women' grouping, there have been a number of questions, particularly 
early in ART development, about the safety and the social impact of the technology. As 
mentioned in section 1.3.1, some concerns are due to the physical short and long term 
health impacts that are not necessarily understood or are not well conveyed to the parties 
involved (Kerian, 1997). Others concerns have to do with the commoditization of 'the 
womb' and the concern for the potential for women or subgroups of women to become 
defined only by their reproductive capability (Kerian, 1997). This is distinguished from 
the 'feminist' grouping of the secular, ban branch beyond just their desire for rules versus 
ban, but also because we define the 'feminist' grouping to have a larger concern for the 
social position and pressures upon women to become mothers and bear children 
(Birenbaum-Carmeli, 2003). An example of an organization that holds more 'feminist' 
group interests would be the Feminist International Network of Resistance to 
Reproductive and Genetic Engineering (FINRRAGE). 
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 The next group within the 'increased rules' branching, is those that focus on the 
future child, the fetus or the embryo. While seemingly this group could be subdivided 
further into those three classifications, there is a lack of evidence that there are 
representations of groups with a concern for one over the others. Many of the interests of 
these groups could be considered to overlap with the 'right-to-life' argument, found in 
abortion rights debates and discourse, but given the difference in technology there are 
some that fall outside of that debate. For example, the concern over future litigation based 
upon the idea of 'wrongful birth', is a concern of law related to the applications of ARTs. 
This litigation has been hypothesized to be a consideration due to birth defects and other 
health outcomes as a result of ART (Losco, 1989; Rosato, 2003). Another concern is the 
valuation and psychological effects of conceptions through ART, for example, the ability 
of parents to bond with children made possible through gamete donation and the 
valuation of children after the expense of ART-related treatments (WHO, 2002). Even 
further, the concerns for the embryo range from its ability to inherit after the death of a 
'parent', its ability to be 'adopted' and the damage incurred due to storage, not to mention 
the concerns over the disposal of them in the event that the couple no longer requires 
them (Charo, 2002). Similarly, concerns for the fetus are related to those concerns found 
in the abortion debate, such as multi-fetal reduction, which is in effect abortion of some 
fetuses for the purpose of maintaining the pregnancy and the health of the remaining 
fetuses (Collopy, 2004). Other concerns relate to the rights of the mother to conduct 
herself in a manner that may be detrimental to fetal development or well-being (Merkens, 
Browner, & Press, 1997). Often referred to as the 'mother-fetal conflict', it provides 
another aspect of ARTs that is controversial. Overall, a key reason for the combination of 
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three categories for this classification branch, is that they are not very distinct from each 
other in the sense that all of the concerns somewhat overlap in time. For example, in 
order to 'protect' the fetus from 'damage' or poor outcome, some steps may have to be 
taken at the time an embryo was being implanted, and therefore, not a fetus. Similarly, 
the measures of 'poor outcome' would not be easily assessed until the fetus had become a 
child, at which point it would have 'rights', whereas in its current state, it does not. 
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Figure 5: Identified target groups in the ART policy arena 
 The final classification group of 'society/public health' is considered to be separate 
from the other concerns of 'women' and 'children', though they are very closely related. 
For example, in this classification system, the concern over the impact of widespread 
donor gamete distribution could be considered a concern of the 'child' group, in that they 
may have less knowledge of their genetic origins, but here it is classified as a 'societal' 
concern over the inability to maintain clear lines of genetic relationships, thereby 
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increasing the potential for overlap of similar genetic backgrounds. These concerns also 
include such issues as the long term outcomes of ART, from a population perspective. An 
example of such would be the tracking of morbidity associated with ART-related births. 
While this too could conceivably fall under the auspices of the previous two categories, 
data related to birth morbidity is currently collected under the auspices of public health, 
though not necessarily tied back to ART. 
 The second stage of this classification analysis was to identify potential agents 
expected to play a part in the management of ARTs, and can be seen in figure 6. This 
system is NOT intended to be a flowchart of the organizational chain of command, only a 
general means of classifying the level of governance involved. Furthermore, it is 
currently made up of only those organizations that have previously participated in policy-
making. There may be other organizations that could fulfill a similar position in 
regulating this industry that have not previously been involved, such as the intervention 
of the FTC on the advertisement of success rates. 
Agents in ART




























































Figure 6: Actors identified to be key in the solution action 
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 The purpose of this classification analysis was to inform and add structure to the 
frame analysis of section 5.2. Given the breadth of the topic of ART and its policy arena, 
it is believed that this analysis did fulfill the five principles of classification analysis 
outlined in Dunn (p. 99-100). Alternative 'opinion' classification systems, such as a 
prevention/solution/ban division or medical/social/religious, may have served a similar 
purpose, but either would have expanded the scope of the project (the former) or created 
too many logical overlaps for the purpose of our frame analysis. 
4.2 Frame Analysis 
For the frame analysis, 48 federal level, 17 state level bills from Georgia, and 48 
state level bills from California were collected using a common set of terms, which can 
be found in Appendix B. As can be seen in Error! Reference source not found., the 
federal level bills were collected for the widest range of dates. California and Georgia 
had a relatively similar range of dates that bills were available for, with California having 
online records available for two years more. This complicates the inter-frame comparison 
slightly, particularly between federal and state levels, because bills were not available for 
all incidences on the timeline of Figure 16. However, because I was also doing an intra-
frame comparison, these bills were left in the sample. Even further, in additional analysis, 
through which I coded for frames using Nvivo (QSR, International, 2009), eight Federal 
level bills were excluded due to size/import error that could not be overcome. 
Table 2: The breakdown of data collected for the frame analysis 
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Table 2: The breakdown of data collected for the frame analysis 






Range of Dates 
Used 
Georgia 17 4 1995-Present 1995-2010 
[2009-2010 
legislative year] 




For bounding purposes, the set of search terms used were narrowed to only those 
that directly referenced ARTs or specific ART technologies. It is acknowledged that not 
only is this set of search terms laden, but it also excludes several potentially promising 
samples. Examples of excluded terms included 'infertility', which resulted in the inclusion 
of several bills that would have broadened the scope significantly. This broadening in 
scope also had tradeoffs, in that it may have caused a significant divergence in topic away 
from the original research question, which would have stretched this project beyond both 
time and resources. 
 The hypothesis in Chapter 3 is that frames containing historically negatively 
constructed actors will result in failure of passage whereas those containing historically 
positively constructed actors will result in successful passage. For purposes of analysis, 
the frames with historically positively constructed actors will be designated ‘traditional’ 
frames and those that contain historically negatively constructed actors will be referred to 
as ‘alternative’ frames. Given the history of 'reproductive rights' and the medical 
institution in the U.S. outlined in Chapter 1, I propose, as can be seen in the frame 
descriptions of Appendix C, that traditional frames contain the patient (or couple or 
spouse) and the physician, and any private professional or consumer organizations, such 
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as in the 'status quo' part of the classification analysis above, Figure 5. Therefore, it is 
proposed that those bills that involve state or federal level government action, monitoring 
or program development will be less successful. This is particularly the case if the 
solution frame does not provide for agency of the ‘traditional ART frame' group, 
particularly the more powerful actors such as physicians. The following four figures are 
models of the hypotheses. Figure 7 is the general framework expected to be in play. 
Figure 8 is the expected case for the identification of an ‘alternative frame’ group as a 
recipient of benefits or the identification of a ‘traditional frame’ group as the cause of a 
problem. Figure 9 is the expected case for the exclusion of ‘traditional frame’ actors from 
the development and management of a solution. Similarly, Figure 10 is the expected 
outcome for cases in which a traditional actor is identified for participation in the solution 




Figure 7: Overall framework for Hypothesis 1, for the purpose of explaining the cases in which a 
frame will or will not result in passage. Modification of the political context model found in 
Blackwell's Companion to Social Movement, p. 70 (Kriesi, 2004) 
 
Figure 8: The case in which an alternative actor is identified as the beneficiary of the problem frame 
or a traditional actor the cause of it. Modification of the political context model found in Blackwell's 




Figure 9: The case in which a bill identifies a solution that removes the option for primarily self-
management on the part of dominant actors. Modification of the political context model found in 




Figure 10: The case in which a bill excludes traditional actors, particularly historically powerful 
traditional actors, for participation in the development and implementation of the solution. 





Figure 11: The overall case of frames over time. It is expected that there should be some appearance 
of feedback. Modification of the political context model found in Blackwell's Companion to Social 
Movement, p. 70 (Kriesi, 2004) 
 Given that the structure of government bills does not guarantee that the problem 
definition will be explicitly stated, it was necessary to develop a system of distinguishing 
problem and solution frames. In this study, the primary means of finding the problem 
definition stemmed from word counts. The secondary step in the case of a dearth of key 
words was to use the statement of purpose of the bill. An additional step of identifying 
the problem definition was to identify whether the actors pointed in the definition were 
recipient of 'benefits' or 'burdens' within bill. This distribution of benefits and burdens 
along with the preconceived actor association with frames was then used to determine 
whether the bill would have been expected to pass or fail. Similarly, the solution 
definition also used actor location and recipient status to determine whether a bill would 
have been expected to pass or fail. A list of frames and actors can be found in Tables 9 & 
10 of Appendix C. 
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 As has been stated by multiple frame scholars before, the methods of frame 
analysis have generally been less grounded (Koenig, 2004). Whereas Goffman's original 
analysis depended largely upon examination of the narrative, it has been pointed out that 
this method often limits the sample size that can be examined. Following in the footsteps 
of those that have attempted to perform frame analysis with computer-assisted qualitative 
data analysis software (CAQDAS), I attempted to use Nvivo for the purpose of this frame 
analysis. As a result, this part of the analysis was broken down into three steps in order to 
target the aspects of legislation that this study was interested in. Given that the 
hypotheses were heavily reliant upon the actors of each piece of legislation and the 
actions upon those actors, it was helpful to start with a word count for each bill, as well as 
across each sample set. The second step consisted of condensing these word lists down to 
just actors or potential actors, given that in the English language, some terms can function 
as nouns and other parts of grammar. The primary purpose of pulling out actors from the 
legislation is two-fold: (1) it allowed for the identification of terms used to describe the 
parties that had already been identified from the literature as potentially important and (2) 
it provided preliminary results regarding the effectiveness of the frames previously 
selected. It is important to note that while all bills were run across a common set of 
actors, the final means of  examining the legislation for frames was to group them by 
successfulness of their passage ('success' of bills) and whether they were produced 
through a California, Georgia or federal legislative body ('level' of bills). 
 The initial step of a word search was performed in part so that common words 
across all bills could be identified and also to provide the researcher with an 
understanding of the contextual differences between each subset of bills, a subset being 
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defined as the success (pass/fail) of a piece of legislation at a given level 
(Federal/California/Georgia). The word count was performed using Nvivo, two times. 
Once on the bills as a collective across a subset defined by its success and level, and once 
across each bill within each subset. The top thousand words were collected and the 'non-
words' cleaned from the count. Non-words consisted primarily of numerals and numeric 
ordinals, which were expected to add little to the narrative. As stated above, this word 
count helped to determine how the use of words may differ between the different subsets 
being examined. A selection from the word count can be seen below in Figure 12. 
 
Figure 12: Federal 'Failed' Bills: An example of the word count comparison between those words 
that were encountered frequently between all individual bills counts and those that were encountered 
frequently in a cumulative word count across all bills 
 From Figure 12, only a few words appear to stand out as potentially important 
concepts within federal bills that failed to be passed. As stated previously, the word count 
was run across the aggregate of a subset, as well as across individual bills within a subset. 
The aggregate count was to determine whether some terms or themes appeared to occur 
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more frequently overall within a given subset. The individual counts were used in a 
second count. This second count served as a means of reinforcing the aggregate count by 
confirming whether a commonly counted word was a theme among many bills or a select 
few. This can be seen in Figure 12 as the difference in counts between column B and D. 
Column B contains the twice counted words, which represent how many bills each word 
was found in. Column D contains the counts of words in aggregate. It is clear from a 
comparison between these columns in Figure 12, that health is an important focus in this 
subset, as it occurs across 43 of the 44 bills and is counted highly in the aggregate. From 
this comparative word count, it could be tentatively argued that most of the bills in this 
subset may contain at least some aspects of the traditional frames of 'consumer' or 
'medical practitioner'. However, given that this is just the first step of this analysis, there 



































































































































































































































































































Distribution of Overall Word Counts-Federal Failed Bill
 
Figure 13: Federal Failed Bills word count distribution 
 Charts such as the one in Figure 14 below, provided some slight additional 
perspective to the word counts. It was hoped that by charting the word counts of bill 
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subsets, a pattern of key words would be distinguishable for the purpose of comparing 
between subsets, but it largely appeared that highly counted words tended to be random. 
For clarification, the chart below is the result of charting the aggregate word count, 
ordered by number of bills occurred in and aggregate count, along the x-axis, while the y-
axis represented the aggregate count. This resulted in the pattern seen above, in which 
each clear peak represents the highest count in a bill count. 
 
Figure 14: Set of actors contained within a word count of Federal level bills that failed to be passed 
 An important aspect of performing the word count, beyond just its facilitation of 
the second step, as will be discussed in the next paragraph, is its usefulness in finding 
potentially uniform word usage that assisted in the finding of the 'problem definition' and 
'solution definition' frames. The default assumption in this study was that the primary 
purpose of each bill was to outline a 'solution frame'. For example, federal failed bills 
often (26/44) designated a problem in a section referred to as 'findings'. For California 
bills, problems were more often labeled by 'existing law' (41/42). Georgia, in contrast to 
the other two cases under study, appeared to have very little wording to distinguish the 
problem frame from the solution frame. There was use of 'findings' for a few Georgia 
bills (5/12), but overall, many of the bills failed to identify the 'problem definition' 
independently from the proposed solution of the bill. 
 From Figure 15, the second step used to find frames can be seen, in which the 
actors from each frame were filtered out of each word count. While it is clear that several 
words are common across many bills, such as 'state'/'states', it is also apparent from this 
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initial parsing, that other words are not as heavily used, such as 'unborn'. These word 
counts were color coded so as to approximate which words would represent potential 
frames or not. From the sparse usage of such terms as 'unborn' however, it can be inferred 
that the term may be highly associated with a particular frame, because it invokes specific 
images regarding (1) reproduction and (2) legitimate actors. However, like the word 
counts, without the associated narrative, drawing conclusions from these terms alone 
would be premature. Overall, this above step of a key actor count provides an important 
boundary identifying step of determining what terms are commonly used to designate 
actors. Even further, it allows for a clarification in tying commonly used terms to frames, 
an important step considering that our frames are actor-centered. An important limitation 
of this step is that the ability to distinguish all actors in a list of words is limited, due to 
some terms serving multiple functions within language, such as 'relative' (a family 
member, or a term relating concepts). There is also the fact that pronouns have the 
potential to mask points of the narrative because they reduce the actor to an even more 
generic term. 
 The third step of finding a frame relied upon several matrices in order to compare 
actor co-occurrences, actors' occurrences within bills, and actors' co-occurrences with 
terms of interest. Figure 15 below shows a matrix that pinpoints the actors contained 




Figure 15: An actors x bills matrix, for federal level failed bills. The purpose of this matrix was to 
identify which bill utilized which actors. 
From the matrices created, the narratives containing actors of interest could be 
pinpointed. 
 Overall, word counts provided an important step in the processing of the narrative 
in this data set. It made it possible to determine how actors appear in bills. Second, it 
provided insight into standard and non-standard wording of bills. While it does share 
some similarities with content analysis and 'keying' in the original form of frame analysis 
(Goffman, 1974, p. 43-44), it is hoped that this means of parsing apart the actors from the 
remainder of the narrative provides some system through which frame analysis can be 
more methodically approached in the future. It is noted that an additional aspect to be 
added in the future may be to also parse out potential verbs and adjectives in order to 
create a further detailed set of matrices to approach the narrative. 
4.2.1 An overview of the contents of federal level bills 
 The federal level legislation provided its own set of challenges. For example, the 
keying to identify statements indicating potential problem statements was not uniform 
across all bills. As mentioned above, twenty-six out of forty-four bills contained the term 
'findings', a term that would clearly identify what was determined to be the problem to be 
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solved. In order to navigate around this issue, it was decided that the purpose statement 
also could serve as the means to determine the problem frame. This was supplemented by 
the narrative found with the 'findings' key, as available. Another issue was the fact that 
there was only a single passed bill, thereby limiting the potential for within-level 
comparisons. Given that this was expected, it was only possible to disseminate what 
frames were potentially in play within the legislation and look at the changes from a 
historical perspective. 
 
Figure 16: Federal timeline of bills. The blue highlighted bill is the only passed bill at this level. 
 Figure 16 above shows the time line of federal level bills collected for this study. 
As can be seen from both this figure and the Chapter 3 outline of data, the number of 
passed bills at this level is limited to one, FCSRCA. For clarification purposes, the data in 
the following sections will be ordered in the manner below, as exemplified by Table 3. 
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The quotes listed in the 'statements of frame' section of the table, will be ordered 
according to the numbering of the quadrants. 
Table 3: Organization of data 
bill purpose Actor Scope  
 1 2  
3 4  
Statements of frame Quotes, listed by quadrant 
 Figure 16 above shows the time line of federal level bills collected for this study.  
4.2.1.1 Federal Successful Bill: FCSRCA 
 Comparison of all the bills cannot be completed without an understanding of them 
within their individual subsets. Given that much of the critique regarding policy has been 
aimed at the federal level, the frames at this level are of primary interest. The limited 
number of successfully passed federal bills limits what can be said about whether frames 
affect the ability of a piece of legislation to be passed. However, it may provide some 
information about the context of ARTs at this level and how they tend to be presented. 
 The first bill examined for frames was the only passed bill at the federal level, 
FCSRCA. The structure of this particular bill has no keyword to designate a separate 
problem statement from its solution statement, so it was concluded that the problem 
statement was implicit within the statement of the purpose of the bill. FCSRCA states 
that its purpose is “to provide for reporting of pregnancy success rates of assisted 
reproductive technology programs and for the certification of embryo laboratories”. 
Given that the approach of this study was based primarily upon the actors' representation 
within the frame, it is important to note that the primary actor of this problem statement is 
'embryo laboratories', as is noted in Error! Reference source not found., below. 
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Table 4: FCSRCA frame 
Fertility Clinic 
Success Rate and 
Certification Act of 
1992 (FCSRCA) 
Stated Purpose Actor Scope  
“to provide for 
reporting of pregnancy 
success rates of 
assisted reproductive 
technology programs 
and for the 
certification of embryo 
laboratories” 
Embryo laboratories 
[target of action];  
practitioners of medicine 
[excluded from action 
upon]; consumers 
[implicit] 
Unclear definitions of ART 
procedure success rates and 
inconsistent or unclear 
procedures taken by fertility 
clinics in the completion of an 
ART cycle, EXCEPT for the 





organizations, 'the state', 
accreditation organizations 
Secretary: Development of (1) a 
model certification program and 
(2) a measure of success rates 
for embryo lab-associated ART 
programs 
 
'the State' & accreditation 
organizations: the 
implementation of a modified 
certification program; collection 
of proscribed data; submission 
of data and certification reports 
to the CDC 
 
consumer & professional 
organizations: source of 
consultation for the development 
of (1) a model certification 
program and (2) a measure of 
success rates for ARTs 
Solution 
Definition 
Statements of frame 1:  
“to provide for reporting of pregnancy success rates of assisted reproductive technology programs 
and for the certification of embryo laboratories” 
 
“In developing the certification program, the Secretary [or the State] may not establish any 
regulation, standard, or requirement which has the effect of exercising supervision or control over 
the practice of medicine in assisted reproductive technology programs.” 
 
“(a) CONSULTATION- In developing the definition under subsection (b), the Secretary shall 
consult with appropriate consumer and professional organizations with expertise in using, 
providing, and evaluating professional services and embryo laboratories associated with assisted 
reproductive technologies.” 
2:  
“to provide for reporting of pregnancy success rates of assisted reproductive technology programs 
and for the certification of embryo laboratories” 
STANDARDS- The certification program shall include the following standards developed by the 
Secretary:  
A standard to assure consistent performance of procedures by each embryo laboratory certified 
under the certification program or by an approved accreditation organization in a State which has 
not adopted the certification program.  
A standard for a quality assurance and a quality control program to assure valid, reliable, and 
reproduceable procedures in the laboratory.  
A standard for the maintenance of records (on a program by program basis) on laboratory tests 
and procedures performed, including the scientific basis of, and the methodology used for, the 
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Table 4: FCSRCA frame 
tests, procedures, and preparation of any standards or controls, criteria for acceptable and 
unacceptable outcomes, criteria for sample rejection, and procedures for safe sample disposal.  
A standard for the maintenance of written records on personnel and facilities necessary for 
proper and effective operation of the laboratory, schedules of preventive maintenance, function 
verification for equipment, and the release of such records to the State upon demand....” 
3:  
“the Secretary shall, in consultation with the organizations referenced in subsection (c), define 
pregnancy success rates and shall make public any proposed definition in such manner as to 
facilitate comment from any person (including any Federal or other public agency) during its 
development.” 
 
“the Secretary shall consult with appropriate consumer and professional organizations with 
expertise in using, providing, and evaluating professional services and embryo laboratories 
associated with the assisted reproductive technology programs.” 
 
“A State may qualify to adopt the certification program if the State has submitted an application to 
the Secretary to adopt such program and the Secretary has approved the application.” 
“A State which has adopted the certification program may use accreditation organizations 
approved under section 4 to inspect and certify embryo laboratories” 
4:  
“Such an application shall include--  
assurances satisfactory to the State that the embryo laboratory will be operated in accordance with 
the standards under subsection (d),  
a report to the State identifying the assisted reproductive technology programs with which the 
laboratory is associated, and...” 
 
“The certification program shall include the following standards developed by the Secretary:  
A standard to assure consistent performance of procedures by each embryo laboratory certified 
under the certification program or by an approved accreditation organization in a State which has 
not adopted the certification program.  
A standard for a quality assurance and a quality control program to assure valid, reliable, and 
reproduceable procedures in the laboratory.  
A standard for the maintenance of records (on a program by program basis) on laboratory tests and 
procedures performed, including the scientific basis of, and the methodology used for, the tests, 
procedures, and preparation of any standards or controls, criteria for acceptable and unacceptable 
outcomes, criteria for sample rejection, and procedures for safe sample disposal.  
A standard for the maintenance of written records on personnel and facilities necessary for proper 
and effective operation of the laboratory, schedules of preventive maintenance, function verification 
for equipment, and the release of such records to the State upon demand.  
A standard for the use of such personnel who meet such qualifications as the Secretary may 
develop.” 
However, a further reading of narrative of the bill reveals references to other actors that 
can be directly tied to the problem statement, thereby providing further context. For 
example, the mandate for the creation of a model certification program states explicitly 
that the Secretary and the state,  
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“In developing the certification program...may not establish any regulation, standard, or 
requirement which has the effect of exercising supervision or control over the practice of medicine 
in assisted reproductive technology programs.” 
In stating that the practice of medicine may not be infringed upon, the U.S. Congress is 
clearly excluding the consideration of a potential actor as part of the problem, i.e. those 
that 'practice medicine'. Even further, it indicates that despite the tie between the practice 
of medicine in ART programs and the embryo clinics of interest, only some of the actors 
in the entity referred to as 'fertility clinics', are under scrutiny: 'embryo laboratories'. This 
statement further excludes the attached body of ART programs from sanctions, i.e. the 
monitoring and certification that is being applied to embryo laboratories. An even less 
explicit actor of this activity are consumers of the fertility clinic. Within the bill, they are 
mentioned a mere two times, both as a term to describe other organizations that may be 
'consulted' in the development of a model certification program. An important point of 
note regarding these three actors in this bill is the fact that, while they all may play a part 
in how the problem is defined, their roles are significantly different. The mentioning of 
the embryo clinics as the explicit actor clearly identifies them as the means of solving the 
perceived problem (Rochefort & Cobb, 1994, p. 23). The expression that sanctions could 
not be extended to those that practice medicine in assisted reproductive technology 
implies something not only about the practitioners, but also about the embryo 
laboratories. From Ingram and Schneider’s social construction of actors matrix, it can be 
hypothesized that both entities practitioners and laboratories may be perceived as 
'contenders' in the policy arena, i.e. actors considered to be stronger but also undeserving 
of benefits. In the language of Schneider and Ingram's social construction framework, 
these actors are considered to be contenders (1997, p. 116-120), because of their power 
 
 84
within the policy area as well as the fact that they are not necessarily positively 
constructed. As such, it is clear that the distinction is made between 'embryo labs' and 
'practice of medicine' as the point on which to apply burdens. Regarding the consumer of 
the fertility clinic, it is not quite clear in which quadrant they reside with regard to the 
Schneider & Ingram social construction of actors matrix, of which a model of can be seen 
in Figure 19 of Appendix C. On the one hand, it appears that they are a dependent, given 
that, from the language of the bill, the primary function of this legislation is to correct for 
an information asymmetry through publication of information on fertility clinics. On the 
other, they also are given the opportunity to structure the certification process, thereby 
creating a more costly policy structure, according to the framework (p. 112, 123). 
 The second part of the frame is the solution definition. The most prominent, 
explicit actor is the Secretary of Health and Human Services, acting through the Centers 
for Disease Control (CDC). However, it also important to note that the implementation is 
carried out through 'the state' and accreditation organizations. Also important in the 
development process are the professional and consumer organizations, which are 
designated as consultants for the development of the program. Again, their role within the 
solution becomes an important aspect of understanding the solution frame. As stated by 
the bill, the Secretary is the primary actor for development and delivery of the model 
certification program, as well as the actor to whom reports are due regarding the data 
collection aspects of the bill. However, the Secretary defers adoption and implementation 
of the programs, as well as immediate data collection and management of the certification 
programs, to 'the state' or accreditation programs. Moreover, states can choose not to 
become an actor in this particular bill, seemingly resulting in their inclusion in the 
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solution definition being more rhetorical and not creating action on the part of the state. 
Similarly, the professional and consumer organizations are also voluntary participants to 
the process, but they are given 'authority' in the sense that they enter into the development 
process as experts on how the model certification program should function. Even further, 
there are the embryo laboratories, which are saddled with the burden of certification and 
observation. 
 Overall, as mentioned before, the embryo laboratories appear to function as 
contenders in the sense described in Ingram and Schneider’s matrix of actors, which can 
be seen in Figure 19. By this, I mean that they are an extension of the fertility clinic, as 
are the medical practitioners. Given the relationship between the different actors, it is 
then necessary to look at the scope, in order to understand how the social construction 
plays out. In this particular bill, the scope of inclusion of each actor is different. The 
Secretary exists in a broad scope of action, but constrained in that action by actors on 
which he may not act. As such, given that his function is more as a tool than a socially 
constructed actor, it is necessary to look at how the constraints to action affect the other 
actors of the bill. Given that the medical practitioner is both not being acted upon and 
receiving the option to manage (through consultation) the burden that is placed on it, it 
appears to function also as a contender, primarily through the fact that it is exempted 
from action and called upon to 'self-manage' through consultation. The embryo 
laboratories also function as contenders, in the sense that they are an extension of the 
practice of medicine, and therefore tied directly to those creating the rules. Even further, 
however, is the fact that little direction action against the embryo laboratories for not 
obtaining certification, is expressed within the wording of the bill. Given that the primary 
 
 86
loss of not obtaining certification would be being listed as being 'not certified', there is 
only slight incentive but no requirement to adhere to the newly created rules. Without 
further examples of passed bills to compare these actors, these constructions are merely 
implied through the set up of the bill, but not conclusive. 
 Given that there are no other passed bills for points of comparison, little can be 
said regarding the frames' effect on the ability of the bill to be passed. However, 
regarding the existence of frames themselves, it seems as if there is evidence of a more 
traditional frame encompassing 'doctors' and 'consumers/couples'. The doctor frame is 
'more visible', in the sense that there is a provision to not impinge upon the practice of 
medicine in ARTs and the requirement that the Secretary consult with 
“appropriate...professional organizations with expertise in using, providing, and 
evaluating professional services and embryo laboratories associated with the assisted 
reproductive technology programs.” The consumer frame used within the bill primarily 
falls within the problem definition and the implicit indications that consumers are the 
actor for whom action is being taken. Non-traditional frames are not present at all. 
 An important note to make at this point is that the 'society'/'state' frame appears to 
have no standing in this form of narrative. Given that the federal government and 'the 
state' are inherent actors in this bill, the government frame becomes illogical. 
Additionally, the embryo clinic, while it appears to have received a burden, also seems to 
function as an extension of the doctor frame. The following bills will be necessary to 
confirm such a pairing, but from this limited analysis, this appears to be the case. 
4.2.1.2 Federal Failed Bills 
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 The forty-four federal failed bills provided additional insight into the structure 
and composition of bill frames, as well as providing further insight into which actors 
tended to receive problem definitions on their behalf, which actors were constructed as 
'problematic' and which actors tended to result in constraints to government action. A 
small selection of the failed federal bills can be seen in Table 5, below. 
Table 5: Examples of frames for two federally failed bills 
HR 1852 Stated Purpose Actor Scope  
“To assure equitable 
treatment of fertility 
and impotence in 
health care coverage 
under group health 
plans, health 
insurance coverage, 
and health plans 
under the Federal 
employees' health 
benefits program.” 
Health insurance issuers 
[acted upon]; Federal 
employees [action on 
behalf of] 
Inequality on the part of health insurers, 




Health insurance issuers, 
actors of ERISA, actors of 
the Public Health Service 
Act 
Assuring that policies covering 
impotence treatment also cover infertility 
treatment 
 
Does not allow for constraints to be 
placed upon the general practices of 
insurance companies, such as placing 
restrictions on restricting which drugs 






“To assure equitable treatment of fertility and impotence in health care coverage under group health plans, 
health insurance coverage, and health plans under the Federal employees' health benefits program.” 
2: 
“(a) IN GENERAL- A group health plan, and a health insurance issuer offering group health insurance 
coverage, that provides for coverage of impotency medications such as viagra shall also provide coverage 
of fertility treatments.” 
3: 
“(b) INDIVIDUAL HEALTH INSURANCE- (1) Part B of title XXVII of the Public Health Service Act is 
amended by inserting after section 2752 the following new section: 
`SEC. 2753. EQUITY IN FERTILITY COVERAGE. 
`(a) IN GENERAL- The provisions of section 2707 (other than subsection (c)) shall apply 
to health insurance coverage offered by a health insurance issuer in the individual market 
in the same manner as it applies to health insurance coverage offered by a health insurance 
issuer in connection with a group health plan in the small or large group market. 
`(b) NOTICE- A health insurance issuer under this part shall comply with the notice 
requirement under section 714(c) of the Employee Retirement Income Security Act of 1974 
with respect to the requirements referred to in subsection (a) as if such section applied to 
such issuer and such issuer were a group health plan.'. 
(2) Section 2762(b)(2) of such Act (42 U.S.C. 300gg-62(b)(2)) is amended by striking 
`section 2751' and inserting `sections 2751 and 2753'. 
(c) FEHBP- Section 8902 of title 5, United States Code, is amended by adding at the end 
the following the following new subsection: 
`(p) A contract may not be made or a plan approved which does not comply with the 




Table 5: Examples of frames for two federally failed bills 
“`(a) IN GENERAL- The provisions of section 2707 (other than subsection (c)) shall apply to health 
insurance coverage offered by a health insurance issuer in the individual market in the same manner as it 
applies to health insurance coverage offered by a health insurance issuer in connection with a group health 
plan in the small or large group market. 
`(b) NOTICE- A health insurance issuer under this part shall comply with the notice 
requirement under section 714(c) of the Employee Retirement Income Security Act of 1974 
with respect to the requirements referred to in subsection (a) as if such section applied to 
such issuer and such issuer were a group health plan.'” 
HR 3940 Stated Purpose Actor Scope  




Embryo laboratories Insufficient availability of information 
regarding the selection of embryo clinics 
Problem 
Definition 
American Fertility Society 




embryo labs; Secretary of 
HHS; the states; 
accreditation organizations 
Consultation with AFS, CoAP and 
consumer organizations, the development 
of a model certification program based 
upon standards set by the Secretary of 
HHS,to be carried out by the states. It is 
also to be monitored by (1) an accepted 
accreditation organization approved by 
the Secretary of HHS or (2) a state AND 
the Secretary of HHS. The states are 
required to qualify to administer a 
program through application to the 
Secretary of HHS for approval. The 
penalty for failure to maintain 
certification standards is the revocation 






“To provide for the certification of embryo laboratories.” 
2: 
“IN GENERAL- Not later than 2 years after the date of the enactment of this Act, the Secretary shall 
develop a model program for the certification of embryo laboratories to be carried out by the States.” 
3: 
“CONSULTATION- In developing the certification program under subsection (a), the Secretary shall 
consult with the American Fertility Society, the College of American Pathologists, and appropriate 
organizations representing consumers of embryo laboratory services.” 
 
“PUBLICATION- The Secretary shall, in consultation with appropriate private organizations involved 
with embryo laboratories, not later than 3 years after the date of the enactment of this Act and annually 
thereafter publish and distribute to the States and the public information showing pregnancy success rates, 
as defined by the Secretary under subsection (e)(2), achieved by each in vitro fertilization program in 
association with embryo laboratories in the United States. Such information shall prominently disclose 
which States have implemented the certification program of the Secretary and which laboratories have been 
certified under such program.” 
4: 
“PUBLICATION- The Secretary shall, in consultation with appropriate private organizations involved 
with embryo laboratories, not later than 3 years after the date of the enactment of this Act and annually 
thereafter publish and distribute to the States and the public information showing pregnancy success rates, 
as defined by the Secretary under subsection (e)(2), achieved by each in vitro fertilization program in 
association with embryo laboratories in the United States. Such information shall prominently disclose 
which States have implemented the certification program of the Secretary and which laboratories have been 
certified under such program.” 
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Table 5: Examples of frames for two federally failed bills 
 
“CERTIFICATION BY STATES- A State may qualify to administer the certification program established 
by the Secretary under section 2(a) within the State if the State has an application to the Secretary to take 
such action approved. Such an application shall include--” 
 
“ADMINISTRATION- A certification program in a State shall be administered by the State and shall 
provide for the certification of embryo laboratories by the State or by an accreditation organization 
approved by the State.” 
 
“ a) IN GENERAL- A certification issued by a State or an accredition organization for an embryo 
laboratory shall be revoked or suspended if the State or organization finds, on the basis of inspections and 
after reasonable notice and opportunity for hearing to the owner or operator of the laboratory, that the 
owner or operator or any employee of the laboratory--  
◦ has been guilty of misrepresentation in obtaining the certification,  
◦ has failed to comply with any standards applicable to the certification, or  
◦ has refused a request of the State or accreditation organization for permission to inspect the laboratory, 
its operations, and records.  
• EFFECT- If the certification of an embryo laboratory is revoked or suspended, the certification of 
the laboratory shall continue in effect for 60 days after the laboratory receives notice of the 
revocation or suspension. If the certification of an embryo laboratory is revoked or suspended, the 
laboratory may apply for recertification after one year after the date of the withdrawal or 
revocation.” 
 
With the federal level bills, the lack of availability of contrasting 'passed' bills resulted in 
no point of comparison to determine whether the frames in use were different than those 
passed. Undoubtedly, at this level, having a broader selection of legislation would have 
clarified the results immensely. That being said, given the results of just this level of bills, 
some interesting results regarding legislative frames become apparent. For one, the 
concept of a 'women' frame and 'society' frame, do not hold up well in the context of 
legislation. This may be because the terms are highly generalized, such that the terms 
would inevitably be used in some form. The society frame is also so close to the 
'government' frame, that distinguishing actions on the part of 'society' or 'the public' is 
drowned out by action being taken in general. Both of these frames could possibly benefit 
from further adjustments to identify whether there are additional actors terms that could 
be used to identify these frames or whether they would benefit from the addition of verbs 
and adjectives. However, the overall legislation presented at this level did present some 
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indications of variation of frames that could potentially affect the success of those frames 
in passage. 
 For the problem definition aspect of the frame, the bills typically identified 
couples and/or consumers as important actors in the bills. The occurrence of 'couple' as a 
term occurred in thirteen of the forty-four bills. Sometimes, these individuals were 
identified as 'the infertile', a term that, from some discourse perspectives, has been 
considered a term indicating dependency (Farquhar, 1996, p. 83). It is important to note 
that 'couples' were rarely targeted in the solution of the frame. The form that they were 
targeted was primarily for the purpose of denying coverage of IVF. For example, a bill 
addressing veterans' benefits only targeted couples in the sense that it excluded the use of 
IVF as a potential health plan covered treatment for infertility.  
(1) The Secretary may-- 
`(A) provide to an eligible veteran (and, if necessary, the veteran's spouse) qualifying 
procreative services, and 
`(B) subject to paragraph (2) of this subsection, reimburse an eligible 
veteran for qualifying adoption expenses incurred by the veteran... 
`(4) For the purposes of paragraph (1) of this subsection, the term `qualifying 
procreative services' means procreative services that are reasonable and necessary to 
overcome the effects of a service-connected disability described in paragraph (3) of 
this subsection, but such term does not include-- 
`(A) procedures to conceive a child using gametes of an individual other than 
the veteran or the veteran's spouse; `(B) procedures to conceive a child through 
in vitro fertilization; or 




Therefore, for all intents and purposes, the couple appears to remain a dependent 
population. Other populations' inclusion in the problem definition of the bills varied. 
 Given the limitations of the approach to these pieces of legislation, the solution 
definition appeared to have the most interesting results regarding the hypotheses 
proposed by this study. For one, one common actor/ tool often featured is the Secretary of 
Health and Human Services (HHS). Also featured in similar positions were the Secretary 
of Veterans' Affairs and the Comptroller General. For the most part, with the exception of 
the three bills that appear functionally similar to FCSRCA, the function of these 
individuals was often to define terms under which to give benefits like ART treatment for 
infertility (Secretary of HHS) or affirm it (Secretary of Veterans' Affairs). Another 
example of a frequent actor of the solution definition was physicians, who often had the 
standing of 'expert' within the wording of the bills, as expected. This often took the form 
of a requirement for verification in order to access some service: 
 “(5) For purposes of this subsection-- `(A) the term `infertility' means--(i) the inability to 
conceive a pregnancy after 12 months of regular sexual relations without contraception or to carry 
a pregnancy to a live birth; or (ii) the presence of a demonstrated condition determined by 2 
physicians (at least 1 of whom specializes in infertility) to cause infertility;”.(HR 1418 IH) 
 
(1) The term `infertility treatment services' means, with respect to an individual entitled to benefits 
by reason of section 226(b), diagnosis and treatment (described in paragraph (2)) by a physician 
(as defined in subsection (r)(1)). (HR 2758) 
 
`(ii) the procedure (including any retrieval incident thereto) is performed at medical facilities that 
conform to the standards of the American Society for Reproductive Medicine, the Society for 
Assisted Reproductive Technology, the American College of Obstetricians and Gynecologists, or 
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any other similar nationally-recognized organization, or a Federal agency that promulgates 
standards for infertility procedures; (HR 1246) 
 
Similarly, professional organizations also served to fulfill the role as 'expert', particularly 
as points of consultation for the government official or office tasked with implementing 
the legislation. With regard to the implementation of action, many of the failed pieces of 
legislation clearly exemplified the traditional frames, which were hypothesized to support 
passage of legislation. For some bills, such as those preceding FCSRCA on the issue of 
embryo laboratory certification, a significant amount of intrusion by the government into 
the practice of medicine and the function of the fertility clinic may have contributed to 
the failure of these pieces. For example, in FCSRCA, an explicit limitation exists for the 
Secretary of HHS: 
SECRETARY- In developing the certification program, the Secretary may not establish any 
regulation, standard, or requirement which has the effect of exercising supervision or control over 
the practice of medicine in assisted reproductive technology programs. (P.Law 102-493) 
In contrast, the three bills addressing the same topic and with similar construction of the 
problem (HR 3940, HR 5110 & HR 756), appear to have no explicitly worded 
limitations. Even further, a point of interest may be the exact means through which the 
Secretary could exact penalties in these bills. For example, all three of the failed, similar 
bills allowed for the Secretary, the state or both, to exact fees in the certification process: 
FEES- The Secretary and a State may each require payment of fees for the issuance and renewal of 
certificates in such amount as they may determine is necessary to carry out their respective 
responsibilities under this Act. (HR 3940) 
 
FEES- The Secretary shall require payment of fees for the issuance and renewal of certificates in 
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such amount as the Secretary may establish to carry out this Act based on the volume and scope of 
the services being performed by the embryo laboratories. (HR 5110) 
 
FEES- The Secretary shall require payment of fees for the issuance and renewal of certificates in 
such amount as the Secretary may establish to carry out this Act based on the volume and scope of 
the services being performed by the embryo laboratories. (HR 756) 
FCSRCA did not allow this to be the case, a potential example of an aspect of a solution 
definition that could be considered burdensome to the privileged actor of the traditional 
frame. In the remaining bills, because there is no clear bill for comparison, the ability to 
attribute frame to their failure is limited. 
 Overall, the general conclusions to be drawn from the frames found in the failed 
legislation solution definitions appeared to represent three different ways that possibly 
could prevent their passage, according to the previously presented 'traditional frame': (1) 
prevention of access to IVF [burdensome on the 'infertile couple'], (2) the placement of a 
burden upon physicians, or (3) the exclusion of privileged actors from their own 
management system. An additional important note is that, out of the forty-four of bills for 
analysis, only five appeared to have any non-traditional frames (i.e. society frames, 
women frames, or children frames): HR 2861, HR 3350, S 1726, S 707, and HR1161. All 
five of these bills were directly addressed to the issue of “infant health” or “women's 
health”, thereby seemingly removing them from having a fully traditional frame. 
However, according to the coding by actors, a different story is told. In fact, by that 
coding, HR 1161 contains many of the traditional frame actors, as well as all of the 
'society'/'government' actors, while using a limited number of the child and female actors. 
This may indicate either (a) that the actor association with each frame is a weak one or 
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(b) that no frames exist within legislation. Given the lack of a point of comparison, in the 
form of successfully passed bills, either one is difficult to conclude. 
4.2.2 An overview of the contents of the California level bills 
 
Figure 17: A time line of California bills. The blue highlighted bills are passed bills 
 The next sample set examined was California legislation. The legislation from 
California, as compared to the federal level legislation, required significant sifting 
through the narrative in order to understand which actors were being addressed for the 
problem and solution definitions. While forty out of forty-two of the bills had a clear key 
term to designate what the defined problem was ('existing law'), the density of the 
narrative complicated the distillation of the important actors and actions from general 
defining terms. The one bill that did not use the 'existing law' term was a resolution and 
therefore had a different structure. Some important structures that made the California 
data set significantly different from both the federal data set and the Georgia data set is 
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the fact that while one version of a California bill might contain one of the ART terms 
searched for, not all iterations necessarily contained it. Given that this study looked 
primarily at the final version of all bills, this significantly trimmed the number of bills 
examined for frames of interest. Of the 42 bills collected, only 27 of them contained the 
original search terms. Another point of interest that makes this subset different from the 
other two is that the passage of the legislative body did not necessarily result in it being 
signed into law. While this had the potential to happen in any of these subsets, neither 
Georgia nor the federal level legislative bodies passed any legislation that did not get 
signed into law, whereas in California four of the 27 bills that passed the legislative body 
failed to become signed into law. Given that the primary interest of this study was 
whether the bill could manage passage through the legislative body, these bills were 
counted among the 'passed' bills. However, this explains why there may be proposed 
legislation that failed to pass, but has similar or the exact same requirements as a 'passed' 
version that predates it. 
4.2.2.1 California Passed Bills 
 On the surface, the passed bills in California appeared to contradict the 
hypotheses completely. For one, while they did appear to draw heavily upon the 
traditional frames of 'physician', 'couple', and 'family', the bills did not appear to apply 
solutions to the social constructions as would have been expected. For example, some 
bills implement clear penalties for transgressions by powerful actors. An instance of this 
is bill AB 2513, which implements a definitive civil penalty of a fine if it is found that a 
physician or surgeon is found to have conducted themselves unprofessionally: 
This bill would require a physician and surgeon who removes sperm or ova from a patient to 
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obtain a prescribed written consent from the patient before the sperm or ova are used for a purpose 
other than reimplantation in the same patient or implantation in the spouse of the patient. The bill 
would provide that violation of the requirement constitutes unprofessional conduct. The bill would 
provide that the misdemeanor provision does not apply to a person who violates the requirement. 
This bill would require a physician and surgeon who fails to obtain the required consent a 2nd time 
to be assessed a civil penalty of not less than $1,000 and not more than $5,000, plus court costs, to 
be paid to the individual whose required consent was not obtained. (AB 2513) 
However, without further analysis of the success of this action, it is not possible to 
determine whether this action is enforceable or is primarily rhetoric aimed at placating a 
dependent set of actors. This could be argued to be the case given that some of the bills 
that permit penalties for such powerful groups managed to get passed through the 
legislature but then failed to become law. Other bills clearly utilize non-traditional 
frames, even when couched with traditional frames of physician and infertile couple. For 
example: 
(b) (1) No later than January 1, 2002, the department, after consultation with the appropriate 
national medical specialty societies, shall develop a standardized written summary in laymen's 
language and in a language understood by the patient or oocyte donor regarding health and 
consumer issues relating to ART and oocyte donation. The summary shall be printed and made 
available by the board to physicians and surgeons and shall include, but not be limited to, the 
following disclosures: 
A) The potential risks to both the mother and the fetus posed by the drugs, medications, and 
hormones used in ART.  
B) The potential risks of implanting multiple embryos, including multiple births.  
C) The potential risks to both the mother and the fetus from multiple births.  
D) The potential risks of oocyte donation, including the risk of decreased fertility and the risks 
associated with using the drugs, medications, and hormones prescribed for ovarian stimulation 
during the oocyte donation process.  
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Even further, there is a significant amount of intervention by government bodies on 
behalf of different actors and even the public. Some actors, such as the couple or 
consumers, are still constructed in a similar manner to how they are constructed in the 
federal level bill. However, the presence of additional actors and social constructions in 
these bills, such as 'child', provide evidence that other frames orientations exist within 
legislation and also have the potential to be passed. The passage of legislation penalizing 
physicians and other medical professionals for transgressions appears to be more 
acceptable, but examples such as passed bill SB 674, provide a contradiction to the 
acceptability of such legislation because, while they state the following, they also fail to 
become law: 
(1) Existing law provides for the licensure and regulation of various healing arts practitioners and 
requires certain of those practitioners to use particular designations following their names in 
specified instances. Existing law provides that it is unlawful for healing arts licensees to 
disseminate or cause to be disseminated any form of public communication, as defined, containing 
a false, fraudulent, misleading, or deceptive statement, claim, or image to induce the rendering of 
services or the furnishing of products relating to a professional practice or business for which he or 
she is licensed. Existing law authorizes advertising by these healing arts licensees to include 
certain general information. A violation of these provisions is a misdemeanor. 
Whether this action is rhetoric or even intended to target other professional groups 
outside of those powerful groups providing ARTs comes into question. However, it does 
provide some explanation as to why the types of regulation vary so drastically around the 
country. 
 Overall, the social constructions within the California passed legislation include 
more actors in addition to providing different constructions for them. The social 
construction of infertile couples appears to remain the same, i.e. they are dependent 
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actors to whom offering the benefits of political action may or may not be optimal. 
However, there are additional dependents within this case that were not present in the 
federal failed case, primarily children, but also women, as the example above shows. 
Another example of an alternative frame appears in the laws mandating testing 
precautions on behalf of a gamete/embryo recipient with regard to testing and informed 
consent. However, there are also bills in which constraints are applied to these new 
actors' participation. For example, the laws relating to oocyte donation require that the 
donors undergo counseling and informed consent before undergoing the procedure and 
are informed that compensation for egg donation is not always provided. For example, 
the wording of AB 1317 is as follows: 
125325. (a) The person or entity posting an advertisement seeking oocyte donation associated with 
the delivery of fertility treatment that includes assisted oocyte production and a financial payment 
or compensation of any kind, shall include the following notice in a clear and conspicuous 
manner: 
"Egg donation involves a screening process. Not all  potential egg donors are selected. Not 
all selected egg donors receive the monetary amounts or compensation advertised. As with any 
medical procedure, there may be risks associated with human egg donation. Before an egg donor 
agrees to begin the egg donation process, and signs a legally binding contract, she is required to 
receive specific information on the known risks of egg donation. Consultation with your  doctor  
prior  to  entering  into  a  donor  contract  is  advised." 
While the informed consent and counseling aspects of this bill are for the benefit of the 
donor, they also act as a constraint on their participation in this transaction, reducing their 
agency. By Schneider and Ingrams' framework, these new actors could be considered to 




4.2.2.2 California Failed Bills 
 The failed bills in California, unlike the passed bills, appear to have slightly less 
variation of frame. While the number of failed bills presented here is a much smaller 
number as a result of excluding bills not addressing ARTs within their body, it becomes 
apparent that the failed bills do not have quite the same amount of variation in actors as 
in the passed bills. For example, within the six California failed bills examined for 
frames, the primary actors in these bills are physicians, insurers and the 'infertile'. Also 
featured were donors and researchers. An interestingly missing frame, which appeared 
heavily in passed bills, is the child frame. Similarly, the woman frame does not appear to 
feature as heavily. However, regarding language and construction of the featured actors, 
there appears to be little difference between passed and failed legislation. Passed bills do 
place some constraints upon actors that have real enforcement mechanisms, but this is 
also found in failed legislation. The only difference between passed and failed is the 
representation of insurance actors, who appear to represent a greater fraction of the actors 
targeted in failed bills than in successful bills. However, there are also significantly fewer 
pieces of failed legislation, which means that the possibility that there will be one bill that 
does or does not contain one actor over another increases. 
 Regarding the frames that were presented in this subset, the primary actor for 
whom policy action was being taken appeared to be consumers. This is the case for two 
bills focusing on insurance coverage and one on the structure of advertising. The failed 
legislation addressing advertising primarily focuses on physicians. Gamete donation does 
not appear to target a particular group, instead imposing penalties on anyone making the 
attempt to sell or buy human tissue. As such, the social construction of each of these 
actors would appear to also be contenders. While the generic terminology to describe 
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actors within the gamete donation bill may make it appear that these actors would be 
classified under the deviant construction, a closer look at the text of the legislation 
appears to limit the punishment to only civil action in the form of a fine, similar to those 
applied to physicians in both the passed bills and failed bills of California legislation. An 
example can be seen below. 
This bill would provide that any person who clones a human cell, or purchases or sells an ova, zygote, 
embryo, or fetus, for the purpose of cloning a human being, shall be punished by a 
 
criminal    fine    ,  by  imprisonment  in  a  county  jail  for 
 
not  exceeding  one  year,  or  by  both  a  fine  and  imprisonment (AB 1251) 
This may also be because the issue is considered to be tied directly to medicine, given that the 
billcontains a clause relating to professional conduct, as in the example below: 
It would make a violation an act of unprofessional conduct under the Medical Practice Act. The bill 
would also require the revocation of the local business license of any business that violates this 
provision. By creating new crimes, this bill would impose a state-mandated local program. 
 Overall, it can be seen that the construction of actors within both California failed 
and passed bills radically differed from the hypothesized relationship between actors and 
actions. While the social constructions are similar to those found in the federal level bills, 
their influence over the ability of bills to get passed is not evident at all. Another 
distinguishing factor of California bills is the inclusion of several non-traditional frames, 
even though they were couched within a more traditional frame such as family. More 
generally, California bills exemplify the limitations of frame on the ability to get bills 




4.2.3 An overview of the contents of the Georgia level bills 
 
Figure 18: Time line of Georgia Bills. The passed bills are highlighted in blue. 
 Of the legislation examined for this study, Georgia had the smallest subset over 
that shortest period of time. As can be seen from the time line above, a majority of 
legislation has occurred after 2005, with three bills occurring before 2005. As can be 
seen, the only ones that managed to pass occurred in 2007 and 2009. As mentioned 
earlier in this section, Georgia bills presented an interesting challenge for analysis. For 
one, Georgia bills appeared to have no key term identifying the present state of policy 
and the goal to be accomplished by new policy. This is similar to the status of 
approximately half of the pieces of federal level legislation. Therefore, the purpose 




4.2.3.1 Georgia Passed Bills 
 As can be seen in the Figure 18 time line, both of the passed bills occurred after 
2005. Even further, it can be seen that one of the passed pieces of legislation is a 
resolution rather than a bill and therefore functions in a different manner than the other. 
Of the passed legislation, the first was passed for the purpose of establishing a committee 
“on Rights Relating to Reproductive and Genetic Technology”. The composition of this 
committee provides a clear example of what concepts are closely associated with ARTs, 
as can be seen in the excerpt below: 
...the Senate Study Committee on Rights Relating to Reproductive and Genetic Technology to be 
composed of seven members of the Senate. The chairpersons of the Senate Judiciary Committee, 
Senate Health and Human Services Committee, and Senate Science and Technology Committee 
shall each be a member, and the other four members shall be appointed by the Lieutenant 
Governor. (SR 280) 
It is clear from this that the primary conceptual associations with ARTs are health and 
science. Given this to be the case, it is clear that the constructions that can potentially be 
applied to this area are potentially perceived to be limited. The other piece of legislation 
dealt with the adoption of embryos (HB 338). From the structure of HB 338, it is clear 
that the child frame is an important aspect of this bill, despite the fact that the bill's 
underlying structure is derived from a more traditional frame. An even more interesting 
aspect of this frame is its general recognition of the embryo as an actor with its own 
interests, as opposed to an object, as is found in many of the other bills utilizing the term. 
This can be seen in such statements as the one below: 
(5)   'Recipient  intended  parent'  means  a  person  or  persons  who  receive  a  relinquished  
24embryo  and  who  accepts  full  legal  rights  and  responsibilities  for  such  embryo  and  any  
25child  that may be  born  as  a  result of  embryo  transfer. (HB 388) 
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Given this case, it is clear that keying, in the Goffman sense, has occurred because the 
entity has undergone a transformation from an object to an actor, in some sense. Even 
further, this bill heavily utilizes the child frame and subsumes the traditional frame of 
family through its language, by emphasizing the embryo and the potential future child to 
be born of that embryo, while removing the distinguishing factors of a more traditional 
frame like 'family', which would be expected to emphasize parenthood and parent-child 
relationships. Alternatively, it also does not utilize a 'couple'/'consumer' frame at all, 
instead placing an emphasis upon the embryo/child guardianship. In effect, this bill is an 
example of utilizing terms to address an alternative frame. 
4.2.3.2 Georgia Failed Bills 
 As can be seen from the time line in Figure 18, the number of failed bills in 
Georgia far outnumber the passed bills. The primary actors of interest within these bills 
consist of couples, insurers, and physicians, similarly to the previous subsets. However, 
Georgia failed bills utilize the child frame far more heavily that previous subsets. For 
instance, in one failed bill, the term 'unborn' is used: presumably to reference that the 
entity in question is an actor only limited by its lack of birth. This example from HB 
1358, can be seen below: 
Inheritance rights shall not flow  to the in vitro human embryo as a legal person unless the  
1in vitro human embryo develops into a fetus and is born in a live birth or at any other time  
2when  rights  attach  to  an  unborn  child  in  accordance  with  law.   As  a  legal  person,  the  in  
3vitro  human  embryo  that  is  born  in  a  live  birth  as  a  result of  embryo  adoption  to  
another  
4couple  shall not retain  its  inheritance  rights  from  the  biological parents." (HB 1358) 
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The heavier use of the child frame may be an example of frames causing the failure of 
legislation, though it can be seen in both passed and failed Georgia bills, that this 
particular frame is more favored. Regarding the other actors, 'physician' is used in half of 
the bills, in which it acts as primarily a source of authority with regard to the 'couple' and 
other actors within. For example, in HB 1073, the physician is the authority through 
which a commissioning couple may enter into a surrogacy contract, and makes 
arrangements for embryos in the case of unforeseen circumstances such as divorce. 
However, as the authority in the ART transaction, the physician also appears to be given 
the burden of 'safekeeping' of embryos and other parties involved, as can be seen in the 
wording of HB 1358, below: 
Any physician  or medical facility that causes  fertilization  of  a  human  ovum  in vitro shall  
1be  directly responsible  for the  safekeeping  of  the  in  vitro  human  embryo. (HB 1358) 
4.2.4 Comparisons between frames and conclusions 
 Across all bills, it becomes apparent that some frames are more easily teased out 
than others. A primary example of an easily distinguished frame would be the 'child' 
frame, which was apparent in both California and Georgia legislation. Other frames, such 
as 'society', were not as easily distilled. It is not clear whether this was the case because 
'society' frames are assumed to occur with any state action, or because the instrument 
with which to identify the frame requires refinement. Similarly, the 'women' frame also 
proved difficult to distill from the legislation presented here. In part, it could also be 
argued that the frames were constrained by the overarching metanarrative of 'health', 
which would automatically place some actors in positions of prominence, while limiting 
or excluding others. 
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 Through this exercise of distilling frames from the many subsets of narrative, a 
few concepts hopefully have become apparent. For one, physicians and other health 
professionals continue to dominate this particular policy arena. This limits the potential 
policy options, as shown previously by Harris (2010). Their heavy involvement over their 
own management, as shown by the frequent use of the individual physician or the 
professional organization representing physicians, provides evidence that they act as 
contenders, according to the Schneider and Ingram social construction classification. 
Even further, it becomes apparent that while it has been argued that their political power 
has waned with the advent of managed care, it is clear that as a group they are still 
perceived favorably enough to act as a trusted expert in activities related to the practice of 
medicine. 
 It is also important to note the emphasis placed upon the consumer/couple as a 
dominant actor to receive benefits, in the form of increased access to the treatment 
through mandates on insurers, or through increased access to information through 
application of certification and screening processes. However, despite the application of 
legislation on their behalf, it does not appear that they carry much political power, which 
is why they have been designated here as being a socially constructed 'dependent' group. 
Even further, some of the legislation that has been formulated on their behalf appears to 
be primarily rhetorical, for example, the mandate upon embryo laboratories certification 
found in FCSRCA (1992). 
 The other remaining actors' role in the framing of legislation relating to this issue 
provide an interesting contrast between the cases under study, for example the emphasis 
on the child frame as the dominant alternative frame in Georgia, whereas the dominant 
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California alternative frame was more heavily focused upon women or the public. 
However, what is clear from the small sample set presented here is that the use of 
alternative frames is limited, and requires further study as to what may determine the 






5.1 Contribution to theory 
 Overall, it is believed that this study has shown the existence of frames within 
legislation. It is hoped that future study will attempt to provide further means through 
which to more systematically approach the study of frames, particularly within 
legislation. While this study only examined those bills that directly reference the topic of 
interest, it is believed that a broader selection of bills could be used to refine the methods 
of systematic frame analysis, for the purpose of use with large data sets. Moreover, the 
examination of multiple iterations of policy could also be of interest in understanding the 
process of frame development. This multiple iterations method could also shed further 
light on the development of ART-related policy, particularly in clarifying the appearance 
and cutting of ART terms from different iterations of bills. 
 Regarding the contributions to the literature, it is believed that this study brings 
multiple aspects of frame analysis to the forefront. First, the attempt to parse out the 
social construction of actors as a means of developing the frame itself provided a 
different way of viewing the actors and their activities within legislation. This is in 
contrast to some of the publications of the MAGEEQ project, which used frame analysis 
for the purpose of evaluating the means by which gender issues were incorporated in 
European Union policy (Verloo, 2004; Lombardo & Meier, 2006), and developed a frame 
based off of four concepts: the diagnosis of what's wrong, attribution of causality to 
whom, the prognosis of what should be done, and the call for an actor to do something 
(Verloo, 2004). Using this initial frame, it was the intent of this study to utilize the social 
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constructions of actors, per the definitions provided by Ingram and Schneider in Design 
for Democracy, to determine the frames of legislation (1997). The purpose of uniting 
these two frameworks for the examination of legislation was to capture the interaction 
between the proposed problem and solution within legislation, thus attempting to distill 
both explicit and implicit actors within legislation. 
 Even further, it was the purpose of this paper to extend previous work on applying 
CAQDAS to frame analysis. The attempt to use a process of distilling word counts was 
only partially successful in describing the narrative of the legislation. It is believed that 
this process could be further improved by further distilling the word counts into other 
grammatical features, and running a matrix analysis across the actors along with these 
additional grammatical features. This could potentially provide further systematization to 
the process of frame prediction and discovery, thus guiding the frame analysis method 
towards a more empirical analytic process. 
5.2 Limitations and contribution to ART policy literature 
 Overall, while it may appear that the data set of this study was far from small, it is 
the belief of the author that it would further benefit from a larger selection of legislation 
in future study, so as to better clarify whether the lack of frames such as those relating to 
women and children at the federal level, or women at the state of Georgia level, is a result 
of the frame not occurring or a limiting factor of the overall metanarrative. Similarly, an 
analysis of the multiple iterations of legislation could also be beneficial in better 
understanding the role, existence and persistence of frames within legislation. 
 Additionally, it is believed that this study provided some clarification of the social 
constructions around different ART actors. While it is limited in the conclusions that can 
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be drawn, it is clear that most of the social constructions are persistent in each of the 
cases studied, despite the fact that they are implemented slightly differently. While some 
social constructions are non-existent in certain cases, such as women and children at the 
federal level, this may be due to jurisdictional issues as much as a lack of mobilization of 
such frames. 
5.3 Policy implications 
 The overarching policy implications tie primarily back to the concept of 
mobilization in social movement theory. It is perceived here that, at the federal level, 
there is little mobilization of non-traditional frames. This may be a function of the 
previously observed fragmentation of actors, as presented by Goggin and Orth (2004). 
However, it could also be argued that this is the result of structural factors such as 
federalism and power distribution. Given the observation that there is persistence of some 
social constructions and frames at all levels, it would appear to indicate that some 
organization may occur beyond just historical structuring. Even further, given the 
historical power balance, as presented in the historical analysis of Chapter 1, the 
development of such a structure should be neither surprising nor its persistence 
unexpected. Without the mobilization of an alternative metanarrative, particularly with 
regard to reproduction, the ability to 'change course' with regard to policy would 
seemingly be difficult, thereby resulting in the current regulatory scheme found in the 




APPENDIX A: TABLES OF REPORTS 
Table 6: EAB Report Recommendations 
Major Ethical Issues  
Moral status of the Embryo “'Profound respect...but....not...full legal and moral rights 
attributed to persons.” 
“Embryo loss associated with attempts to assist otherwise 
infertile couples bear children of their own...may be regarded 
as ethically acceptable from an ethical standpoint, under 
certain conditions (emphasis own)” 
 Safety of mother and offspring “it is concerned, as well, about the physical and mental 
health of the children born following such a procedure and 
about their legal status. Many women have told the Board 
that in order to bear a 
child of their own they will submit to whatever risks are 
involved....Department should not interfere with such 
reproductive decisions, it has a legitimate interest in 
developing and disseminating information regarding safety 
and health so that fully informed choices about reproduction 
can be made.” 
Adverse effects of technological intervention “...broad prohibition of research involving human in vitro 
fertilization is neither justified nor wise. Among the 
developments warned against by some who testified before 
the Board, a few ( e.g. , the 
cloning of human beings and the creation of animal/human 
hybrids) are of uncertain or remote risk.” 
 
“Other abuses may be avoided by the use of good judgment 
based upon accurate information of the type collected by the 
Board and now being disseminated in this report.” 
Federal funding “The Board concluded that it should not advise the 
Department on the level of Federal support, if any, of such 
research; but it concluded that Federal support, if decided 
upon after due consideration of all that is at issue, would be 
acceptable from an ethical standpoint.” 
Overall Report Conclusions  
Support of in vitro fertilization/ embryo transfer research to 
better understand the fertilization process 
More data would be beneficial to draw additional 
conclusions from regarding the rate of abnormal embryo 
creation and further experimentation in animal models  
Ethically acceptable to conduct research involving human in 
vitro fertilization 
With 2 caveats and 5 sub-caveats: 
(a) human research without embryo transfer involves: (1) 
research that complies with all provisions governing research 
with human subjects; (2) research is designed to establish 
safety and efficacy and obtain acquire information for that 
purpose that is not otherwise attainable; (3) gametes are 
obtained from informed persons on their use and that have 
consented to that used; (4) embryos will not be held beyond 
normal implantation period; (5) advisement of the public will 
 
 111 
Table 6: EAB Report Recommendations 
Major Ethical Issues  
occur in the discovery of a higher than normal risk of 
abnormal offspring production 
(b)research involving the transfer of gametes through IVF 
only be conducted with married couples 
Ethically acceptable for the department to conduct or 
support IVF research, but chooses not to address the level, if 
any, funding 
Assuming the caveats of conclusions 2 are met 
 
 
Table 7: OTA 1988 Report Recommendations 
Policy issue Potential congressional action Policy options 
Should the Federal Government 
improve collection of data on 
reproductive health? 
“The Federal Government has an 
interest in collecting 
data in three areas of infertility: factors 
contributing to infertility, its 
prevalence, and the outcome of certain 
treatments.” 
 
“Option I: Take no action.” 
“Option Z: Appropriate funds for the 
Secretary of Health and Human 
Services to make grants to State public 
health departments for the establishment 
of a national surveillance system on 
chlamydial infection.” 
“Option 3: Direct the Secretary of 
Health and Human Services to enhance 
the collection of data on infertility.” 
“Option 4: Establish a systematic 
method for registering 
the birth of IVF babies and for 
following 
the development and health of these 
infants.” 
Should efforts toward prevention of 
infertility be enhanced? 
“The Federal Government supports no 
identifiable activities expressly directed 
toward prevention of infertility. It 
supports several activities allied with 
prevention of infertility, such as NCHS 
collection of descriptive data about 
infertile couples, contraceptive research 
funded by NIH and the Agency for 
International Development, and 
programs of the Centers for Disease 
Control that aim to prevent sexually 
transmitted diseases.” 
“Option 1: Take no action.” 
“Option 2: Amend the Public Health 
Service Act to extend the program of 
grants for prevention and control of 
sexually transmitted diseases to include 
prevention of infertility secondary to 
sexually transmitted diseases.” 
“Option 3: Evaluate Federal efforts to 
prevent infertility.” 
“Option 4: Establish a demonstration 
project for identification of risks for 
infertility.” 
“Option 5: Enhance education in 
reproductive health.” 
Should the Federal Government ensure 
that consumers of selected infertility 
services have the information to make 
informed choices? 
“Congress generally does not 
regulate medical practice, with the 
exception of drawing broad criteria 
for care delivered at Veterans’ 
“Option 1: Take no action.” 
“Option 2: Encourage the use of a 
consensus review or conference on the 
use of IVF, gamete intrafallopian 
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Table 7: OTA 1988 Report Recommendations 
Policy issue Potential congressional action Policy options 
Administration hospitals or 
reimbursed by Federal insurance 
programs. Nor are medical 
techniques subject to consumer 
protection legislation, with the 
notable exception of Food and Drug 
Administration regulations for 
testing drugs and devices, and for 
regulating advertising of their 
indications and efficacy. Rather, 
quality assurance and consumer 
protection issues are left to State 
legislatures, professional societies, 
consumer groups, and word-of-
mouth.” 
transfer, and other innovative 
treatments for infertility.” 
“Option 3: Extend consumer protection 
laws to selected infertility services.” 
Preexisting mechanisms for gaining 
access to infertility diagnostic and 
treatment services adequate? 
Currently, those who can afford to 
pay for infertility services out-of-
pocket have the greatest access. To 
consider use of newer medical 
technologies, infertile individuals 
need to be able to pay anywhere 
from several hundred dollars to 
more than $22,000. Individuals with 
some private insurance coverage 
generally can expect to have a large 
portion of their expenses covered 
during the diagnostic phase, with 
considerable variability of coverage 
for infertility treatments.” 
Option 1: Take no action. 
Option 2: Direct the Health Care 
Financing Administration of the 
Department of Health and Human 
Services to review and report on the 
extent of existing coverage for 
infertility diagnosis and treatment 
services under the Medicaid and 
Medicare Programs 
Option 3: Amend the existing Federal 
Medicaid Program to add a new 
reimbursement category for services 
related to the diagnosis and treatment 
of infertility. 
Option 4: Amend Title 5 of the U.S. 
Code to provide that any carrier offering 
obstetrical benefits under the health 
benefits program for Federal 
employees shall also provide benefits 
for medical procedures to overcome 
infertility, including procedures to 
achieve pregnancy and to carry 
pregnancy to term. 
Option 5: Facilitate adoption, a social 
alternative to infertility treatment. 
Should the Veterans’ Administration 
provide infertility diagnosis and 
treatment? 
For the VA to provide care to a 
veteran, at least four conditions 
must be met: the veteran must 
have a disability, the VA care must 
be for that disability,the care must 
be necessary, and the care must 
constitute hospital care (including 
Option I: Take no action. 
Option 2: Direct the Administrator of 
the Veterans’ Administration to 
interpret disability to include the 
inability to procreate. 
Option 3: Amend Title 38 of the U.S. 
Code to specify that infertility 
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Table 7: OTA 1988 Report Recommendations 
Policy issue Potential congressional action Policy options 
medical treatments). These 
provisions mean that veterans 
currently obtain only limited 
treatment for infertility from the 
VA. 
treatments including but not limited to 
IVF, gamete intrafal]opian transfer, 
and artificial insemination may be 
provided by the Veterans’ 
Administration 
Should the transfer of human gametes 
and embryos be regulated? 
Sperm are sold by commercial 
sperm banks throughout the United 
States and have been for many 
years. 
 
Donation of unfertilized ova is 
today occurring at a number of 
infertility clinics. A few have begun 
to pay women to undergo hormone 
stimulation and ovum retrieval, 
sometimes in the course of 
voluntary sterilization by tubal 
ligation. Ovum banking using 
frozen ova has yet to become 
available, but considerable research 
is under way to make this feasible 
 
Embryos that remain after IVF 
procedures are not yet sold, as 
clinics and hospitals have chosen 
instead to give parents the choice of 
having them frozen, destroyed, or 
donated. 
Option 1: Take no action. 
Option 2: Mandate national standards 
for protection of paid ovum donors. 
Option 3: Mandate national standards 
for protection of recipients and 
offspring. 
Option 4: Ban commercial sales of 
embryos. 
Should anyone accepting or transferring 
human gametes keep nonidentifying 
genetic records on behalf of the 
potential child? 
Donation of human gametes is 
usually accompanied by an oral 
patient history including important 
genetic information that can become a 
formal written record. Such information 
is routinely obtained by those who 
operate sperm banks as they screen 
donors. Currently, however, the 
type of information that is collected 
and the ways in which it is 
maintained and transferred vary 
greatly. This variation is 
particularly significant 
because the predictive value of 
genetic history may increase in 
coming years. 
Option 1: Take no action. 
Option 2: Mandate that operators of 
sperm, ova, and embryo repositories, or 
anyone who transfers these materials, 
maintain written records 
detailing the non-identifying genetic 
history of all gamete donors and that 
this information be available to the 
recipients of gametes or embryos 
and the eventual offspring. 
Should commercialized surrogate 
motherhood be regulated by the Federal 
Surrogate motherhood is an 
infrequent but increasingly 
Option 1: Take no action. 
Option 2: Review developments in State 
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Table 7: OTA 1988 Report Recommendations 
Policy issue Potential congressional action Policy options 
Government? popular arrangement used by 
infertile couples, singles, and 
homosexuals as an alternative 
to adoption and perhaps infertility 
treatment in their efforts to form a 
family. Surrogacy arrangements 
are based upon principles of 
contract and family law, and 
therefore are largely within 
the traditional domain of State 
legislative activity. 
law related 
to surrogate motherhood. 
Option 3: Facilitate development of 
State legislation 
related to surrogate motherhood 
Option 4: Facilitate interstate 
cooperation and harmonization 
of State laws. 
Option 5: Mandate national standards 
for surrogate 
motherhood arrangements or 
commercial 
intermediaries 
Option 6: Facilitate international 
agreements concerning 
transnational surrogacy arrangements. 
Option 7: Ban commercialized 
surrogate motherhood. 
Do some areas of reproductive research 
require additional support? 
Federal support of human 
reproductive research 
is concentrated in two agencies of 
the Public 
Health Service: NIH (in particular, 
the National 
Institute of Child Health and 
Human Development 
and the National Institute of 
Environmental Health 
Sciences) and CDC (in particular, 
the National Institute 
for Occupational Safety and Health 
and the 
National Center for Health 
Statistics). 
Option 1: Take no action. 
Option Z: Expand Federal support for 
research in male infertility. 
Option 3: Expand Federal support for 
research on the psychology of 
participants in assisted conception. 
Option 4: Direct the Secretary of Health 
and Human Services to review, solely 
for scientific merit, research involving 
human sperm, eggs, and early embryos. 
Option 5: Mandate the appointment of 
an Ethics Advisory Board within the 
Department of Health and Human 
Services. 
Option 6: Direct the Secretary of Health 
and Human Services to implement (and 
update as needed) the 1979 
recommendations of the Ethics 
Advisory Board. 
Option 7: Direct the congressional 
Biomedical Ethics Board to develop 
guidelines for federally funded research 
with human sperm, eggs, and embryos. 
 
Table 8: PCB Report Recommendations (specifically regarding ARTs) 
General conclusions  
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Table 8: PCB Report Recommendations (specifically regarding ARTs) 
A.1. Institutional governance a) There is minimal direct governmental regulation of the practice 
of assisted reproduction and  
b)extensive, voluntary professional self-regulation of the practice of 
assisted reproduction. 
A.2. Substantive areas of 
concern 
a) There is no comprehensive mechanism for data collection, 
monitoring, or oversight of the effects of ARTs on children or 
gestational mothers, 
b) there is no uniform law of access, 
c) there is no oversight of novel practices once moved into clinical 
practice, 
d) there is no uniform system of public review and deliberation 
regarding human or social significance of ARTs 
E. Commerce There is no comprehensive mechanism for regulation of commerce 




APPENDIX B: LIST OF SEARCH TERMS 
List of Search terms used to find ART bills 
• in vitro fertilization/invitro fertilization 
• IVF 
• assisted reproduction 
• assisted reproductive medicine 
• assisted reproductive technology 
• medically assisted reproduction 
• infertility treatment 
• fertility treatment 
• human reproductive technologies 
• gamete intrafallopian transfer 
• zygote intrafallopian transfer 
• artificial insemination 
 
EXLUDED TERMS 
• infertility [alone] 
• fertility [alone] 
• infertility drugs [not in conjunction with other terms] 
• reproductive HARM 
• reproductive health/care [alone] 
• reproductive toxicity 
• interpregnancy care 
• fertility drugs 
• fertility preservation 
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APPENDIX C: FRAMES & SOCIAL CONSTRUCTIONS 
Table 9: Frames 





feminist • Changes female role 
• alters value of female 
body 
• creates incentive to 
'loan out' one's body 
• allows for the 
(re?)construction of 
the female body as 











• Alters value of child 
• There is a lack of 
representation of the 
child in the process, 
outside of the parent 
• alters value of 
embryo 
• creates the possibility 
of abortion 
• increases the health 








• Collect data on  
additional animal 
models 
• Require informed 
consent 
• Collect data on the 
resultant children 
of IVF 
• Evaluate the 
psychological 
wellbeing of both 
child and parents 
• Create rules on the 
number of 






woman • Little provision of 
'sufficient' drug 
testing 
• representation of 
woman is as 
'desperate 
dependent' 







• Collect longitudinal 
data on fertility 
treatments and 
users 














society • Long term fertility 
impact 
• Creates a need for 
new legal definitions 
• Provides new 





• Collect longitudinal 
IVF birth data 
• Create legal 
clarification of 
'familyhood' 
• create rules on the 








Table 9: Frames 
 Position Diagnosis Attribution of 
Causality 
Prognosis Proposition 
• Differential access/ 
economic costs 
(Creation of a 
disparity between 
haves and have-nots 
with regard to 
reproductive access) 
• Potential 'misuse' 
(eugenics, sex-
selection, cloning) 




• 'Market' for human 
parts (gametes) and 
bodies (surrogacy) 
• The potential for an 
increase in disabled 
babies 
• The potential for 
unclear genetic 
lineages (siblings 
that have grown up 
with different 
'parents') 









• create clear rules 
on the use(s) of 
PGD 
• create limits on age 
access and use of 
IVF 
• institute strict rules 
on cloning 
• collect clear genetic 




religion • Circumvents nature/ 
God's will 
• 'Defeating' the 
purpose of 
'procreation' 
• Creates the 
possibility for the 
destruction of 
embryos 
'doctors' • Ban IVF use legislators 
socio-
technological 
• Allows for too much 
technological 
intervention 









• Insufficient access 
• High cost 






Table 9: Frames 
 Position Diagnosis Attribution of 
Causality 
Prognosis Proposition 
• Inaccurate success 
rates 
• Telling the child their 
parentage 
• Positive versus 
negative right to 
genetic reproduction 
insurance to cover 
access to IVF 
treatments 




'live birth rates' 
• Otherwise create 
rules making the 





Physician • Too much 
intervention by the 
government 
• Sufficient governance 
at the professional 
level 
Government • Maintain 
professional 
autonomy 













Table 10: List of actors distilled from all bills 
1 : administrator 31 : donor 61 : organization
2 : adult 32 : embryo (2) 62 : owner
3 : agency 33 : employee 63 : parent
4 : agent 34 : employer 64 : participant
5 : applicant 35 : entity 65 : partner
6 : attorney 36 : family 66 : patient
7 : beneficiary 37 : female 67 : people
8 : board 38 : fetus 68 : person
9 : body 39 : government 69 : personnel
10 : business 40 : group 70 : petitioner
11 : center (2) 41 : guardian 71 : physician
12 : child 42 : gynecologist 72 : policyholder
13 : citizen 43 : holder 73 : population
14 : client 44 : hospital 74 : product
15 : clinic 45 : human 75 : professional (2)
16 : commissioner 46 : husband 76 : program
17 : committee 47 : individual 77 : public
18 : community 48 : institute 78 : recipient
19 : company 49 : institutions 79 : representative
20 : consumer 50 : insurance 80 : school
21 : contractor 51 : insurer 81 : secretary (2)
22 : coordinator 52 : juvenile 82 : society
23 : corporation 53 : laboratory 83 : spouse
24 : counsel 54 : life 84 : stakeholder
25 : county 55 : member 85 : state (2)
26 : couple 56 : mother 86 : surgeon
27 : court 57 : nonprofit 87 : unborn
28 : department 58 : obstetrician 88 : woman
29 : director 59 : office 89 : workers

























Table 11: Nvivo stop terms 
stop words 
if s into on as 
will such no or these 
and that in with  
not the for was  
but Their by to  
and Then be they  





APPENDIX D: BILLS 
Table 12: The bills 
Federal HR 1931: `Childless Veterans Assistance Act of 1989'. 1989 
HR 1199: no title 1989 
HR 5110: `Fertility Clinic Success Rate and Certification Act' 1990 
HR 1161: `Women's Health Equity Act of 1991'. 1991 
HR 3940: `Fertility Clinic Success Rate and Certification Act of 1991' 1991 
HR 756: `Fertility Clinic Success Rate and Certification Act'. 1991 
HR 4773`Fertility Clinic Success Rate and Certification Act of 1992'. 1992 
S 1757: `Health Security Act'. 1993 
HR 568: `Contraception and Infertility Research Centers Act of 1993'. 1993 
S 168: Affordable Health Care for All Americans Act’’. 1995 
HR 2774: no title 1999 
HR 2706: `Family Building Act of 1999'. 1999 
HR 4532: `Equity in Fertility Coverage Act of 2000'. 2000 
S 2160: `Fair Access to Infertility Treatment and Hope Act of 2000'. 2000 
S 874: `Fair Access to Infertility Treatment and Hope Act of 2001'. 2001 
HR 2608: `Cloning Prohibition Act of 2001'. 2001 
HR 2172: `Cloning Prohibition Act of 2001'. 2001 
HR 1246: no title 2001 
HR 389: `Family Building Act of 2001'. 2001 
S 303: `Human Cloning Ban and Stem Cell Research Protection Act of 2003'. 2003 
S 1726: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2003 
HR 3350: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2003 
HR 3026: no title 2003 
HR 3014: `Family Building Act of 2003'. 2003 
HR 1852: `Equity in Fertility Coverage Act of 2003'. 2003 
HR 969: `Medicare Infertility Coverage Act of 2003'. 2003 
HR 801: `Cloning Prohibition Act of 2003'. 2003 
HR 4872: `Retinoblastoma Awareness and Prevention Act of 2004'. 2004 
S 707: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2005 
S 876: `Human Cloning Ban and Stem Cell Research Protection Act of 2005'. 2005 
HR 2861: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2005 
HR 2759: `Equity in Fertility Coverage Act of 2005'. 2005 
Hr 2758: `Medicare Infertility Coverage Act of 2005'. 2005 
HR 2574: ‘‘Respect for Life Embryonic Stem Cell Act of 2005’’. 2005 
HR 1822: `Human Cloning Ban and Stem Cell Research Protection Act of 2005'. 2005 
HR 1418: `Infertility Coverage for Federal Employees, Military Personnel, and their Families Act'. 2005 
HR 735: `Family Building Act of 2005'. 2005 
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Table 12: The bills 
S 363: `Hope Offered through Principled, Ethically-Sound Stem Cell Research Act' 2007 
S 812: `Human Cloning Ban and Stem Cell Research Protection Act of 2007'. 2007 
HR 2892: `Family Building Act of 2007'. 2007 
HRes 322: not title 2007 
HR 1424: `Paul Wellstone Mental Health and Addiction Equity Act of 2008'. 2008 
HR 493: `Genetic Information Nondiscrimination Act of 2008'. 2008 
S 1258: `Family Building Act of 2009'. 2009 
HR 697: `Family Building Act of 2009'. 2009 
California SB 1780: Health insurance: infertility treatment coverage. 1994 
AB 1101: Health care coverage: contraceptive drugs: family planning: reproductive health. 1995 
SB 1363: Personal rights: human tissue. 1995 
SB 1964: Discrimination in employment and 
housing. 
1996 
SB 1555: Sperm, ova, or embryos: use and implantation 
without authorization. 
1996 
AB 2513: Physicians and surgeons: assisted reproduction 1996 
SB 1349: Committee on Business and Professions. Vocations: 
Pharmacy Law: sanitizers. 
1997 
AB 1251: Human cloning. 1997 
AB 441: Tissue donors: sperm donors. 1997 
AB 764: Food and drug inspections. 1997 
AB 589: Health care coverage: clinical practice guidelines. 1998 
AB 2040: Parent and child: assistive reproductive technologies. 2000 
SB 1630: Assisted reproductive technology. 2000 
AB 525: Health benefits: reproductive health care. 2000 
AB 1826: coverage: infertility treatment. 2002 
SB 1272: Stem cells: human tissue: research. 2002 
SB 1557: Human cloning. 2002 
SJR 38: Stem cell research. 2002 
AB 1996 2002 
SB 1230 2002 
SB 133: Human cloning. 2003 
AB 267: Cloning: humans. 2003 
SB 771: Human cells: embryo registry: egg cell donation. 2003 
AB 2380: Parent and child relationships. 2004 
SB 18: Reproductive health and research. 2004 
AB 2512: Fetal pain prevention. 2006 
SB 1260: Reproductive health and research. 2006 
SB 1325: Adoption. 2006 
SB 1704: Health care benefits. 2006 
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Table 12: The bills 
SB 313: Adoption. 2007 
SB 443: Tissue donors: sperm donors. 2007 
SB 1726: Adoption. 2008 
SB 1184: Public Health 2008 
AB 941: Adoption. 2009 
AB 1317: Assisted oocyte production: advertisement: 
information. 
2009 
AB 1397: Tissue donation. 2009 
AB 1543: Medicare supplement coverage. 2009 
SB 674: Healing arts. 2009 
SB 1150: Healing arts. 2010 
AB 1487: Tissue donation. 2010 
AB 2020: Family law. 2010 
AB 2426: Surrogacy facilitators. 2010 
Georgia HB 1073 1996 
SB 451 1998 
HB 1012 2003 
SB 537 2006 
SR 280 2007 
HB 1384 2008 
HB 1358 2008 
SB 330 2009 
SB 204 2009 
SB 169 2009 
HR 5 2009 
HB 489 2009 
HB 351 2009 
HB 1 2009 
SR 156 2009 
HB 338 2009 
HB 228 2009 
 
Table 13: Time line 
Federal Human Embryo Transfer 1985 
Alternative Reproductive Technologies: Implications for Children and Families 1987 
Federal Employee Family-Building Act of 1987 1987 
Consumer Protection Issues Involving In Vitro Fertilization Clinics 1988 
Federal Employee Family-Building Act of 1987 1988 
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Table 13: Time line 
Medical and Social Choices for Infertile Couples and the Federal Role in Prevention and Treatment 1988 
HR 1931: `Childless Veterans Assistance Act of 1989'. 1989 
HR 1199: no title 1989 
HR 5110: `Fertility Clinic Success Rate and Certification Act' 1990 
HR 1161: `Women's Health Equity Act of 1991'. 1991 
HR 3940: `Fertility Clinic Success Rate and Certification Act of 1991' 1991 
HR 756: `Fertility Clinic Success Rate and Certification Act'. 1991 
Fertility Clinic Services 1992 
HR 4773`Fertility Clinic Success Rate and Certification Act of 1992'. 1992 
S 1757: `Health Security Act'. 1993 
HR 568: `Contraception and Infertility Research Centers Act of 1993'. 1993 
S 168: Affordable Health Care for All Americans Act’’. 1995 
HR 2774: no title 1999 
HR 2706: `Family Building Act of 1999'. 1999 
HR 4532: `Equity in Fertility Coverage Act of 2000'. 2000 
S 2160: `Fair Access to Infertility Treatment and Hope Act of 2000'. 2000 
S 874: `Fair Access to Infertility Treatment and Hope Act of 2001'. 2001 
HR 2608: `Cloning Prohibition Act of 2001'. 2001 
HR 2172: `Cloning Prohibition Act of 2001'. 2001 
HR 1246: no title 2001 
HR 389: `Family Building Act of 2001'. 2001 
S 303: `Human Cloning Ban and Stem Cell Research Protection Act of 2003'. 2003 
S 1726: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2003 
HR 3350: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2003 
HR 3026: no title 2003 
HR 3014: `Family Building Act of 2003'. 2003 
HR 1852: `Equity in Fertility Coverage Act of 2003'. 2003 
HR 969: `Medicare Infertility Coverage Act of 2003'. 2003 
HR 801: `Cloning Prohibition Act of 2003'. 2003 
HR 4872: `Retinoblastoma Awareness and Prevention Act of 2004'. 2004 
S 707: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2005 
S 876: `Human Cloning Ban and Stem Cell Research Protection Act of 2005'. 2005 
HR 2861: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2005 
HR 2759: `Equity in Fertility Coverage Act of 2005'. 2005 
Hr 2758: `Medicare Infertility Coverage Act of 2005'. 2005 
HR 2574: ‘‘Respect for Life Embryonic Stem Cell Act of 2005’’. 2005 
HR 1822: `Human Cloning Ban and Stem Cell Research Protection Act of 2005'. 2005 
HR 1418: `Infertility Coverage for Federal Employees, Military Personnel, and their Families Act'. 2005 
HR 735: `Family Building Act of 2005'. 2005 
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Table 13: Time line 
S 363: `Hope Offered through Principled, Ethically-Sound Stem Cell Research Act' 2007 
S 812: `Human Cloning Ban and Stem Cell Research Protection Act of 2007'. 2007 
HR 2892: `Family Building Act of 2007'. 2007 
HRes 322: not title 2007 
HR 1424: `Paul Wellstone Mental Health and Addiction Equity Act of 2008'. 2008 
HR 493: `Genetic Information Nondiscrimination Act of 2008'. 2008 
S 1258: `Family Building Act of 2009'. 2009 
HR 697: `Family Building Act of 2009'. 2009 
California SB 1780: Health insurance: infertility treatment coverage. 1994 
AB 1101: Health care coverage: contraceptive drugs: family planning: reproductive health. 1995 
SB 1363: Personal rights: human tissue. 1995 
SB 1964: Discrimination in employment and 
housing. 
1996 
SB 1555: Sperm, ova, or embryos: use and implantation 
without authorization. 
1996 
AB 2513: Physicians and surgeons: assisted reproduction 1996 
SB 1349: Committee on Business and Professions. Vocations: 
Pharmacy Law: sanitizers. 
1997 
AB 1251: Human cloning. 1997 
AB 441: Tissue donors: sperm donors. 1997 
AB 764: Food and drug inspections. 1997 
AB 589: Health care coverage: clinical practice guidelines. 1998 
AB 2040: Parent and child: assistive reproductive technologies. 2000 
SB 1630: Assisted reproductive technology. 2000 
AB 525: Health benefits: reproductive health care. 2000 
AB 1826: coverage: infertility treatment. 2002 
SB 1272: Stem cells: human tissue: research. 2002 
SB 1557: Human cloning. 2002 
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In the last 30 years, in vitro fertilization (IVF) has created a significant amount of 
controversy around the world. Within the U.S., policy movement has been limited, 
occurring primarily at the state level, which has created a fragmented system of rules to 
manage the technology. However, there appear to be indications that how the issue is 
presented, and which actors are chosen to be represented in legislation, may impact the 
passage of policy, thereby also providing a reason for why little policy movement has 
occurred. In this study, pieces of federal, California and Georgia legislation were 
examined for the occurrence of differing frames, as identified by the actors presented, in 
order to determine whether different frames occurred in passed legislation than those 
found in failed legislation. It was determined that, while actors did not differ significantly 
between passed and failed legislation, there were some slight differences between actors 
used at the federal level, as well between the different state levels. Even further, the 








BRIEF INTRODUCTION TO ASSISTED REPRODUCTIVE 
TECHNOLOGIES AND THE POLICY REGULATORY ISSUES 
 
 In the United States, the clinical application of assisted reproductive technology 
(ART) has been understood to enjoy freedom from governmental intervention, 
particularly in contrast to many other developed countries. Although the research aspects 
of the technology (embryo research, cloning, etc.) have undergone extensive scrutiny and 
been subject to a number of policy restrictions, the clinical aspects have largely remained 
free of government policy constraints (Bleiklie, et al., 2004, p.83 ). In fact, the clinical 
application and use of ARTs have widely been observed to be largely exempt from 
governmental oversight, data collection and regulation, particularly at the federal level 
(Goggin & Orth, 2004, p. 83; DeMelo-Martin, 1999, p.65 ). In Bleiklie, Goggin and 
Rothmayer's Comparative Biomedical Policy, Goggin's chapter on the U.S. ART policy 
observes that the U.S. has little in policy with relation to access to ARTs. Even further, 
both the chapter by Goggin and a white paper by Rebecca Harris recognize the emphasis 
upon professional self-regulation as the primary rule type related to ARTs  (Goggin & 
Orth, 2004, p.92; Harris, 2010). Harris also points out that the traditional means of 
managing medicine seems to be the dominant model of managing ARTs in the U.S., 
stating that “[t]he model for medical regulation has been professional self-regulation, 
with licensing and liability torts as the primary tools of compliance. This places power 
squarely in the professional societies and medical practitioners (as well as medical 
malpractice insurance companies).” (Harris, 2010). 
 The few policy studies of the ARTs, such as those using Bleiklie, et al.' s 
Comparative Policy Design Framework (CPDF) and the white paper by Harris, make 
attempts to explain facets of the policy problems of the ART arena. Neither one, 
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however, appears to capture the full story of the lack of policy change within the U.S. 
policy context. The CPDF's particularly extensive study of institutional structure, actor 
coalitions, and policy designs (p. 5-13), informed the approach of this study, particularly 
the understanding of the coalition groups in existence. The Harris study provided some 
insight into the power situation of the arena. However, these earlier studies tend to appear 
highly static in nature, particularly ignoring the dynamics and history of the interactions 
they are studying. This study is an attempt to understand the policy arena as a dynamic 
system with strong policy currents that maintain the political policy structures. 
 This study views the policy making in a given arena as a dynamic, iterative 
process and focuses on how problem definition and policy framing affect the 
development and successful passage of ART policies on the federal and state levels. 
Some barriers to policy creation that have been pinpointed are due to the fragmentation of 
opposition groups (Rothmayr, et al., 2004, p.228 ), but this study proposes that additional 
constraints are due to the problem constructions (and solutions) found within the policies 
themselves and are influenced by the historical institutional structures of medical 
governance. 
1.1 A general overview of the technologies and the approach of this study 
 ARTs have held a relatively unique position in the U.S. policy world. Since their 
debut on the world medical stage in the late 1970s, they have been hailed as the solution 
to infertility problems faced by numerous 'traditional' couples each year. With the birth of 
Elizabeth Carr in 1981, the first 'test-tube baby' born in the U.S., hundreds of infertile 
couples in the U.S. found that they would now have the opportunity to have children to 
whom they were genetically related, just as other more fertile couples had been doing for 
generations. Further, numerous 'non-traditional' couples/parents would also be able to 
have children of their own. Through the years, ARTs have not escaped scientific scrutiny 
and appear to be both safe and effective. 
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 Despite this, these technologies as a treatment for infertility have not been free of 
criticism from other scholarly disciplines. Many of these critiques have stemmed from 
the fields of ethics and law, since many of these technologies either interfere with 
previously accepted ethical norms and beliefs, or because many of the controversies 
relate to complex, interrelated rights issues of the parents, their expected children, the 
practicing professionals, or other impacted groups, such as surrogates. For example, 
consider the argument outlined by Robert Blank and Janna Merrick in their book Human 
Reproduction, Emerging Technologies and Conflicting Rights (1995), about the lenses 
through which one can view reproductive rights: (1) the right not to have children, (2) the 
right to have children and (3) the right to determine the quality or characteristics of said 
children (1995, p. 5). Alternative bodies of critique also have developed in parallel to 
these mainstream arguments, such as in feminist law, in the sociology of medicine, in 
feminist ethics, and from the religious and pro-life communities. 
 These critiques often focused upon the impact of ART on the 'pillars' of society, 
such as family, health, and the research possibilities created through the use of these 
technologies (de Melo-Martin, 1999). Even further, questions have arisen regarding the 
ethical and economic incentives that arise due to the availability of such technology, such 
as embryo sex-selection and the transfer of excess embryos (Schonfeld, 2003; Collopy, 
2004). Moreover, some doubt has been cast on the effectiveness of evaluation methods 
such as health technology assessments, due to possible applications of socially 
constructed biases embedded in the assumptions of these methods (de Melo-Martin, 
1999). Examples of arguments over the impact of ART use include the altered role of 
women in society (Wilker, 1986; Kerian, 1997), the long-term effects of fertility drugs 
used in conception (Rutnam, 1991), the incentive to postpone conception (Heitman, 
1995), and the advent of gamete donation and surrogacy (Robertson, 1996; Kierien, 
1997). It has also been noted by scholars that there has been little federal policy 
development, despite the number of critiques. The sole exception to this is the Fertility 
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Clinic Success Rate and Certification Act of 1992 (FCSRCA), which publishes whether 
fertility clinics have a standardized process for transfer that falls within professional 
standards, and their success in accomplishing live births through their transfer process 
(Goggin & Orth, 2004, p.90). 
 Despite the fact that critiques of this technology are far from scarce, federal policy 
regarding their management has been limited in the last twenty-plus years that it has been 
in use (Eggen, 1991; de Melo-Martin, 1999). In fact, the management and regulation of 
ART practice has often appeared to gain saliency in public and political discourse only in 
the case of high-profile developments, such as the controversy surrounding 'octomom', or 
in cases of ethical conundrums, such as the price of egg donation. (Kolata, 1999; Kolata, 
1998; Naik, 2009). Even during these developments, passage of policy has not 
necessarily occurred. The reasons for the saliency of these issues have not always been 
clear. For example, the saliency of the 'octomom' event may have been derived from the 
fact that she relied upon public assistance to support her family, almost as much as the 
fact that she was the first to give birth to surviving octuplets (Bowe, 2009).  
Alternatively, the saliency of egg donation in New York appears to have been more 
focused on the ethics of economic incentives (Kolata, 1999; Kolata, 1998). While major 
reports such as 2004's Reproduction and Responsibility by the President's Commission on 
Bioethics pinpointed several areas of ethical concern and provided subsequent policy 
recommendations, little policy appears to have materialized (PCB, 2004). 
 In part, the lack of policy at the federal level has been argued to be a false 
indicator of policy movement and that a majority of regulatory action occurs at the state 
level (Adamson, 2002). It is important to note that this position of deferring to federalist 
principles is not unusual in the U.S., particularly with regard to medical policy (OTA, 
1988; PCB, 2004). According to Goggin & Orth, the states have been far more proactive 
in establishing oversight of ARTs than what is found at the federal level (2004, p. 92). An 
additional facet of regulation is the role of professional organizations, which are argued 
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to provide a number of self-imposed rules and which collect a significant amount of data. 
They are also recognized to play a significant role in the engagement of non-medical 
members of the community in oversight (Adamson, 2005; Aronson, 2000). This system 
of rules has largely been argued to suffer from significant fragmentation, which 
exemplifies how much the U.S. regulatory structure still differs from its counterparts and 
how little comprehensive oversight occurs (Rothmayr, et al., 2004, p.231). 
 With regard to public scrutiny, some highly publicized cases have reached 
mainstream media attention (Kolata, 1999; NYT, Feb. 12, 2009), but the issue of 
additional ART oversight appears to be pursued more heavily in scholarly and legal 
forums rather than public forums. There has been little exploration as to why this is the 
case, but it has been proposed that social construction within the policy arena may have a 
significant impact on how policy plays out (Rothmayr, et al., 2003, p.251). This may also 
be the case for the public forums. However, the intersection of ethics, law and policy on 
this topic has proven to be fertile ground for discussion, and has instigated a number of 
debates, including the role of ethics in policy analysis (Amy, 1984; Kenny & Giacomini, 
2005), and the extent to which policy may intervene in the lives of private citizens 
(Kenny & Giacomini, 2005). 
 To some extent, this debate between scholarly communities can be traced to the 
dispute over whether ART use is a private, health-related decision or a public and social 
health concern. In the sight of many, particularly medical professionals and consumers, it 
has been argued that ART applications are a matter of couples exercising their 
reproductive rights (Robertson, 1996). Key to this argument is the establishment of 
negative reproductive rights through the federal courts, examples of which include Roe v. 
Wade, among others (Roe v. Wade, 410 U.S. 113 (1973)). At points, there have even been 
attempts to extend this argument towards the positive right to reproduce, as evidenced by 
the disputes regarding coverage of procedures by employers, private insurance and 
publicly funded healthcare plans (Gordon, 2005). This concept of a right to reproduce has 
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been heavily relied on to trump many arguments for additional oversight, as additional 
oversight, data collection or monitoring could have the potential of interfering with 
privacy (Robertson, 1996). 
 In contrast to the reproductive rights argument, there is a diverse number of 
arguments against the open policies currently governing ART use, including 
considerations of the long-term impact upon women, the rights of the children produced, 
and cost to society overall. Examples of oppositional positions include the impact of 
health history knowledge on the part of children produced via donors (Daniels, 2000), the 
long term repercussions of drugs used in fertility treatments on the women using them 
(Jennings & Callahan, 2001), and the longitudinal data on children produced via IVF 
(Green, 2004). Beyond the argument about the need to institute policies to protect 
potentially vulnerable actors (such as women, children, or the infertile couple) and 
society, questions have also arisen regarding the effectiveness of internal, professional 
oversight in an industry that clearly benefits from the continuance of limited external 
oversight (Charo, 2002). Given the findings that infertile 'couples' may have altered 
perceptions of risk and that the physician holds some 'self-interest' within the transaction, 
questions regarding the clarity and objectivity of decision-making in these transactions 
have arisen also (Grobman, et al., 2001). 
 Social constructions have also been argued to play a role in the debate, both in 
how actors are targeted through policy and which actors are able to gain political 
legitimacy and access to the political arena (Goggin & Orth, 2004, p.93-96). The effects 
of actor social construction in this arena, as well as knowledge social construction, have 
not been heavily researched previously and therefore, the implications for policy have 
been unclear. As proposed by Helen Ingram and Anne Schneider, social constructions 
can play a role in policy power dynamics (Ingram & Schneider, 1997, p. 192-3), but can 
also potentially restrict policy solutions and even which problems are considered (Ingram 
& Schneider, 1997, p. 106). For example, the social construction of doctors as 'experts', 
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'uninfluenced by market forces', 'ethically above self-interest', have been argued to not 
only contribute to the ways through which they are targeted in policy, but also the 
historical means through which they can wield power politically (Stevens, 2002, Varone, 
Rothmayr & Monpetit 2006). As such, the role of social constructions is not minor in the 
study of this policy arena. 
 The purpose of this study is to understand the role and effects of frames in this 
policy arena, with frames here referring to the wording and rhetoric used to refer to the 
wording and structure of problems and solutions in a particular policy area. The 
institutional arena has been somewhat defined by previous studies (Bleiklie, et al., 2004; 
Varone, Rothmayr & Monpetit 2006), as have some of the power balances that may 
define the boundaries of the arena (Harris, 2010, Varone, Rothmayr & Monpetit 2006). 
This study hopes to shed further light on the role of frames in explaining the persistence 
of actor social constructions. A more tangential focus of this study is the historical 
constructions of actors, such as medical professionals, the historical development of 
reproductive rights and how the relationship between these two things yielded certain 
policy frames that gained traction early in the establishment of the ART policy arena1.  
Therefore, the initial focus of analysis will be on the history of specific actors of 
medicine and reproduction in ART. The following chapter will contain a breakdown of 
relevant groups and organizations for the purpose of finding frames and the final portion 
will consist of an examination of federal and state level legislation pertaining to the use 
of ARTs. The remainder of this chapter focuses on the state of the technology, an outline 
of past and current policies, the critiques of both the technology and its management, and 
will address the historical structures present. The subsequent chapters will address the 
                                                 
1
 Feedback is an important aspect of the effects of historical constructions on policy creation, but is 
outside of the scope of this current study. Even so, the author does acknowledge that history can be viewed 
as constraining the available views on a particular policy problem through factors such as power balances, 
status quo bias and institutional availability. 
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theoretical and methodological approaches of this study, followed by the results and 
conclusions. 
1.1.1 What ARTs are and How They Work 
 As defined by the Centers for Disease Control (CDC), assisted reproductive 
technologies are “all fertility treatments in which both eggs and sperm are handled” 
(CDC, 2009). This definition does refer to many of the technologies often utilized for 
treatment of infertility/involuntary childlessness, and it also neglects several treatments or 
technologies often included in the broader classification of 'reproductive technologies', 
such as artificial insemination (by donor [AID] or by husband [AIH], hereafter referred to 
solely as AID) and fertility-enhancing drugs (Blank & Merrick, 1995, p. 96-98). While 
IVF and its associated techniques are the only technologies managed by the CDC through 
FCSRCA legislation, it is important to note that the other two forms of reproductive 
enhancement also are controversial and closely related in nature. 
 Currently, the most common technologies used in assisting reproduction, as 
reported in the 2007 Assisted Reproductive Technology report published by the CDC, are 
IVF, with or without intracytoplasmic sperm injection (ICSI), gamete intrafallopian 
transfer (GIFT) and zygote intrafallopian transfer (ZIFT). Developed in 1978, IVF is the 
oldest of the three techniques mentioned above, with ZIFT and GIFT being developed in 
1984 as a means of improving the success rates of ARTs (Asch, 1994, p.75-76). IVF and 
ZIFT are the most similar to each other, both involving the creation of an embryo outside 
of the body prior to implantation, whereas GIFT involves the implantation of individual 
gametes into the fallopian tubes, at which point fertilization is expected to occur (Asch, 
1994, p. 75). ICSI, in contrast with the other three techniques mentioned, only acts as a 
mechanism to assure fertilization, through the injection of sperm into the ovum rather 
than incubating the gametes together within a culture medium (Asch, 1994, p. 76; CDC 
ART Report, 2007, Appendix B). 
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1.1.2 Drawing the line & limiting the scope 
 While IVF with or without ICSI, GIFT, ZIFT, AID and fertility-enhancing drugs 
all have ethical issues associated with them, their management is largely separate. The 
U.S. Food and Drug Administration (FDA) has clear jurisdiction over the management of 
fertility-enhancing drugs. It has some control over aspects of AID and ART through the 
regulation of use and testing of human tissue (Adamson, 2005; Adamson, 2002). The 
CDC however, monitors ART data in ways that AID are not managed, for example, 
tracking of success rates. Little evidence of AID management outside of the FDA's 
management of human tissues exists. For the purpose of maintaining clarity and 
consistency, this study will accept the limits of the CDC's definition of ARTs. While 
sources will not be excluded based on the inclusion of AID management, legislation 
solely directed at AID will not be considered. As a result, it is acknowledged that this 
may bias the study as a means of understanding policy frames in this area. However, it 
will also provide the necessary exploratory boundaries to assure a clear explanation of 
how frames affect policy direction in technology. It is also important to note that the 
examination of policy frames will be limited to legislation; while public media may play 
a role in ART political development, they will not be considered a primary source of data 
in this study. 
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Figure 1:A general overview of the history of ARTs 
1.2.1 What ARTs are and How They Work 
 Policy movement targeting ARTs was limited prior to the birth of Elizabeth Carr 
in 1981 (Cohen, et al. 2005). In fact, the 1978 Ethical Advisory Board's (EAB) evaluation 
of the ethical acceptability of ART is one of the few public policy actions of the 1970s 
(deMelo-Martin, 1998, p. 65-66). Other examples include the National Research 
Council's Committee on Life Sciences and Social Policy's technology assessment (HEW, 
1979) and a 1975 regulation issued by the Department of Health, Education and Welfare 
(HEW), under which funding for IVF was banned until the EAB had reached some 
conclusions on the ethical acceptability of the technology (Grobstein, 1983). Much of the 
scrutiny of ART did not occur until after the birth of the first IVF baby (Grobstein, 1983). 
Even with the advent of ethical approval, however, which was included in EAB's 1979 
report to the HEW (de Melo-Martin, 1999; EAB, 1979), public funding was not released 
due to the expiration of the EAB prior to giving approval of funding. Following the 
expiration of the board's charter in 1980, little policy action appeared to be taken based 
upon the report's recommendations, and further federal examination of ART did not 
occur until the Office of Technology Assessment's (OTA) reports on it in the 1980s 
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(Bonnicksen, 1986). The segment of the time line of in which the above policy action 
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Figure 2: A timeline of ART from 1970-1984 
As acknowledged above, there are a number of technologies that play a role in treating 
infertility, such as AID. Many of these technologies are not currently regulated under the 
same standards as ARTs. AID, as a means of treatment for infertility, was a technique 
utilized since early in the twentieth century to assist some infertile couples in 
reproduction (Smith, 1968). While this technology predates and provides the scientific 
foundation of many of the techniques now generally referred to as ARTs, it is governed 
by laws based upon the handling of materials, and is not covered by FCSRCA. It is not 
clear as to why AID is distinguished from other ARTs because, as can be seen throughout 
the literature (Beller & Weir, 1994; Walters & Singer, 1982), many of the ethical and 
social issues that arise from IVF (or GIFT) also occur with AID, with the exception of 
embryo experimentation (Asch, 1994). 
 ARTs were introduced for commercial use in the U.S. in the early 1980s, with the 
birth of Elizabeth Carr, but they debuted on the world stage as a means of treating 
infertility in 1978, with the birth of Louise Brown. The introduction of IVF as a 
technique available within the U.S. would not come for another four years, but its 
introduction as a technique potentially to be used on humans raised a number of questions 
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based on the potential for ethical conflict. In 1979, the EAB released its initial report to 
the HEW (later the Department of Health and Human Services (DHHS)) for the purpose 
of establishing whether IVF was ethically acceptable (EAB, 1979). This early policy 
report provided insight into the potential for ethical and safety issues, and also laid the 
groundwork for the possibility of public funding of the technology. The EAB determined 
several important points with regard to the management of IVF2 and established that 
proceeding with IVF research in the U.S. was an ethically sound and acceptable course of 
action (Studdard, 1981). As a result of this report, doctors and scientists led by Howard 
Jones at Eastern Virginia Medical School, were able to successfully culminate the first 
U.S. IVF baby in Elizabeth Carr in 1981 Studdard, 1981).  
It is important to note that this early report covered an exceptional amount of 
ground on the ethics of new biomedical technologies and provided an interdisciplinary 
perspective on the challenges facing the technology. It managed to include opinions from 
legal, ethical, social science and medical scholars in its attempt to understand the 
multidimensional implications of ART use. From a legal standpoint, the report 
determined that the right to privacy as it relates to reproduction and marital relationships, 
or 'reproductive rights', most closely applied to IVF clinical use (EAB, 1979, p. 65). 
However, legal arguments divided their understanding of ART use between clinical and 
laboratory applications of the technology (EAB, 1979, p. 68). Other ethically based 
arguments on ART also make this distinction. As such, this study addresses only the 
management of clinical aspects of this technology (EAB, 1979, Ch. 4; Studdard, 1981). 
                                                 
2
 The points include (1) risks to mother and potential child were not clearly established and a review 
of additional animal models could improve understanding of the health risks and effects; (2) further 
technology research involving humans was ethically acceptable given that (a) human subjects guidelines 
were followed, (b) research was designed to determine safety that could not otherwise be determined 
through other models, (c) the people involved would be explicitly informed of the use of their gametes, (d) 
the embryos would not be sustained abnormally longer than the normal time of completion for 
implantation, and (e) that the public as well as 'interested parties' would be informed of the outcome if the 
procedures showed evidence of higher than normal abnormalities in offspring; (3) it did not address the 
issue of funding of such research. 
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1.2.2 Policy treatment of ARTs from the advent of commercial use to the 
establishment of FCSRCA 
 By the time the first IVF baby was born in 1981, policy recommendations and 
legislation on clinical use and application of ARTs were limited. However, with the 
availability of ART to treat infertility, scholarly, public and political debate erupted, 
focusing on the use and monitoring of these new technologies (Hyer, 1978; Lee, 1986). 
As ARTs became more available, the reality of social impacts began to reach the 
forefront of the debate. The concepts of property, parenthood, legitimacy and family had 
all shifted, and it became apparent that new rules and definitions would have to be 
developed, as the previous ones no longer clearly applied. (EAB, 1979; Wadlington, 
1983)  
 A primary point of interest during this decade of ARTs was the safety and 
efficacy of the technology (EAB, 1979; Kurinczuk, 2003). As explained in the third 
paragraph of section 2.1, following the ethical approval of IVF by EAB, research 
proceeded that culminated in the birth of Elizabeth Carr in 1981. From this work, a 
number of new IVF and similar techniques were developed, including GIFT, Perionatal 
Oocyte and Sperm Transfer (PROST) and ZIFT. The birth also provided a catalyst for 
policy development in the ART arena (Bonnicksen, 1986). Between 1981 and 1992, the 
management and analysis related to ARTs fell within the domain of OTA. During this 
period, they published one study addressing policy development pertaining specifically to 
infertility and ARTs and several others that addressed the role of new biotechnologies in 
society and medicine. (OTA, 1988a; OTA, 1988b; OTA, 1987). The 1988 infertility 
report provided a number of insights into the ethical3, legal4 and policy5,6 issues 
                                                 
3 The right to reproduce, the moral status of the embryo, the relationship between parents and 
children, the patient's right to know (regarding experimentation), confidentiality and honesty, and the 
responsibility of one generation for the one(s) after it. 
4 Transactions relating to the transfer of gametes, embryos and neonates, as well as what the 
definition of parenthood is within the legal context (as compared to the genetic/scientific context) 
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underlying both clinical and laboratory use of ARTs (OTA, 1988b). Overall, a number of 
policy options were addressed, including additional regulation. However, the report also 
reinforced the idea that much of the power of governance for ARTs lay at the state level, 
through professional licensing and jurisdiction over health issues and family law. (OTA, 
1988a, p.172)  As a result, few federal government options found in the report were 
implemented. Congress also held several hearings on issues of the implications, access, 
and consumer protection related to these technologies, but they too resulted in little 
policy action (Blank & Merrick, 1995). 
 In contrast to the federal level, state level and professional organizational level 
policy movement was not insignificant. On the professional side, the Society for Assisted 
Reproductive Technology (SART) began collecting success rates for member clinics in 
1985, through a system that would later provide the framework for measures 
implemented by the CDC in its oversight capacity (CDC, 2009). Given this action, and 
work done by the American Fertility Society (now known as the American Society for 
Reproductive Medicine [ASRM]), a number of professional measures were put in place 
for practitioners of ARTs (Blank & Merrick, 1995, p. 96;). Since this time, regulation in 
the U.S. has mostly consisted of self-regulatory guidelines established at the professional 
level (Adamson, 2005). These professional organizations, along with consumer 
organizations such as RESOLVE and the American Fertility Association (AFA, formerly 
the American Infertility Association) also dominated much of the discourse on ART, 
through coalitions such as National Coalition for Oversight of Assisted Reproductive 
                                                                                                                                                 
5 This section clearly articulates costs (of infertility as well as infertility treatment), issues related to 
quality of product, and the breakdown of the affected population(s). It also, briefly addresses the state of 
management of that technology as it related to policy product at that time, which was largely considered to 
be an issue to be dealt with at the state level (with regard to clinical practice), given that it was considered a 
'medical issue' and a consideration for family law, both state level matters.(OTA, 1988, p.10) 
6 The OTA report on IVF also identified nine areas in which potential policy options existed, 
including: (1) data collection, (2) infertility prevention measures, (3) consumer information/ awareness, (4) 
infertility treatment access, (5) assessing the reproductive health and well-being of veterans, (6) gamete and 




Technologies (NCOART) and legislative advocacy (Adamson, 2005; SART, 2010). They 
also played significant roles in the management and implementation of FCSRCA through 
both provision of oversight and acting as a facilitator for the collection of additional 
clinic data. 
 With regard to state policy action during this period, some states were quite active 
in creating legislation related to ARTs. At least 11 states created policy mandating either 
insurance coverage or the offer of coverage for infertility treatment. Two of these states, 
California and New York, specifically excluded the coverage of IVF (NCSL, 2009). Even 
further, several states instituted restrictions on insemination, ranging from a ban on self-
insemination to a requirement that insemination be conducted by a physician 
(Blankenship 1993). Overall, while state policy action was not stagnant during this period 
of time, it also was fragmented, creating a number of different types of policies. 
 The key policy move of the decade at the federal level, however, was the 
development and enactment of the FCSRCA of 1992. In the late 1980's and early 1990's, 
a few clinics were cited for false advertisement of success rates, a term often used to refer 
to live-birth rates, by the Federal Trade Commission (FTC) (FTC, 1990, p. 26). As a 
result, Congress moved to implement legislation to 'protect' the ART consumer from false 
advertisement. Once during the second session of the 101st Congress (1989-1990), and 
twice during the first session and once during the second session of the 102nd Congress 
(1991-1992), a bill was introduced with the intent for providing a system of certification 
for fertility clinics and a reporting/tracking system for their success rates (H.R. 756; H.R. 
3490; H.R. 5110; Pub.L. 102-493). The final introduction of the bill in 1992 passed both 
houses of Congress and was enacted. This piece of legislation is the single example of 
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1.2.3 Policy treatment of ARTs from FCSRCA to present 
 After the passage of FCSRCA in 1992, one might expect that this represented a 
change in attitude towards centralized ART policy. However, much of the successful 
policy change since FCSRCA has been in areas of access more so than oversight. As 
acknowledged in the fifth paragraph of the last section, part of the reason behind the 
implementation of FCSRCA was a response to an FTC violation on advertisement of 
success rates (Adamson, 2005). Whether FCSRCA has been successful at correcting for 
this issue is less clear and evaluative study of its effectiveness appears to be limited. With 
regard to other aspects of ART policy, however, the CDC has published the results of 
their current oversight activities publicly since 1997 (CDC, 2005). Further, the PCB 
revisited the issues facing ARTs in 2004 (PCB, 2004). The report states many of the 
points made by earlier reports from the EAB and OTA regarding potential means of 
managing ARTs, such as a need for additional data from which to draw conclusions and 
the need to create additional infertility prevention measures (EAB, 1978; OTA, 1988a). 
With regard to changes in management strategy, a few high profile cases have created 
short-lived turmoil in the policy arena and, yet again, little has morphed into public 
policy change. Changes in professional self-regulatory guidelines, on the other hand, 
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have been far more dynamic, often responding to public outcry (Adamson, 2005; 
Adamson, 2008). However, not all of this change has been transparent, with guideline 
access largely being restricted to members of ASRM (ASRM, 2010). Overall, policy 
change within the last 18 years has largely been limited to state regulation and 
professional self-regulation. 
 At the state level, the legislative action has been varied. Some states, such as 
Louisiana, Pennsylvania and New Hampshire, have been very active in creating laws to 
govern ART use within their states (PCB, 2004; Adamson, 2005). Some states have 
implemented rules not only on the status of the embryo (Havins, 1999), but also the 
requirements, rights and responsibilities of all parties that are directly involved, including 
establishing an owner or guardian of embryos once they are created (Havins, 1999). 
Moreover, states have taken some action regarding informed consent and other measures 
to improve the outcomes for the consumer, on top of those provided by FCSRCA 
(Rosato, 2003). Even given this policy action, however, a number of gaps are still 
acknowledged to exist, one of which has been the lack of uniformity of policy across 
states. However, this lack of uniformity has generally been explained by the structure of 
the U.S. government, which creates fragmentation through its separation of powers and 
federalist structure (Blank & Merrick, 1995). 
1. The state of the law and legal structures in ARTs 
 The judicial regulatory history impacting ARTs begins with judicial decisions 
made about the right to reproduce or not reproduce. Griswold v. Connecticut established 
a right to reproductive choice about contraception within the context of marriage 
(Griswold v. Connecticut, 381 U.S. 489, 1965; de Melo-Martin, 1999, p. 64). Roe v. 
Wade established the right to privacy in reproductive choice about abortion (Roe v. Wade, 
410 U.S. 113 (1973)). Skinner v. Oklahoma guaranteed the right to reproduce without 
interference (Skinner v. Oklahoma, 316 U.S. 535 (1942)). While all of these cases were 
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key in establishing what are known as negative reproductive rights, the rights of 
individuals to be free of governmental interference in their reproductive choices, many 
argue that a more essential right in the assisted reproductive world is a positive right to 
reproduce, which would guarantee not only the right to be free from government 
intervention in one's reproductive choices, but also that it is the responsibility of the 
government to provide infertile couples with the means to reproduce, including the 
provision of services like ART. (de Melo-Martin, 1999, p. 65) 
 Beyond the judicial decisions regarding one's right to use ART for the purpose of 
reproduction, there have also been some rulings regarding the outcomes of the procedure 
or steps within the procedure. These include cases establishing familial and property 
rights and concerning physicians' discretion to provide treatment (Ekstut, 2008). For 
example, several rulings have been made regarding establishment of parentage of a 
resultant embryo, in the case of surrogacy or gestation and gamete donation, and 
establishment of parenthood by parties (Eckstut, 2008; K.M. v. E.G., Cal. 2005; UPA, 
2002) or in the case of changes in the relationship between gamete donors (or 'parents') 
(Eckstut, 2008; UPA, 2002), and the ability of the embryo/child to inherit with 
postmortem implantation (Eckstut, 2008; UPA, 2002). In the case of surrogacy contracts, 
gamete donation and establishing parentage, it can clearly be seen that the norms defining 
parenthood that formerly informed family law have changed, not only due to a division of 
genetic and physical parenthood, but also because of the potential financial incentives 
offered to surrogates and donors (Levine, 2010). A number of ethical concerns arise due 
to these new incentives, such as the commodification of women's bodies and human 
gametes, coercion, and risk discounting (Collopy, 2004; Redshaw, Hockley & Davidson, 
2007; Levine, 2010). There is also great potential for discrimination in the provision of 
services, particularly against non-traditional couples and single parents, based on the 
wording of some judicial rulings and statutes (Eckstut, 2008). Yet another emerging area 
is embryo status. Ownership/property status, adoption status and postmortem birth all are 
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examples of situations in which the norms that underlay family and property law, no 
longer clearly apply. Ideas of consent, parentage, and legitimacy for the purposes of 
inheritance are now confused due to the shift in when activities can temporally take 
place, as in the case of a pregnancy achieved after the death of one of the parents, or 
adoption of an embryo though it often lacks the legal status of a post-natal child (OTA, 
1988, p. 224). 
 However, a number of states also have made attempts to clarify statutory 
confusion due to ART practice, ranging from establishing ownership or guardianship of 
embryos at insemination, creating legislation to determine the parentage of the child 
produced, and establishing the timetable for legitimacy in the case of inheritance (Moses, 
2006, p. 33). As such, many have argued that ARTs are not 'free' from regulation 
(Adamson, 2005). The counter argument to this point however has often been that since 
regulatory statutes and judicial rulings are not consistent across states, the industry 
remains effectively unregulated (Valverde, 2007; Moses, 2006). 
 These cases reveal the legal challenges posed by ARTs, as they render the prior 
regulatory structures irrelevant or unclear. The norms governing previous rulings have 
now been altered by the new possibilities in reproduction and parenting, as well as access 
to services (Moses, 2007). What is clear is that the consequences of using ART are much 
broader than just the positive or negative right to reproduce and the decisions made 
regarding them are likely to be far reaching. 
1.3 Policy, regulatory and other critiques 
 The issue with ARTs is not only that regulatory oversight is insufficient but also 
that there are a number of ethical, scientific, and social implications of these 
technologies. According to physicians and consumer groups for the infertile, ARTs 
provide a way to ease the suffering associated with the inability to produce children in the 
traditional manner (Adamson, 2005). Even further, these technologies provide new 
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avenues of research to cure diseases suffered by thousands of people every day, such as 
diabetes and Parkinson's, through cell-based therapies (NIH, 2009). However, the 
critiques of the use and management of these technologies also are significant. The U.S. 
policy development on this issue has been limited, resulting in a permissive regulatory 
structure in the industry. At the federal level, this manifests as a structure that is limited 
in both oversight and rule development (Bleiklie, et al., 2003). Even further, as discussed 
in section 2.4, much of the decision making power exists at the state and professional 
levels (Moses, 2005). This structure has been one of the targets of critique, given that it is 
relatively unique amongst the developed countries that utilize ARTs (Bleiklie, et al., 
2003). But regulatory structure is not the only source of critique of ARTs. There have 
also been questions on the scientific safety of these technologies, as well as their social 
impact. This section will briefly address some of the science critiques that question the 
safety of ARTs, and social critiques, which object to the use of ART for reasons beyond 
science. The final part of this section will address the regulatory critiques, or those 
critiques that propose means to address the problems pinpointed by these social and/or 
science critiques. 
1.3.1 The state of the law and legal structures in ARTs 
 Within the science of ARTs, there is a limited amount of questioning of the safety 
and outcomes of the technology as it is currently used. Often these critiques do not argue 
that use of IVF be banned, but often they do point out the problems with how it is applied 
and how well the implications are understood. The latter is often expressed in terms of 
the long and short term health impacts. For example, it has long been acknowledged that 
pregnancies achieved through ART show an increased risk of multiple births (Doyle, 
1996; CDC: Assisted Reproductive Technology, 2010) and ovarian hyperstimulation 
syndrome (OHSS) (Keith & Oleszczuk, 1999). There have also been indications that 
there is an increased risk of morbidity for both mother and resultant child through the 
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ART process (Grobstein, et al., 1983; CDC, 2010). A number of health complications for 
singleton children of ART have also been reported. For example, low birth weight has 
been reported for both singletons and multiples, and previous studies have linked it to a 
number of long term health issues for children conceived through ART (Omblet, et al., 
2006; McDonald, et al., 2009). The issues relating to health impacts on children 
conceived via ART appear to be confirmed through the CDC's ten year surveillance 
program of ART outcomes (CDC website, 2009). However, it has also been pointed out 
that the conditions suffered by IVF children cannot be conclusively linked to ART usage 
because of the possibility that the result may be due to the subfertility of the parents 
(McDonald, et al., 2009). 
 There are also the psychological aspects of ART to consider. Foremost is the 
indication of greater acceptance of risk by couples undergoing ART in order to reach 
their optimal number of children (Collopy, 2004). There have also been questions 
regarding the long term health, development and welfare of children produced from ART. 
Specific examples include the bonding process between parent and child when donor 
gametes are used for conception and the valuation of children due to the economic and 
physical costs associated with achieving conception (Little, et al., 2006). 
 Alternatively, even in light of the questions, it is also unfair to characterize the use 
of this technology as being without merit. Responses to some of the critiques include the 
argument that these technologies ameliorate some of the psychological suffering caused 
by infertility (Jordan, 1999; Schmidt, 2006), making it possible for non-traditional 
couples and individuals to build families (Liu, 2009), and create new avenues for 
research and disease treatment (citation). Moreover, it is pointed out that many of the 
early issues that plagued ARTs, such as high percentages of multiple births and low live-
birth success rates, have steadily decreased in prevalence as the technology has matured 
(Toner, 2002). Therefore, it is postulated that many of these issues will be resolved given 
time, without government intervention or oversight (Adamson, 2002). Even further, this 
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line of argumentation proposes that proposed solutions would in fact hamper the 
development of the technology (Gleicher, 2005; Moses, 2005). For example, the 
proposition to limit the number of embryos transferred, in order to minimize the 
occurrence of multiple births, (1) would be a one-size-fits-all solution for a problem that 
requires case-by-case evaluation; and (2) would increase the cost of treatment to achieve 
a single birth because it could increase the number of cycles involved (Little, et al., 
2006). 
1.3.2 Social/social science critiques 
 Regarding the social impacts of ART, beyond those impacted by current law, as 
discussed in this chapter there are also a number of ethical and sociological issues to be 
addressed regarding ARTs. For example, there are questions not only about the health of 
the mother and child during and after the procedure, but also about the impact of the 
technology itself on the valuation of these individuals in society (Schonfeld, 2003). It has 
been argued by a number of feminist writers that these technologies change the role of 
the woman from 'person' to 'womb', and this change in social norms thereby devalues the 
position of women in society that they have worked so hard to redefine (Kerian, 1997). 
This section will be split into three parts, and although some aspects of these parts 
overlap in discipline, the arguments presented are distinct. 
1.3.2.1 Sociological & Political Science Critiques of ARTs 
 Within the sociological scholarly community, ARTs have received a wealth of 
attention, particularly within the study of the sociology of medicine. Given the role of 
ARTs in changing social and physiological norms that have previously existed, as 
addressed in section 1.4 of this chapter, it is clear that there is a social component to the 
practice and outcomes of ART. Much of the motivation for this study stems from the 
arguments regarding 'medicalization' within this field. As defined by Peter Conrad, 
medicalization is the process through which a problem becomes defined by medical 
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terms, utilizes a medical frame for its understanding, or involves a medical intervening 
force for the purpose of 'correction' (Conrad, 1992). His definition provides one 
perspective from which to view the critiques that will be presented here. 
 Medicalization, particularly of childbirth and reproduction, has been a prominent 
lens through which critiques of ARTs have developed. A primary point of interest in this 
set of critiques is the development of 'involuntary childlessness', a socially constructed 
status expressing want, into 'infertility,' a disease or disability requiring treatment 
(Finkelstein, 1990). The medicalization process as a lens through which to view ARTs 
and their use has featured heavily in feminist critique, as will be addressed in section 
1.3.2c. However, more general medicalization critiques also play a role in the 
understanding of ART, such as Conrad and Leitner's examination of the role of  
'infertility as a disease' in the debate over insurance reimbursement, coverage and 
litigation regarding coverage (Conrad & Leitner, 2004). Even further, this critique 
extends into the effects of medicalization on people's decision-making, primarily it's role 
in their pursuit of some technologies, such as IVF or surrogacy (Richard, 1990). Overall, 
the medicalization critique focuses not only upon the role of medicine in defining 
expertise as it relates to concepts such as infertility, but also its role in the pursuit of 
certain treatments such as ARTs. 
 Another prominent point that has been made about ARTs is its creation of new 
families by expanding the option to reproduce not only to the 'biologically infertile', but 
also the 'socially infertile'. Groups included in this definition of socially infertile are those 
who could not reproduce due to choices regarding sexual and interpersonal relations and 
those who choose not to reproduce by traditional means, for example, because of 
lifestyles or potentially devastating genetic problems they would prefer not to risk 
passing onto their offspring (Shultz, 1990). While not objectionable on face value, these 
new reproductive options have often been pointed out to create new areas of concern 
because of the involvement of external partners such as surrogates and gamete donors. 
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This has not only complicated previous legal understandings of parenthood, as addressed 
in section 1.2.4, but also the cognitive and social perceptions of 'parenthood', 'family', and 
the fundamental understanding of relationships (Robertson, 1996). Therefore, the division 
of previously indivisible 'stages' of parenthood (genetic, gestational, and social), has 
created a loss of information for both the individual and society as a whole that has not 
been successfully reacquired. 
 The additional sociological considerations on ARTs to be addressed in this paper 
fall within the following two categories of ethical critiques and feminist critiques. While 
it is acknowledged that this current outline only touches upon a fraction of the critiques 
associated with ARTs, it was determined that these were of the most importance to this 
study. Other critiques, such as the impacts of social construction on non-traditional 
couple access, while important in the larger study of ART, are not among the subjects of 
interest in this study. 
1.3.2.2 Ethical Critiques of ARTs 
 By far the largest body of critique and support for ARTs appears in the ethics 
literature. A number of ethical arguments have been made in favor of minimal 
government intervention in ART practice, based upon the implications of these 
technologies for the well-being of both biologically and socially infertile couples (Shultz, 
1990) as well as the protection of procreative liberty (Robertson, 1996). However, others 
have pointed out important countervailing ethical considerations, including the rights of 
the embryo and the resultant child (Clements, 2009), how well informed the party 
undergoing the procedure is with respect to the risks and long term implications 
(Grobman, et al., 2001), and the utilization of multifetal reduction to address the transfer 
of multiple embryos (Coleman & DeBuono, 1999).  Further considerations involve the 
right of children to know the means of their conception and, if necessary, access their 
genetic information. The former issue of understanding the means of one's conception, in 
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part conflicts with the rights of the parents' privacy regarding their own reproductive 
choices (Robertson, 2004). However, it also relates to the argument in favor of the 
collection of longitudinal health data on children conceived by IVF, which has been 
suggested as a means to gain a better understanding of the potential health and health 
policy issues that may arise due to IVF (Fastoulis, 1999). 
 Beyond the ethical implications related to the embryo however, are the issues 
related to social pressures upon couples to have a child, thereby forcing a less than 
optimal choice selection, and the implications of the reduced risk perception and 
increased risk discounting of infertile couples (Collopy, 2004). While it has often been 
noted that physicians have guidelines relating to the provision of clear information to the 
prospective patients, it has often been suggested that ARTs, like experimental techniques, 
should require informed consent. In part, this has been argued for the reasons related to 
their perception of risk, and the social pressures associated with their 'infertile status' 
(Schmidt, 2006). However, there has also been the suggestion that the implementation of 
informed consent or some similar documentation would assure the prevention of self-
interested parties taking advantage of parties for the purpose of gain, be it the physician 
of a couple for the purpose of financial gain or the couple of a surrogate for the social 
gain (Houmard & Seifer, 1999). 
 Overall, it can be seen that ARTs are not without a number of ethical 
considerations, not all of which are easily handled by policy. However, as it pertains to 
our study, the existence of these ethical conflicts provides some insight into the diversity 
of frames potentially held by the public. It is also important to note that this is not an 
exhaustive list of all ethical considerations related to ART use or research, but those that 
relate most closely to our study's interest in public values regarding the clinical 
application of ARTs. Other tangential considerations not mentioned above include those 
risks and incentives of surrogates and gamete donors, particularly egg donors, because of 
the invasiveness of the techniques involved in creating and maintaining pregnancy 
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through IVF, as well as what incentives are created by allowing for compensation in 
these cases. 
1.3.2.3 Feminist Critiques of ARTs 
 A number of critiques of ARTs exist under the general umbrella of 'feminism'. 
Some of these critiques oppose the use of ARTs, based on previous power relations both 
within and outside the medical establishment, as well as the psycho-social implications 
(Ettore, 2000). These studies often take the form of historical analyses of the 
medicalization of childbirth or critiques of the patient-doctor relationship, in which one 
party is dependent upon the other due to perceived expertise (Birenbaum-Carmeli, 2003). 
Other critiques focus on the potential consequences for women within society because 
gestation still remains an aspect of reproduction in which the burden falls upon the 
woman. This critique often focuses upon the potential for exploitation and 
commoditization of women as 'incubators' (Kerian, 1997). Alternatively, critiques have 
also focused upon the likelihood of women bearing most of the burden of ART 
procedures in the short and long term, through things like hormone injections to increase 
the likelihood of implantation, the impact of gestation, and other unknown, long-term 
implications (Luke, et al., 2007). However, additional feminist arguments advocate for 
use of the technology, as well as expansion of access, since they create the ability of 
women to procreate independent of men, thereby providing yet another form of 
procreative freedom for women. Even further, some arguments also cite the psychosocial 
impact of infertility upon women, not from the perspective of medicalization or social 
pressures surrounding childlessness, but instead from a perspective of procreative 
freedom. While the arguments both for and against the use of this technology are 
expansive, it is more important to acknowledge the existence of the debate than to 
expound upon the specific arguments at this point. Some of these arguments are 
addressed within the case studies, as they pertain to the frame analysis. 
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1.3.3 Regulatory/Policy proposed alternative approaches 
 The focus of this paper is both the critiques presented above and also the lack of 
oversight and regulation found within the policy arena, the latter of which has often been 
the motivation behind a number of the critiques above. A number of regulatory 
suggestions have been proposed to solve the issues addressed by the critiques listed 
above. Some minimal regulatory or oversight frameworks have been proposed in the U.S. 
to date, such as those proposed in the EAB report of 1979, the OTA report of 1988, and 
the PCB report of 2004 (EAB, 1979, p. 104-108; OTA, 1988, p. 15-31; PCB, 2004, 
p.183-204). There have also been a number of scholarly regulatory frameworks proposed, 
many of which overlap with those of the official reports. The primary reason for the 
interest in these proposed regulative approaches is that they represent alternative lenses 
through which ART policy frames may be constructed. In this section, the regulatory and 
oversight approaches proposed in formal reports will be addressed first, followed by 
those covered in the scholarly literature. 
 When EAB first confirmed the ethical acceptability of ARTs in 1979, specifically 
IVF, they included a number of caveats and suggestions for potential oversight regarding 
ARTs, largely because ARTs involved a number of health risks and other unknowns. One 
point that they emphasized in their summary was that their approval was based upon the 
argument that the use of IVF was “defensible but...legitimately controverted” (p. 100). In 
effect, they established that, while it would be ethically acceptable to move forward with 
additional IVF research, the ethical arguments against it were neither unfounded nor 
unwarranted. They advocated for additional animal model research to improve efficacy 
and provide better data about the risks (p. 104). They also concluded that research 
involving humans would be ethically acceptable given a number of caveats, as addressed 
in footnote 1 of section 1.2.1 (p. 106) and that support by HEW would be ethically 
acceptable within the bounds of those caveats of research involving humans, though they 
specifically did not address whether this should include federal funding of such research 
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(p. 108). They also concluded that additional data should be collected by multiple 
organizations, including the National Institute of Child Health and Human Development 
(NICHHD), in conjunction with private and international organizations (p. 112), and that 
the establishment of a 'uniform or model law' should be created for the purpose of further 
clarifying the legal status of children born of ARTs (p. 113).  
 Following from this, given that the EAB was not renewed in 1980, the OTA 
became the primary body for assessment of ARTs. They produced a report focusing 
specifically upon the ethics and policy options related to the use of ARTs in 1988 (OTA, 
1988). They also produced two reports related to AID and the implications of new 
biomedical technologies on 'rights' around the same time, which provided further context 
for how politically salient biomedical technologies had become. The issues that they 
identified in their 1988 report, were as follows: (1) the right to reproduce, (2) the moral 
status of the embryo, (3) the bonding between parent and child, (4) research involving 
patients, (5) the confidential aspects of ART use and the extent of 'truth-telling', and (6) 
inter-generational responsibility (p. 11). The report touched on many aspects of ARTs, 
including feminist and religious perspectives on ARTs, the legal perspectives associated 
with it at the time, how it was addressed with regards to federally provided benefits, such 
as veterans benefits, and how other countries have addressed issues with ARTs. Their 
conclusions with regard to policy options for ARTs, particularly which aspects of ART 
were open for congressional action, were data collection on reproductive health, research 
on preventing infertility, consumer information and awareness, consumer access, veteran 
reproductive health, gamete and embryo transfer, recordkeeping, surrogacy, and research 
(p. 15). They further elaborated that there was interest for the federal government in each 
of these areas, including7:  
1. extension of federal bills to enhance education regarding reproductive health, 
                                                 




2. enacting comprehensive and less localized, longitudinal studies related to ART 
use, 
3. expansion of healthcare benefits provided by the federal government to include 
ART procedures, 
4. institution of national standards for gamete donation, and 
5. expansion of infertility research. 
While the list presented here is not a comprehensive list of considerations, the 
overarching story found in these recommendations is that a number of regulatory and 
oversight policy options were proposed in response to the issues posed by ART use. 
 The final major report regarding ART use is that of the PCB, which was released 
in 2004. They also identified a number of ethical issues to be addressed, including more 
common considerations such as the implications for potential biological intervention into 
human procreation and the impacts upon the participants of the procedure, as well as 
more tangential issues for our study such as disposal, and research on and post-
production use of embryos (p. 36). More important than the ethical issues presented in 
this report, are the direct and indirect ways through which ART were outlined to be 
regulated by government, in which direct forms of governance include physician 
licensing for ART procedure performance and location and indirect forms of governance 
including Investigational New Drugs (IND) restrictions by the FDA at this point in time. 
Moreover, even with the expansive list of federal, state and non-governmental regulations 
in place, it was determined that the 'patchwork' regulatory system was inadequate to 
properly provide sufficient protections for those involved (p. 78). Several policy options 
were provided, both as alternatives to or augmentations of the current system (Part II, p. 
181). Some of these included the creation of a new regulatory agency, additional 
legislative action and increased monitoring (p. 186, 189, 194). However, this report also 
recognized the increased costs associated with both its institutional and substantive policy 
options, as well as uncertainty regarding the implications and decreasing incentives to 
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alter the current structure (p. 183). With regard to recommendations, the council offered 
three broad recommendations8: Increased federal data collection, reporting, and 
monitoring regarding use and effects (p. 208), increased oversight by professionals and 
professional societies (p. 215), and additional, targeted legislation (p. 218). 
 A number of scholars have also raised additional important regulatory 
considerations, going beyond these expansive reports. While many of them have mainly 
emphasized the need for additional oversight (Grobstein, et al. 1983; Cohen, 1997; Islat, 
1998), some have also questioned the proposed means of regulation because they are 
insufficiently reinforced by current mechanisms, such as informed consent for patients 
(Cohen, 1997). What has also been pointed out is the emphasis within the current system 
on costs and benefits, which, while important, have largely overwhelmed other concerns 
(Andrews & Elster, 2000). 
 Therefore, the overall conclusion beyond those measures proposed by much of the 
larger reports and further emphasized by many of the scholarly publications is that, 
regardless of what regulation were to be put in place, a large barrier beyond the cost, 
which exists for most legislative action, is the breadth of concerns additional regulation 
would need to address. For example, informed consent would be expected to have 
minimal impact without additional data collection and publication. Even further, the 
conflict of social versus economic values is also a consideration which impacts the 
passage or consideration of new regulation. 
1.4 A Short History of Medicine and Reproductive Rights 
                                                 
8 The full list of recommendations and subheadings can be found in  of Appendix 1 
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 In order to flesh out the socio-political relationships of how the frames that are 
hypothesized to exist in the bills, it is necessary to provide some history on medicine9 in 
the United States, as well as reproductive medicine. Not only has this means of 
governance been suggested to play a role in the understanding of how these technologies 
may be governed and by who, it may have had some impact on the composition of 
interest groups and who is considered a legitimate participant in the development of 
policy. 
 In the US, the intertwining of the abortion debate and the ARTs debate have often 
resulted in them being cast as flip sides of the same coin. As such, the mobilization of 
resources and interest groups therefore is strongly impacted the development of the 
frames and therefore it is important to introduce how reproductive has been framed and 
how the actors have behaved. 
1.4.1 A General Overview of American Medicine 
 Medicine, in the modern U.S. context, has a unique history, with the institution of 
medicine emerging during the early twentieth century (Starr, 1982). The establishment of 
American medicine as an institution and the implications of it are important to this study; 
it will be argued that these were key in shaping the legislation related to ARTs practice. 
In order to contextualize this argument, a brief history of American medicine since the 
beginning of the 20th century will be the starting point of this analysis. Women's health 
and reproduction in America as a medical practice is a second important topic that will be 
                                                 
9
 As has been pointed out by numerous scholars, part of the reason that the regulatory structures in 
areas like assisted reproductive technologies differ so drastically from other developed countries is due to 




proceeded to. From there, a brief overview of the legal aspects of government 
intervention in the institution of medicine will be given. 
1.4.2 American medicine in the 20th century: A brief history of the development of 
the 'institution of medicine' in the U.S. 
 The present day system of medicine, with medical doctors occupying the 
organized and influential positions that they do today, is an artifact of the last century, 
rather than American history (Starr, 1982). In fact, according to Paul Starr, the 
development of the current system of medicine was more of the development of an 
institution rather than the development of medical practice (p. 8). Starr's analysis 
indicates that a key part of the American medical system is scientific and technological 
advancement (Starr, 1982 p. 10-12; Wilsford, 15). Moreover, standardization paired with 
a cultural shift towards health and a reliance upon the professional as an expert in the 
application of medical care (Starr, p.20; Wilsford, 1991, p. 8). 
 An early development in the history of 'modern medicine', was the increased 
standardization of the profession, and its connection with state licensure. Often argued as 
the key turning point in American medicine, the increased standardization of medicine 
created the ability for M.D.s to create barriers to entry to their field and effectively an 
economic monopoly upon the field of medicine (Starr, 1982, p.20). According to a 
centennial article on the founding and development of the American Medical Association 
(AMA), it was in 1905 that this organization created a 'Council on Medical Education', 
with a headquarters, for the specific purpose of providing oversight and a minimum 
standard of medical education (Fishbein, 1947). In 1906, state licensure boards began to 
require graduation from a medical school designated by the AMA as meeting minimum 
requirements (Walker, 1929). The establishment of being an entity responsible to a 
'greater good' than the market also provided not only justification for the market barriers, 
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but also provided an air of distinction to the profession that, in turn, increased its 
legitimacy and its authority (Starr, 1982, p.20). 
 Also important to the development of 'modern medicine', was the advancement of 
science. The advent of pharmaceuticals and devices to treat people's ailments allowed the 
medical profession to gain acceptance and legitimacy in two ways: (1) it allowed the 
profession to distinguish itself from competitors within the health market and (2) it 
provided further justification for monopolization of the market because of the increased 
complexity of information for the consumer (Starr, 1982, p. 24; Law & Kim, 2005).  
 Beyond the ground work laid in the 'early' history of medicine in the U.S. 
providing for physician professional dominance, later actions within medicine also 
contributed to the current politics of medicine in the U.S. The role of state and federal 
governments in the management of medicine is distinct in the U.S., with the state holding 
a majority of the power to regulate. However, early 20th century health related 
legislation, including the Federal Food, Drug and Cosmetic Act and the Federal 
Occupational Safety and Health Act, allowed for greater federal intervention. Both of 
these were enacted under the auspices of “commerce law" over which the federal 
government has jurisdiction (Starr, 1982, p. 51-54). An alternative example of health 
policy that was established in the 1960s are the Medicaid and Medicare programs, 
established under the Social Security Act. While Medicaid involves a joint effort between 
the state and federal governments both are examples of how the federal government is not 
absent in historical health policy-making. 
 The structural limits and domains of medical policy, coupled with early 20th 
century development of 'professionalization,' have resulted in particularly strong 
professional autonomy.  The organizational/structural changes that have occurred also 
have contributed a unique facet to the policy-making process, resulting in the 
development of a powerful interest group with regards to health-related policies. 
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1.4.3 American medicine in the 20th century: Reproduction in American Medicine 
1.4.3.1 Perceptions of Women and Medicine 
 Another important historical aspect of medical practice, particularly regarding the 
issue of ART, is the relationship between women and doctors. A number of perspectives 
have been generated about how the traditions of medicine have impacted the 
development of medical practice, particularly as it relates to women, womanhood, 
reproduction and childbearing. The early thoughts on female sexuality and evolution of 
medicalized child birth play an important role in the understanding of ARTs as well as 
the opposition to it (Strickler, 1992). The medicalization critique also plays a strong role 
in the discussion, particularly with regard to infertility and the female body overall. 
Relatedly, the pro-status quo ART argument hinges on the idea that childbirth and 
infertility are medical issues to be handled by medical professionals. The historical 
development of these arguments is key to understanding how 'medical autonomy' matters 
to the ART debate, and also bridges the gap between medical autonomy and reproductive 
rights. I argue that the disconnect between these two perspectives on the childbearing 
process is part of what hinders the development of ART policy. 
 The starting point of this argument is the mid-nineteenth century, which was the 
point in time that physicians began to exact more control over the medical market. 
According to Charlotte Borst, obstetrics as an area of specialty in medicine was initially 
plagued with licensing issues (Borst, 1992, p. 201), competition from midwives (Borst, 
1992, p. 207-208), and a general lack of respect from the wider physician community 
(Borst, 1992, p. 204). However, obstetrics did develop into a specialty, approximately 
around the 1930s (p. 201), after altering its focus from surgery to general practice. The 
impact of this was two-fold. First, it resulted in the expulsion of women-doctors from the 
practice, largely due to the thought that obstetrics was 'a man's work'. Second, it resulted 
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in a movement away from (and, at points, an elimination of) midwifery, which had 
previously dominated the area of childbearing (Borst, 1995, p. 118). In effect, women 
were largely removed from the act of childbirth, except as the patient. 
 The relationship between medicine and feminism also has a history dating back to 
the early 20th century. While some facets of this relationship will be addressed in the 
next section, it is important to at least preface it as a segment of the relationship between 
women and medicine. 
1.4.3.2 Issues in women's reproductive medicine in the U.S. 
 Regarding perceptions of reproductive medicine, the development of obstetrics as 
a 'well respected field' was a long journey. In the early years of its establishment in the 
U.S., obstetrics was still viewed as a 'surgical science' and it was not until its joining with 
the association of gynecologists and a shift from surgery to general practice as its base of 
knowledge that it established itself as a 'legitimate' specialty of medicine (Zetka, 2008). 
The development of reproductive medicine with respect to women has been an ongoing 
example of those 'with power' and those 'with less'. 
 The primary perspective through which the progress of 'reproductive medicine' 
can be seen is through the change in perspectives on (1) access to contraception and 
abortion, and (2) pregnancy. The latter has been addressed above, through the 
examination of the rise of obstetrics and the stances on women as both practitioners and 
as patients. The former can be seen through the movements to ban contraception access 
independent of a physician in the early 20th century (Lester & Blakely, 1918). With 
regard to abortion, it was distinguished from contraception early on (Lester & Blakely, 
1918; Ruppenthal, 1919). Whereas a number of states banned both equally, a few 
distinguished between abortion in the case of a pregnancy posing a threat to the life of the 
mother and other forms of contraception and abortion (Ruppenthal, 1919). With regard to 
statutes on birth control in Georgia and California, the two states selected for the case 
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studies of this paper, Georgia seemingly had no laws on the books regarding birth 
control.  In contrast, California had laws that made it illegal to distribute, sell, compose, 
publish, print, give or loan [an] 'obscene or indecent writing, paper or book', a concept 
which included literature on birth control (Ruppenthal, 1919). This was later revised to 
omit '“or any notice or advertisement for producing or facilitating miscarriage.”' (p. 53). 
1.4.4 American medicine in the 20th century: ART, the state and the State 
1.4.4.1 Federalism: the role of the State and the state in the management of medical 
practice 
 According to Wilsford's comparative analysis between the U.S. and France, a key 
part of the American medical institution's development was its relationship with the state 
(p.3). From this perspective, the 'statelessness' of the U.S., paired with many of its 
traditions, such as a strong sense of individuality and a commitment to the concept of 
pluralism, contributed to the development of a stronger medical institution in the U.S. 
than in France (p. 62-72). As Leyerle points out, the development of the American 
healthcare system and the medical institution that drives it was a structural process. As 
such, any changes to this institution would also have to be structural (1984, p. 7). 
Examples such as those given above (the establishment of rules regulating medical 
education, determination of alternative licensing structures (BMJ, 1891), and other forms 
of professional standardization), show the effectiveness of the structural development of  
medicine and its process. It also shows the role of the state in the establishment of these 
rules and the importance of state power in the development of medicine. 
 For example, early in the process of the establishment of medical professionals as 
the preeminent experts in the maintenance of health, it was state boards that demanded 
adherence to AMA standards and created licensing (BMJ, 1891; Fishbein, 1947) and that 
began administering licensing exams for the medical profession (Walker, 1929). Given 
that the general consensus is that the U.S. Constitution grants to the states the power to 
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manage and govern with respect to health issues and, therefore, medical practice, the 
federal government has little jurisdiction (Christoffel, 1982, p. 49). While it has managed 
to circumvent this through the application of law within areas in which it does hold 
jurisdiction (such as interstate commerce or funding through grants), the constitutionality 
of such applications has not always been clear (p. 52-55). The takeaway point from this, 
however, is the importance of structure in the development of medicine and its current 
management. 
1.4.4.2 Medical autonomy 
  A slightly less prominent but still salient issue in the ART debate is the issue of 
medical autonomy. While there is evidence to suggest that this autonomy from 
'government', particularly federal and other entities, may date back to early in the 
establishment of the medicine as an American institution, whether this is the case was 
first argued by authors using the professional dominance model in analysis of the field. 
Under this model, it was proposed that professionals (such as physicians) manage to exist 
autonomously through embedding members within bureaucracy, which allows them to 
maintain control over entry into their field and the appearance of specialized knowledge 
(Prechel & Gupman, 1995). However, it has also been argued that this autonomy has 
been slowly eroded away by new organizations within the field of healthcare and by the 
increased awareness and interest of patients in participating in their own care (Prechel & 
Gupman, 1995). 
1.4.5 Reproductive Rights and politics in the U.S. 
 The development of rights and law in the U.S. has been a critical part of the 
assisted reproductive technology debate. A large part of this could be argued to be 
culturally specific to the U.S., particularly the relationship between what have been 
termed 'reproductive' rights and the management of ART technologies. In addition to the 
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rights of the physicians to practice medicine unhindered, the role of reproductive rights 
also has weighed heavily in the ART policy arena. The ability of the infertile couple to 
exercise a negative right10 has been a compelling reason for a lack of policy intervention. 
However, the contention about whether this right should be extended to a 'positive right'11 
has been less clear. As a result, contractual and family law have also become deeply 
embroiled in this debate. The following section will provide the key institutions, 
landmark cases, timeline and major groups that have shaped the reproductive rights 
debate. 
1.4.6 A Brief History of Reproductive 'Rights' in the U.S. 
 First of all, it is necessary to establish what institutions are instrumental in 
enforcing and driving these rights--the courts. Rulings such as Roe v. Wade and Griswold 
v. Connecticut altered the previous structures regarding both childbirth and reproductive 
medicine (Starr, 1982, p.391). However, state legislatures have also been very formative 
in this debate. Moreover, the medical field has also contributed to the discussion, given 
its role as the 'experts' within this area.  Given the possible evidence of a decline in 
physician autonomy due to third party health organizations, it is important to 
acknowledge the role of insurance companies and managed healthcare organizations in 
the development of and access to the products involved in utilizing one's rights to make 
reproductive decisions. As such, the role of federal level administrative bodies such as 
the Federal Drug Administration (FDA) and National Institutes of Health (NIH) and other 
federal level health care bodies have also impacted the ability of individuals to exercise 
this right (Noah, 2004). 
                                                 
10
 The right by which the government is obligated to refrain from interfering in reproductive choices. 
11
 The right to government assistance in the pursuit of their goals. 
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 A key conceptual institution in this debate has been the U.S. Constitution. Often, 
it has been interpreted to guarantee individuals the right to decisional privacy--through 
the 14th Amendment prohibition on state deprivation of liberty without due process of 
law--of which the ability to reproduce without interference from the law and the state is 
an example (Havins, 1999). Alternatively, through the 14th Amendment, the right to 
reproduce can be constructed as a 'positive' right, at least with regard to insurance 
coverage. However, the application of this interpretation has been less widespread, as can 
be seen by the levels of access for infertility/fertility treatment across states and federal 
legislation regarding the application of federal dollars towards such treatments (Goggin 
& Orth, 2004, p.83-84). 
1.4.7 The relationship between reproductive rights, medical practice and ART 
management 
 Reproductive rights, early structural aspects of the development of the medical 
profession, and the structure of the healthcare system overall, have all played a role in the 
development of ART management. Given the monopoly on reproductive medicine 
derived from the rise of obstetrics in the early 20th century and the close relationship 
between the medical institution and science, the IVF developments in science during the 
1940s and 50s and its 1980s applications in medicine should be less than surprising. Even 
further, given the role of 'specialized knowledge' in the exclusivity of the profession, the 
monopoly of obstetrics on knowledge relating to reproduction has also been a key part of 
the development of the construction of 'involuntary childlessness' as 'infertility'. 
 The structural arrangements within the medical profession, particularly the 
arrangements of organizations related to specialties, the role of organizations such as the 
American College of Obstetrics and Gynecology (ACOG), ASRM and SART also have 
played a role in how ART policy management has developed. Beyond the simple 
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explanation of the 'power' of the medical institution itself, the role of the 'professional 
organization' in policy development directly ties back to social movement theory and the 
issue of the mobilization of bias. Given the creation of ASRM and SART in the 1980s, 
the development of alternative and oppositional movements could arguably be said to 
have been hindered in part by the fact that the rules of the 'game' had already been 
previously established and the bias towards the status quo institution within the arena, 
primarily the institution of medicine. While the organization and economic resources of 
ASRM and SART, as compared to other organizations such as right-to-life organizations 
(RTL) and feminist organizations, undoubtedly play a part in the successful creation of an 
oppositional movement in this area, the structural aspects of access to discourse and 
development of legitimacy in that discourse cannot be ignored. 
 The monopolization of the American medical institution on reproduction (and 
therefore the constructions of knowledge relating to reproduction), also may explain how 
this particular issue has been played out in the policy arena. The tie to previous 
reproductive rights issues clearly has also affected the development of the management of 
the technology, primarily with regard to (1) the legitimacy of some oppositional groups 
and (2) the ability to mobilize others. The former can be argued by examining some of 
the available hearings in Congress and the parties invited to testify. For example, in the 
case of  the hearing before the House Committee on Children, Youth and Families, the 
testimony consisted of three doctors and a representative from the office of pro-life 
activities of the National Conference of Catholic Bishops (Alternative Reproductive 
Technologies: Implications for Children and Families, 1987). The latter has been shown 
somewhat in previous literature, such as Bleiklie's comparative study and the existence of 
'fragmentation' within the action coalitions (2003). While there is less clear historical 
evidence of barriers to mobilization of groups, it provides a potentially interesting area 
for future research. 
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1.4.8 The defining cases & 'historical events' 
1.4.8.1 Medical autonomy 
 In the development of the ART policy arena, there have been particularly 
poignant cases that have been cited with regard to ART reproductive rights. The primary 
cases of interest have obviously been Roe v. Wade and Griswold v. Connecticut, which 
relate directly to the 'reproductive rights' ties to ART. The basic argument derived from 
Roe v. Wade has been the negative right to reproduction, as stated previously. Griswold v. 
Connecticut, on the other hand, preceded Roe v. Wade in establishing the guarantee of the 
U.S. Constitution to the right to privacy with regard to reproduction. Its landmark 
decision established the right of couples to access contraception and prevent the 
establishment of other laws that would infringe upon a couple's right to privacy relating 
to reproduction. Another often cited reproductive rights case is Skinner v. Oklahoma, 
which abolished the ability of the state to institute compulsory sterilization as part of 
criminal punishment. This case provides much of the groundwork for later barriers to 
state intervention in reproductive activities. 
 More recent examples of key ART legal rulings include the case of 'Baby M' and 
Davis v. Davis, which provided the framework for many states to enact statutes regarding 
surrogacy and custody/use of embryos in the event of circumstance changes since their 
development (Davis v. Davis, 842 S.W.2d 588 (1992); In re Baby M, 537 A.2d 1227, 109 
N.J. 396 (1988)). These cases have resulted in the breaking of new ground in the areas of 
both family law and property law, and have even forced some jurisdictions to establish 
the legal standing of embryos. While most of the recent rulings apply more at the state 
level than the national level, they still resonate nationally.  
 Overall, the legal system has played a significant role in the development of 
ARTs, creating additional structural constraints to a political system already bound by 
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other structural barriers built by other institutions. In fact, political structures as barriers 
to types of policy developments abound in this area, as evidenced by history. However, 
history does not show definitively whether there are in fact any constraints within the 
legislative policy process. 
1.5 Summary of research questions and orientations 
 The theoretical foundations of this study will include path dependency framework 
and social movement theory, both of which inform the proposed research questions. I 
propose that the policy process related to clinical ART practice, as detailed in the 
preceding sections, has taken the route that it has due to lock-in of policy frames. I 
believe that this lock-in is due not only to the fragmentation of political coalitions, but 
also the history of access in the policy arena and past precedent. Through historical and 
frame analyses, I believe it is possible to 'track' a set of widely used policy frames (held 
by those that benefit from power asymmetries) through proposed and successful policy, 
thereby providing evidence of path dependence of these frames. 
 This is of interest to and contributes to the wider scholarly community in two 
ways. For one, it could provide a means of empirically studying frames. For another, I 





UNDERLYING THEORIES AND FRAMEWORKS 
2.1 General Overview of the frameworks and theories 
  The nature of the debate surrounding this technology has often devolved into one 
of ethics, and therefore one that cannot be resolved through policy. And though a few 
authors have made inroads into the way in which policy has progressed on this topic, both 
in the U.S. and abroad, there are still gaps regarding the political dynamics that have 
contributed to the policy changes and lack thereof, particularly within the U.S. context. 
This study seeks to fill one of these gaps by understanding the nature of the policy 
change, particularly the relationship between this change and the frame of the problem. 
Key to this discussion of the ART policy dynamics is the concept of problem framing. 
While several authors, including Goggin and Orth (2004), Rothmayr and Varone (2002), 
and Montpetit, Rothmayr and Varone (2005) have been very informative in outlining the 
policy arena of ARTs from a comparative perspective, their analyses largely provided a 
potential framework, not an explanation of why policy has failed to be implemented, 
particularly in the U.S. context. This paper argues that problem frames are the drivers and 
maintainers of the current policy state found in the U.S. It is important to note that I am 
not arguing that problem framing and problem definition caused the policy state, only 
that given the political structure, they facilitate it’s maintenance in the current direction. 
 Again, a tangential focus of this study is also the directionality of the process, and 
by this I mean that it is 'path dependent'.12 It may explain why policy hasn't happen, 
presenting an effective 'non-event'. 
                                                 
12
 The concept of path dependency, in short, is that future decision making is severely constrained by 
past decisions. While it cannot be addressed in this study, the path dependence of this particular policy area 
could further shed light on the historical barriers to policy making in this area 
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 As mentioned throughout Chapter 1, little federal policy has been made in the 
U.S. regarding this technology, and it has been hypothesized that this is due in part to the 
social constructions of actors as well as the fragmentation of collective action coalitions 
(Bleiklie, et al., 2003, p. 101). Some work has been done on the role of power within the 
policymaking arena as it impacts the passage of policy, and this work’s acknowledgment 
of the fragmentation within the policy arena has furthered the insight into the power 
dynamics involved (Harris, 2010). 
 In this paper, however, the focus is not on power dynamics or the fragmentation 
found in actual or potential coalition groups, per se. Instead, the focus is on how 
problems are articulated through framing, which may in turn affect the ability of 
coalitions to form. Relying on previous work done on social construction and problem 
definition, I hope to utilize public documents, more specifically legislative bills, to 
exemplify consistency in framing (Verloo, 2004). 
 In this chapter, I will cover a small portion of social movement theory for the 
purpose of explaining how framing plays a role in policy making.  Additionally, the 
elements of policy framing will be discussed. 
2.2 Social Movement Theory 
 In trying to understand the means of both path dependence and problem definition 
in the problem of ARTs, it is also necessary to understand the role of social movements 
in creating change. Admittedly, a key aspect of this discussion, addressed by previous 
scholars looking at the ART arena through both discursive and collective action lenses, is 
that there is a great deal of fragmentation of oppositional collective action. This can be 
seen through Farquhar's examination of the ART discourse (1996) as well as in Bleiklie, 
et al.'s comparative study of ART policy (2003). However, the problem being addressed 
in this paper regarding ART is why NO policy change has been observed in this 
particular policy arena at the federal level, essentially a 'non-event'. This becomes a 
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question of whether the 'non-event' is a case of a problem not addressed or a non-
problem. My premise and this study assumes that there is a 'problem', and social 
movement theory provides some insight into how this could be. For one, the political 
perspectives of social movement theory provide insight into how politics can constrain or 
facilitate policy developments (Kiese, 2004, p. 66-90). It also provides insight into the 
structural aspects of mobilization of bias as a factor in how problems get placed upon the 
policy agenda. 
 Social movement theory's primary importance to this study is its justification of 
the selection of path dependence as the analytic framework. In the political science 
context of social movement theory, path dependence is somewhat justified. Two key 
points of the path dependence framework are the role of institutional density and political 
opacity, which have often been noted to be insufficiently explained. Social movement 
theory from a political perspective provides some insight into how the institutional 
density and opacity of politics may create an opportunity for some arenas to be 'path 
dependent'. 
2.2.1 Social Movements & Political Frames 
 The political 'context' of social movement theory, according to Blackwell's 
Handbook on Social Movement Theory, is based upon two important aspects: cultural 
model and institutional structure (p.69-79). It is this institutional structure that is the 
primary focus of this paper, with the cultural model aspect of political context being 
secondary, but both require some elaboration. The cultural model, as outlined by Kiese, is 
one in which stable cultural artifacts are of primary importance (p. 72). Kiese points out 
that it is the cultural institutions that affect the ability of actors to decide to act 
collectively (p.70-71). Of particular interest is Koopmans and Stathams' discursive 
opportunity, as presented by Kiese (p.72). As elaborated by him, the ability of groups to 
create discourse on their issue and create symbolic legitimacy is very important to 
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successfully mobilize groups within a movement. The ability to create this discursive 
legitimacy, however, is dependent also upon the structural strategies of political actors for 
'dealing with challengers' commonly present in the political system (p.71). This cultural 
model can provide a great deal of insight into the constraints of ART policy making from 
a mobilization and message standpoint, particularly with regard to how 'legitimate' parties 
appear to be. It also has potential in the study of two facets of the debate: (1) 'legitimacy' 
of access and input on Congressional decision-making, such as who testifies before 
Congress or gets placed on commissions for the purpose of investigations, and (2) the 
effects of a fragmented oppositional group on the policy process. As will be addressed in 
the next section, resource mobilization also plays a role in how cultural models play out. 
 The second part of the political context framework is the institutional structures 
aspect. From this perspective, it is argued that the institutional structure strongly 
influences how the policy arena develops. As explained by Kiese, the openness of a 
policy making body can both constrain and facilitate actors from participating. As he 
outlined in his chapter of Blackwell's Handbook on Social Movements, in conjunction 
with cultural models, “opportunity sets” can be developed (p. 72). The institutional 
structure aspect of policy making, as applied here, is derived from historical 
institutionalism, i.e. the perspective that historical actions influence future actions and 
decisions. To summarize, Thelen points out that historical institutionalism looks at the 
development of institutions as a product of process as compared to the rationalist 
perspective of coordinated functions (1999). From this perspective, feedback and 
historical incidences become greater in importance because they determine future 
interactions and 'structures'. However, in this study, the examination is not of the effects 
of a 'social movement' but instead on the inability to generate such a movement. Meyer 
argues that the political context approach is derived from the concept that 'grievances' are 
not chosen “out of a vacuum”, but are the result of political structure (2004). This 
continues along the same lines as the historic constructionists, insisting that 'context' (or 
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'history') matters. His argument continues along the lines of rebutting the common 
critique of political process theory, by arguing that agency can only be understood within 
the confines of the “rules of the games” (2004, p. 128). 
 Nonetheless, political context authors are addressing the mobilization of 
movements, whereas in this study it is the limitedness of mobilization that is of interest. 
Utilizing the 'opportunity sets' expressed by Koopmans and Statham, provides more 
insight (1999). Their model of 'discursive opportunities' and 'institutional opportunities' 
as interacting measures of the ability to mobilize and 'gain legitimacy', shows the 
interaction between discourse, institutions, and political opportunity from a 'non-event' 
standpoint. Their model provides four options for movement outcomes: full response, co-
optation, preemption, and marginalization (p. 248), in which preemption, co-optation and 
marginalization all could represent possible examples of 'non-events'. The selection of 
which, however, cannot be explained fully by the political context theory, but in 
Figure 4: The model of political context, from social movement theory (Kriesi, 2004). 
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conjunction with mobilization of bias. Figure 4, above, shows the political context model 
as designed by Kiese. The portion of the model that is of most interest to this study is the 
structures aspect, which is labeled as segment 1 of the diagram. Within this, I am 
interested in the political institutions and cultural models. 
2.2.2 Social Movements & Mobilization of Bias 
 From the perspectives of power and the policy process, resource mobilization 
from social movement theory also plays a part. While the political structures and process 
are integral to this story, the differential impact of being able to properly mobilize 
resources and 'people' for a particular cause could potentially impact both part 2 and part 
3 of the political context model above. With consideration of the Koopmans and Statham 
model of political opportunity sets, mobilization of bias strengthens the argument for a 
path dependent framework as well, given that their argument essentially defines the 
conditions under which groups become marginalized. Mobilization of bias explains the 
continued lock-in of marginalization in the policy cycle. 
 From a social movements perspective, mobilization of bias derives from EE 
Schattschneider's 1975 seminal work on biases in political movements (Strolovitch, 
2006). Beyond just the immediate implications of his terming 'mobilization of bias' as an 
important concept of the political system, his work has also been used to explain the 
importance of symbols in social movements (Strolovitch, 2006; Cobb, 1998). His work 
has also inspired the development of several theoretical perspectives, including problem 
definition and problem framing, which this paper draws heavily upon. 
 Beyond Schettshneider, however, is the concept that mobilization of bias 
embodies the importance of power in the discourse on policy and policy action (Bachrach 
& Baratz,1963). From the perspective of Bachrach and Baratz, this power distribution as 
the target of research is not based on a 'ruler' model nor a question of whether 'anyone' 
has power, but instead on how the structure provides for actions and who gains or loses 
 
 49
due to that structure (1963). From there, status quo bias could be analyzed and only from 
that point could an analysis of participation occur (p. 952). 
2.2.3 Social Movement & ART policy arena development 
 While the question of this paper relates to the 'frames' of policy and how these 
frames affect policy making, social movement theory provides a great deal of explanation 
as to why context is necessary. It has been argued that fragmentation of coalitions and 
power have played significant parts in the development of the ART policy arena 
(Bleiklie, et al., 2003; Harris, 2010). The role that fragmentation and power play in the 
greater policy arena has not been clearly expressed, however. Social movement theory 
provides insight into not only what role fragmentation of oppositional groups plays in the 
development of policy, but also how this fragmentation may be utilized so as to maintain 
a particular policy-making process/arena. The political context of social movement 
theory provides the explanation that structures and history are important, and that politics 
is not just a matter of resources or the ability to mobilize, but must be understood within 
the confines of the rules of the political game in which resources or the ability to mobilize 
are brought to bear. Similarly, the mobilization of bias aspect of social movement theory 
provides an explanation of the role of power and particularly the role of symbols and 
discourse in the management of power. Even further, both of these facets of social 
movement theory tie directly in with the chosen approach: policy frame analysis. 
2.3 Social Constructions, Problem definitions and Policy Frames 
2.3.1 Social Constructions, Problem definitions and Policy Frames 
 Social construction of actors also informs the structure of path dependency, by 
delineating potential group interactions. More specifically, it provides a means of 
understanding and organizing the power relations that are played out through the 
implementation of policy. In the case of ARTs regulation, the social construction 
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framework acts as the object that is being passed down through the path, in the form of a 
policy frame. Helen Ingram, Anne Schneider and Peter DeLeon offer six propositions 
that characterize how policy design and process interact with social values (Ingram, et al., 
2007, p.98-112). The propositions of Schneider, Ingram and DeLeon are as follows: (1) 
policy designs determine who can participate in the policy making process through 
explicit and implicit means, (2) power determines the distribution of benefits and burdens 
to target groups, in a given policy, (3) policy designs differ according to the social 
construction of the target group, (4) social constructions created by policymakers are 
largely dependent upon 'approval or approbation', (5) the shape and structure of public 
policy is a potent, but not the only force for the change of social construction of given 
target groups, and (6) the context of policy design matters when predicting policy change 
(Ingram, et al., 2007, p.98-112). Application of these propositions reveals how social 
values and constructs can become important to future decision-making. In effect, the 
group social construction within a policy and the values of a society or a subset of the 
society interplay through policy feedback loops, as a result of the perceived success of 
previous policy outputs containing those social constructions (p. 112-113).  
 Social construction has been argued and understood to play a central role in the 
ARTs policy arena for a significant amount of time. (Bleiklie, et al., 2003) Although a 
number of social constructions have been argued to be in play, it has not been clearly 
documented how these social constructions may exist in policy or what role they play in 
the policy process. This study is interested in whether early policies can determine the 
outcomes of later policy debates and, therefore, later policy. The social construction 
framework allows this to be measured by focusing on the lock-in mechanism. The social 
constructions of traditional target groups would be expected to be found within 
successfully passed legislation and the social constructions of alternative target groups 
would be expected to be found in less successfully passed legislation. In the frames, 
found in Appendix C, the proposed social constructions of actors can be seen, in 
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conjunction with the proposed relationship they are hypothesized to have within each 
frame. 
2.3.2 Problem definition & Problem Frames 
 One of the problems often attributed to path dependency theory is its inability to 
explain how lock-in occurs. In this study, it will be argued that this is primarily through 
problem definition and problem framing. David Rochefort and Roger Cobb describe a 
number of different ways of defining a problem, such as the social construction of 
conditions, referred to as the 'social construction of reality' (1994, p. 5-6). Problem 
definition can also affect what are 'valid issues' and whether those issues reach the agenda 
in order to be considered (1994, p. 8). On a more basic level, even the understandings 
within society can have an innate problem definition that can color how problems are 
realized (1994, p. 7). Additionally, problem definition is largely a product of discourse 
and rhetoric; in effect, the definition of a problem depends on how it was explained, what 
'facts' are presented, and the relationship that is presented between ideas (1994, p. 9). 
Thus, discourse is imperative in understanding how problem definition affects many 
problems. 
 With regard to path dependency policy, problem definition not only adds to the 
complexity and ambiguity of political arenas mentioned by Pierson, but also heavily 
affects power asymmetries. This interplay among these four concepts of problem 
definition, social construction, policy frames and political structures can thereby be 
expected to create path dependency in policy-making, by virtue of limiting (1) agenda 
access and (2) political arena access, thereby restricting the recognition of potential 
problems and/or solutions. The theoretical perspectives of political context aspects of 
social movement theory and the mobilization of bias, introduce an alternative way of 
thinking about the impact that the introduction of ARTs has had and will be expected to 
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have, specifically, how pre-existing cultural and political structures can constrain future 
policy development. 
 As compared to problem definition, policy frame analysis has slightly more 
substance with regard to operationalization. Frame analysis has its origins in several 
areas. For one, it derives heavily from the frame concepts of social movement theory, 
such as collective action frames (Snow & Benford, 2000; Diani, 1996; Williams, et al., 
2001). It also has connections to public opinion frames (Druckman, 2001). There are also 
connections to discourse analysis. In this context, I have chosen to look at the policy and 
the frames contained within the policy rather than the frames that create movement 
through groups and public opinion. The key difference between policy frame and 
problem definition lies in Snow's paraphrased interpretation of Goffman, in which he 
defines it as a '”schemata of interpretation that enable individuals to locate, perceive, 
identify and label occurrences within their life space and world at large” (1986, p. 464). It 
contains a 'diagnosis' and a 'prognosis' according to Lombardo and Meier (2006). This 
study, while adhering to the general aspects of the Multiple Meanings of Gender Equality 
(MAGEEQ) frame analysis, will use the terms ‘problem definition’ and ‘solution 
definition’ to define the diagnosis and prognosis aspects of the frame (Lombardo & 
Meier, 2006). 
2.3.3 Understanding problem definition and policy frames in the context of ARTs 
 From a discursive perspective, there has been a great deal of controversy 
regarding how ARTs are discussed. The divisions between people in support of freedom 
in ART practice, those in favor of a complete ban and even those in favor of allowance 
but stronger rules are divided often by 'fuzzy' lines. Dion Farquhar, in her book The Other 
Machine, clearly parsed out the main divisions often seen within the realm of ARTs 
(1996). As she points out, the oppositional groups face more than one issue in 
formulating their position, including the fact that they might share an interest in the same 
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outcome as another group in support of a ban on ART, but their underlying reasons 
differ. However, she provides a clear framework from which to work in understanding 
and developing 'frames' through which to examine ART policies. 
 There appears to be very little previous frame analysis regarding ARTs, 
particularly with regard to policy frames and in the U.S. political context. Our approach 
to understanding the policy arena of ART is exploratory and unproven, but not 
unfounded. Given the wealth of literature on perspectives on ART, from 'pro', 'anti' and 
'stringent' directions, it is believed that policy frames not only can be developed for ART, 
but that these frames can provide some insight into stability in the ART policy process. 
2.4 The map for here on out 
 As stated earlier, this study seeks to assess (1) what current policy frames are 
articulated in the legislation produced relating to the clinical use and practice of ARTs 
and (2) how alternative policy frames are treated in the case of legislative passage. In the 
next chapter, the methods will be addressed. It is hoped that these methods will add 
something to the theory of framing. The fourth chapter is the frame analysis of 
legislation, which will act as the core of this study and the means of supporting the 
proposed hypotheses, also to be found within Chapter 3. Finally, the fifth chapter will 
contain the conclusions drawn from the fourth chapter, as well as address the theoretical 





3.1 Study data and research questions 
 While it is acknowledged that a huge part of the ART debate is based upon ethics, 
it is possible to understand the lack of policy change through policy theory, and 
specifically policy analysis. Though it may not be possible to resolve the debate with 
policy, it is possible to better understand the dynamics of the specific arena and how 
these dynamics appear to cause policy inaction. As alluded to in Chapter 1, I propose that 
key aspects of legislative policy movement are dependent upon the frames applied to the 
issue rather than the distributions of power or institutional arrangements alone. While a 
key underlying aspect of these frames may be derived from the values that stakeholders 
hold, I have chosen to examine policy change or lack thereof as explained from the 
perspective of problem definitions and frames. 
 In trying to understand ART policy in the US, not many pieces of legislation 
pertaining to ART are available. FCSRCA and its related policy statements are the 
primary piece of successful legislation at the federal level. In addition there are a few 
scattered pieces of successful legislation that exist at the state level. Given that this 
particular policy problem is very 'ill-structured' from a policy analysis perspective, the 
analysis in this paper shall be three-fold (Dunn, 2008). The first step was performed in 
Chapter 1, in which the different problems being 'perceived' by 'stakeholders' were 
defined through an abbreviated historical analysis, for the purpose of providing 
perspective on the stakeholders and context of the problems. The second step is the 
classification analysis, for the purpose of delineating the perceived groups of common 
problem definition. These two analyses (historical and classification analysis) are 
expected to provide the necessary frames for the third analysis, which will be a frame 
analysis of policies. 
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 Therefore, historical analysis will be used to provide the 'backdrop' and context of 
the technologies within the political system, as well as to contextualize the origins of 
those frames that are proposed to exist. It will provide some insight into how 'key' 
stakeholders and all other stakeholders are recognized in this particular problem arena. 
This historical analysis will also heavily shape the understanding of the second and third 
segments of the policy context model presented in Chapter 2, figure 4.  
 Classification analysis and frame analysis were used to develop the applicable 
frames and analyze the frame differences between successfully and unsuccessfully passed 
legislation, respectively. For the purpose of the classification analysis, the three main 
reports on the status and use of ARTs were utilized, supplemented by samples of 
scholarly literature. As classification analysis is dependent upon logical consistency in 
order to assess its performance, Dunn outlined five rules to increase the probability of 
meeting that criterion: (1) substantive relevance, (2) exhaustiveness, (3) disjointedness, 
(4) consistency, and (5) hierarchical distinctiveness (Dunn, p. 99-100). Hence, this study 
uses documents that appear to have fully structured the 'problem' of ARTs (the reports), 
along with supplementary documents to satisfy the exhaustiveness requirement. The 
purpose of using classification analysis as opposed to other problem structuring 
methodologies that may reduce the potential for 'solving the wrong problem', is because 
of the lack of clarity of what the 'problem' with ARTs is. As alluded to with the question 
this study is based on, it may be the result of different constructions of what constitutes a 
problem. 
 For the frame analysis, legislation from the federal level and two state level 
congressional bodies were collected for the purpose of coding for policy frames by 
distilling the actors from each piece of legislation and comparing these actors and the 
narrative associated with them, to the idealized frames created through the literature and 
the classification analysis.  The means through which these actors will be distilled is a 
three part process of (1) obtaining a word count, (2) distilling the actors from this word 
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count, and (3) re-matching the actors within their portion of the narrative of each bill. The 
purpose in performing this action is to (1) separate out the actual wording used to 
describe actors in legislation, as opposed to assuming that the idealized terms are used; 
and (2) to get an idea of what words appear to be a central feature of bills the state and 
federal levels of government bills, overall. 
 The historical analysis is key to my argument. First, the structure of the U.S. 
governmental system is an important aspect of why ARTs are managed in the way that 
they are. The federalist structure in conjunction with the separation of power divides the 
arenas of access and increases the political complexity and opacity of ART policy 
problems. While it has been argued that this structure facilitates the ability of groups to 
access power, by providing multiple arenas of access, it could also be argued that this 
split in arenas increases the probability of fragmentation of oppositional groups because 
the means of altering policy are so varied. While this paper does not aim to argue that 
point, it is hoped that the historical analysis will provide some insight into how the US 
political system may structurally provide for certain outcomes over others. 
 Stemming from separation of powers, federalism and bounded rationality is the 
following argument: Policy arenas in which the primary frames are heavily influenced by 
federalism and the separation of powers tend to be path dependent in their management. 
Therefore, the management of the ART policy arena, given that it is heavily influenced 
by both 'reproductive rights' and 'medical practice' arguments, should be path dependent. 
The hypotheses are therefore as follows: 
H1: Legislative action is dependent upon the frame of the policy problem and the policy 
solution  
H1a: legislative action will be unsuccessful when the diagnostic aspect of the policy 
frame targets benefits to a group outside of the “traditional ART frame” 
H1b: Legislative action will be unsuccessful when the solution definition of the policy 
frame targets burdens to a group inside the “traditional ART frame” via an outside agent 
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H1c: Legislative action will be successful when the prognostic aspect of the policy frame 
targets agency to a group inside the “open ART frame” 
and 
H2: Early problem definitions created a path dependence of policy management in the 
ART policy arena by association of dominant frames with 'reproductive rights' and 
'medical autonomy' 
3.2 Data Collection 
 In this study, all federal level bills from 1989 onward associated with IVF were 
collected from THOMAS, a federal database containing congressional documents, 
hearings and public laws. Associated revisions were also collected. The primary method 
of determining appropriate word searches was to utilize Congressional subject terms 
listed with FCSRCA. Additional search terms were developed from the 'keywords' of a 
diverse number of scholarly writings on ART, including subject words from Fertility and 
Sterility, the main publication of ASRM. While the sample of bills may be biased slightly 
towards a 'pro-ART' frame, much of the literature on ARTs seems to indicate that a 
common set of terms largely seems to be understood to apply to their use. Nonetheless, 
this is acknowledged to be a potential weakness in this bill search technique. The reason 
for the selection of 1989 as the start year although ART practice in the US had begun in 
1982 is that THOMAS only lists full texts of bills from 1989 onward online, and due to 
time and financial constraints, it was not possible to access bills from the central 
depository, for the purpose of collecting bills proposed prior to 1989, for the purpose of 
analysis. 
 Data was also collected at the state level, limited to two state cases. The state of 
Georgia was selected because legislation was recently introduced that would have 
managed ART clinical use and practice in the form of State Bill 169. The second case 
selected was the state of California, in part because it was the location of the most recent 
 
 58
controversy related to ART, 'octomom'. This selection was also due in part to the fact that 
it is one of the few states in the U.S. having several pieces of active legislation directly 
relating to the use and availability of ARTs (NCSL, 2011). The search terms used for 
collected bills were the same as those used at the federal level, in order to maintain 
consistency over the two cases for later comparison. As with the sample of federal bills, it 
is acknowledged that this selection has the potential to bias the outcome of the bill search. 
 Of the bills collected, not all were utilized because of the narrowness of the topic, 
focusing on the management of clinical use and implementation of ARTs. While I 
acknowledge that legislation regulating and monitoring IVF research laboratory 
techniques and practices is not inherently independent of legislation attempting to 
regulate and monitor clinical IVF practice, I have attempted to limit the examination of 
bills to those that specifically address the medical/clinical practice of ARTs. Therefore, 
any bills that applied specifically to laboratory research protocols and IVF were discarded 
as they could not be coded within the frames constructed. 
 A minor part of the data collected was information regarding hearings for a 
selection of the bills. The primary purpose of collecting this information was to determine 
the more obvious actors that participated in developing the views related to the policy 
arena. This was primarily done at the federal level, because these hearings were the most 
easily accessible. Also for the historical analysis portion of this project, historical 
writings were used as the primary source of information. Secondary sources, such as 
scholarly works on the history of medicine and medical policy in the U.S. were also 
relied upon to build the story of how the history of medical autonomy and 'reproductive 
rights' influenced the development of frames and perspectives in the debate. 
 The classification analysis was based on logical divisions as informed primarily 
by the three large government reports created on IVF and other related technologies. This 
was supplemented by scholarly articles in discourse analysis, which has done some work 
on the division of different stakeholder groups in the ART arena; published medical 
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opinions; feminist critiques; religious critiques; legal writings; and other secular critiques. 
While this is acknowledged to have its limitations, particularly with respect to whether it 
successfully addresses the 'right question', per Dunn, it was believed that the main issue 
to be addressed before any analysis of frames in policy, was a 'clarification of concepts', 
which does not appear to have occurred in previous policy analyses of ART issues 
(Dunn, 2008, p. 96). 
3.3 Summary of Sources 
 In total, 105 bills were collected. At the federal level, this included 52 bills of 
which 44 failed to be passed and one was passed into law. Originally, 52 bills had been 
collected at the federal level, but due to the use of the computer-assisted qualitative data 
analysis software (CAQDAS), NVivo (QSR, International, 2009), it was not possible to 
import all of the bills into the program, therefore the eight federal bills that were not 
imported were not used. At the state of California level, there were 43 bills collected, of 
which 18 failed to be passed. At the state of Georgia level, 17 bills were collected of 
which 13 failed to be passed. Given that we have collected bills as the primary set of data 
and a limited amount of related hearing information, the primary means of indicating 
'failed' bills will just be whether or not they managed to be passed through both the house 
and senate bodies at the federal and state levels of government. A more detailed 
description of the legislation collected for this study can be seen in Appendix D. Even 
further, in Table 13 of Appendix D, the legislation along with the publications on ART 
by federal level organizations can be seen. Both of these items are organized by year of 
the final version of the bill. The green shading indicates the years where a Congressional 
hearing on the topic of ‘ART’ occurred. 











Table 1: The data for the frame analysis 
Federal 44 (52) 1 1989-Present 1989-2010 
[2009-2010 
legislative year] 
Georgia 17 4 1995-Present 1995-2010 
[2009-2010 
legislative year] 








CLASSIFICATION AND FRAME ANALYSIS 
4.1 Classification Analysis 
 The cleavages of this analysis were challenging, primarily because I have chosen 
to adhere to the principles of classification analysis outlined by Dunn. Given that he 
outlined 5 principles of classification analysis: (1) substantive relevance, (2) 
exhaustiveness, (3) disjointedness, (4) consistency, and (5) hierarchical distinctiveness 
(Dunn, p. 99-100), it was found that adhering to disjointedness and consistency became 
problematic because of the possibility of multiple frames existing within a single 
document. However, I chose to interpret the need for consistency to apply to the unit of 
measure (in this case, individual word/phrases/concepts) without the whole bills having 
to consist of a single frame. 
 The classification analysis can be seen in the figures below. The primary division 
between groups was one of those who favored 'more stringent' rules for ART use and 
those that favored 'less stringent' or 'status quo' rules for ART use (hereby, referred to as 
'status quo'). In Dion's The Other Machine, similar distinctions were classified as liberal 
discourses and other discourses, of which other included fundamentalist and radical 
discourses (1996, p.18-25). As can be seen from the diagram in figure 5, the 'status quo' 
group is divided only between 'couple' and 'practitioner' foci. This division is resultant of 
two papers by David Adamson, in which he outlines the 'hierarchy of interests' in the 
ART policy arena to be primarily patients, in which he included gametic materials and 
future children, and secondarily 'physicians and embryologists', followed by all other 
interests, including professional organizations (Adamson, 2002; Adamson, 2005). 
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 The divisions found within the 'more stringent rules' group, were initially based 
upon whether these groups were in favor of the technology within a spectrum of rules to 
be applied, or in favor of a complete ban. The reason for placing both 'rules' based and 
'ban' based groups under the same umbrella of 'more rules' is primarily because 
prohibition can be seen as yet another form of greater stringency. Within this division, the 
Catholic Church and secular objectors are those that support no use of ART. Within 
Dion's analysis scheme, these groups could be considered analogous to religious 
fundamentalist, secular fundamentalist and feminist radicals (p.95-127). 
 The division of 'increased rules' groups between women, child/embryo/fetus and 
society/public health, was through a number of arguments in the scholarly literature. 
Regarding the 'women' grouping, there have been a number of questions, particularly 
early in ART development, about the safety and the social impact of the technology. As 
mentioned in section 1.3.1, some concerns are due to the physical short and long term 
health impacts that are not necessarily understood or are not well conveyed to the parties 
involved (Kerian, 1997). Others concerns have to do with the commoditization of 'the 
womb' and the concern for the potential for women or subgroups of women to become 
defined only by their reproductive capability (Kerian, 1997). This is distinguished from 
the 'feminist' grouping of the secular, ban branch beyond just their desire for rules versus 
ban, but also because we define the 'feminist' grouping to have a larger concern for the 
social position and pressures upon women to become mothers and bear children 
(Birenbaum-Carmeli, 2003). An example of an organization that holds more 'feminist' 
group interests would be the Feminist International Network of Resistance to 
Reproductive and Genetic Engineering (FINRRAGE). 
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 The next group within the 'increased rules' branching, is those that focus on the 
future child, the fetus or the embryo. While seemingly this group could be subdivided 
further into those three classifications, there is a lack of evidence that there are 
representations of groups with a concern for one over the others. Many of the interests of 
these groups could be considered to overlap with the 'right-to-life' argument, found in 
abortion rights debates and discourse, but given the difference in technology there are 
some that fall outside of that debate. For example, the concern over future litigation based 
upon the idea of 'wrongful birth', is a concern of law related to the applications of ARTs. 
This litigation has been hypothesized to be a consideration due to birth defects and other 
health outcomes as a result of ART (Losco, 1989; Rosato, 2003). Another concern is the 
valuation and psychological effects of conceptions through ART, for example, the ability 
of parents to bond with children made possible through gamete donation and the 
valuation of children after the expense of ART-related treatments (WHO, 2002). Even 
further, the concerns for the embryo range from its ability to inherit after the death of a 
'parent', its ability to be 'adopted' and the damage incurred due to storage, not to mention 
the concerns over the disposal of them in the event that the couple no longer requires 
them (Charo, 2002). Similarly, concerns for the fetus are related to those concerns found 
in the abortion debate, such as multi-fetal reduction, which is in effect abortion of some 
fetuses for the purpose of maintaining the pregnancy and the health of the remaining 
fetuses (Collopy, 2004). Other concerns relate to the rights of the mother to conduct 
herself in a manner that may be detrimental to fetal development or well-being (Merkens, 
Browner, & Press, 1997). Often referred to as the 'mother-fetal conflict', it provides 
another aspect of ARTs that is controversial. Overall, a key reason for the combination of 
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three categories for this classification branch, is that they are not very distinct from each 
other in the sense that all of the concerns somewhat overlap in time. For example, in 
order to 'protect' the fetus from 'damage' or poor outcome, some steps may have to be 
taken at the time an embryo was being implanted, and therefore, not a fetus. Similarly, 
the measures of 'poor outcome' would not be easily assessed until the fetus had become a 
child, at which point it would have 'rights', whereas in its current state, it does not. 
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Figure 5: Identified target groups in the ART policy arena 
 The final classification group of 'society/public health' is considered to be separate 
from the other concerns of 'women' and 'children', though they are very closely related. 
For example, in this classification system, the concern over the impact of widespread 
donor gamete distribution could be considered a concern of the 'child' group, in that they 
may have less knowledge of their genetic origins, but here it is classified as a 'societal' 
concern over the inability to maintain clear lines of genetic relationships, thereby 
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increasing the potential for overlap of similar genetic backgrounds. These concerns also 
include such issues as the long term outcomes of ART, from a population perspective. An 
example of such would be the tracking of morbidity associated with ART-related births. 
While this too could conceivably fall under the auspices of the previous two categories, 
data related to birth morbidity is currently collected under the auspices of public health, 
though not necessarily tied back to ART. 
 The second stage of this classification analysis was to identify potential agents 
expected to play a part in the management of ARTs, and can be seen in figure 6. This 
system is NOT intended to be a flowchart of the organizational chain of command, only a 
general means of classifying the level of governance involved. Furthermore, it is 
currently made up of only those organizations that have previously participated in policy-
making. There may be other organizations that could fulfill a similar position in 
regulating this industry that have not previously been involved, such as the intervention 
of the FTC on the advertisement of success rates. 
Agents in ART




























































Figure 6: Actors identified to be key in the solution action 
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 The purpose of this classification analysis was to inform and add structure to the 
frame analysis of section 5.2. Given the breadth of the topic of ART and its policy arena, 
it is believed that this analysis did fulfill the five principles of classification analysis 
outlined in Dunn (p. 99-100). Alternative 'opinion' classification systems, such as a 
prevention/solution/ban division or medical/social/religious, may have served a similar 
purpose, but either would have expanded the scope of the project (the former) or created 
too many logical overlaps for the purpose of our frame analysis. 
4.2 Frame Analysis 
For the frame analysis, 48 federal level, 17 state level bills from Georgia, and 48 
state level bills from California were collected using a common set of terms, which can 
be found in Appendix B. As can be seen in Error! Reference source not found., the 
federal level bills were collected for the widest range of dates. California and Georgia 
had a relatively similar range of dates that bills were available for, with California having 
online records available for two years more. This complicates the inter-frame comparison 
slightly, particularly between federal and state levels, because bills were not available for 
all incidences on the timeline of Figure 16. However, because I was also doing an intra-
frame comparison, these bills were left in the sample. Even further, in additional analysis, 
through which I coded for frames using Nvivo (QSR, International, 2009), eight Federal 
level bills were excluded due to size/import error that could not be overcome. 
Table 2: The breakdown of data collected for the frame analysis 
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Table 2: The breakdown of data collected for the frame analysis 






Range of Dates 
Used 
Georgia 17 4 1995-Present 1995-2010 
[2009-2010 
legislative year] 




For bounding purposes, the set of search terms used were narrowed to only those 
that directly referenced ARTs or specific ART technologies. It is acknowledged that not 
only is this set of search terms laden, but it also excludes several potentially promising 
samples. Examples of excluded terms included 'infertility', which resulted in the inclusion 
of several bills that would have broadened the scope significantly. This broadening in 
scope also had tradeoffs, in that it may have caused a significant divergence in topic away 
from the original research question, which would have stretched this project beyond both 
time and resources. 
 The hypothesis in Chapter 3 is that frames containing historically negatively 
constructed actors will result in failure of passage whereas those containing historically 
positively constructed actors will result in successful passage. For purposes of analysis, 
the frames with historically positively constructed actors will be designated ‘traditional’ 
frames and those that contain historically negatively constructed actors will be referred to 
as ‘alternative’ frames. Given the history of 'reproductive rights' and the medical 
institution in the U.S. outlined in Chapter 1, I propose, as can be seen in the frame 
descriptions of Appendix C, that traditional frames contain the patient (or couple or 
spouse) and the physician, and any private professional or consumer organizations, such 
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as in the 'status quo' part of the classification analysis above, Figure 5. Therefore, it is 
proposed that those bills that involve state or federal level government action, monitoring 
or program development will be less successful. This is particularly the case if the 
solution frame does not provide for agency of the ‘traditional ART frame' group, 
particularly the more powerful actors such as physicians. The following four figures are 
models of the hypotheses. Figure 7 is the general framework expected to be in play. 
Figure 8 is the expected case for the identification of an ‘alternative frame’ group as a 
recipient of benefits or the identification of a ‘traditional frame’ group as the cause of a 
problem. Figure 9 is the expected case for the exclusion of ‘traditional frame’ actors from 
the development and management of a solution. Similarly, Figure 10 is the expected 
outcome for cases in which a traditional actor is identified for participation in the solution 




Figure 7: Overall framework for Hypothesis 1, for the purpose of explaining the cases in which a 
frame will or will not result in passage. Modification of the political context model found in 
Blackwell's Companion to Social Movement, p. 70 (Kriesi, 2004) 
 
Figure 8: The case in which an alternative actor is identified as the beneficiary of the problem frame 
or a traditional actor the cause of it. Modification of the political context model found in Blackwell's 




Figure 9: The case in which a bill identifies a solution that removes the option for primarily self-
management on the part of dominant actors. Modification of the political context model found in 




Figure 10: The case in which a bill excludes traditional actors, particularly historically powerful 
traditional actors, for participation in the development and implementation of the solution. 





Figure 11: The overall case of frames over time. It is expected that there should be some appearance 
of feedback. Modification of the political context model found in Blackwell's Companion to Social 
Movement, p. 70 (Kriesi, 2004) 
 Given that the structure of government bills does not guarantee that the problem 
definition will be explicitly stated, it was necessary to develop a system of distinguishing 
problem and solution frames. In this study, the primary means of finding the problem 
definition stemmed from word counts. The secondary step in the case of a dearth of key 
words was to use the statement of purpose of the bill. An additional step of identifying 
the problem definition was to identify whether the actors pointed in the definition were 
recipient of 'benefits' or 'burdens' within bill. This distribution of benefits and burdens 
along with the preconceived actor association with frames was then used to determine 
whether the bill would have been expected to pass or fail. Similarly, the solution 
definition also used actor location and recipient status to determine whether a bill would 
have been expected to pass or fail. A list of frames and actors can be found in Tables 9 & 
10 of Appendix C. 
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 As has been stated by multiple frame scholars before, the methods of frame 
analysis have generally been less grounded (Koenig, 2004). Whereas Goffman's original 
analysis depended largely upon examination of the narrative, it has been pointed out that 
this method often limits the sample size that can be examined. Following in the footsteps 
of those that have attempted to perform frame analysis with computer-assisted qualitative 
data analysis software (CAQDAS), I attempted to use Nvivo for the purpose of this frame 
analysis. As a result, this part of the analysis was broken down into three steps in order to 
target the aspects of legislation that this study was interested in. Given that the 
hypotheses were heavily reliant upon the actors of each piece of legislation and the 
actions upon those actors, it was helpful to start with a word count for each bill, as well as 
across each sample set. The second step consisted of condensing these word lists down to 
just actors or potential actors, given that in the English language, some terms can function 
as nouns and other parts of grammar. The primary purpose of pulling out actors from the 
legislation is two-fold: (1) it allowed for the identification of terms used to describe the 
parties that had already been identified from the literature as potentially important and (2) 
it provided preliminary results regarding the effectiveness of the frames previously 
selected. It is important to note that while all bills were run across a common set of 
actors, the final means of  examining the legislation for frames was to group them by 
successfulness of their passage ('success' of bills) and whether they were produced 
through a California, Georgia or federal legislative body ('level' of bills). 
 The initial step of a word search was performed in part so that common words 
across all bills could be identified and also to provide the researcher with an 
understanding of the contextual differences between each subset of bills, a subset being 
 
 74
defined as the success (pass/fail) of a piece of legislation at a given level 
(Federal/California/Georgia). The word count was performed using Nvivo, two times. 
Once on the bills as a collective across a subset defined by its success and level, and once 
across each bill within each subset. The top thousand words were collected and the 'non-
words' cleaned from the count. Non-words consisted primarily of numerals and numeric 
ordinals, which were expected to add little to the narrative. As stated above, this word 
count helped to determine how the use of words may differ between the different subsets 
being examined. A selection from the word count can be seen below in Figure 12. 
 
Figure 12: Federal 'Failed' Bills: An example of the word count comparison between those words 
that were encountered frequently between all individual bills counts and those that were encountered 
frequently in a cumulative word count across all bills 
 From Figure 12, only a few words appear to stand out as potentially important 
concepts within federal bills that failed to be passed. As stated previously, the word count 
was run across the aggregate of a subset, as well as across individual bills within a subset. 
The aggregate count was to determine whether some terms or themes appeared to occur 
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more frequently overall within a given subset. The individual counts were used in a 
second count. This second count served as a means of reinforcing the aggregate count by 
confirming whether a commonly counted word was a theme among many bills or a select 
few. This can be seen in Figure 12 as the difference in counts between column B and D. 
Column B contains the twice counted words, which represent how many bills each word 
was found in. Column D contains the counts of words in aggregate. It is clear from a 
comparison between these columns in Figure 12, that health is an important focus in this 
subset, as it occurs across 43 of the 44 bills and is counted highly in the aggregate. From 
this comparative word count, it could be tentatively argued that most of the bills in this 
subset may contain at least some aspects of the traditional frames of 'consumer' or 
'medical practitioner'. However, given that this is just the first step of this analysis, there 



































































































































































































































































































Distribution of Overall Word Counts-Federal Failed Bill
 
Figure 13: Federal Failed Bills word count distribution 
 Charts such as the one in Figure 14 below, provided some slight additional 
perspective to the word counts. It was hoped that by charting the word counts of bill 
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subsets, a pattern of key words would be distinguishable for the purpose of comparing 
between subsets, but it largely appeared that highly counted words tended to be random. 
For clarification, the chart below is the result of charting the aggregate word count, 
ordered by number of bills occurred in and aggregate count, along the x-axis, while the y-
axis represented the aggregate count. This resulted in the pattern seen above, in which 
each clear peak represents the highest count in a bill count. 
 
Figure 14: Set of actors contained within a word count of Federal level bills that failed to be passed 
 An important aspect of performing the word count, beyond just its facilitation of 
the second step, as will be discussed in the next paragraph, is its usefulness in finding 
potentially uniform word usage that assisted in the finding of the 'problem definition' and 
'solution definition' frames. The default assumption in this study was that the primary 
purpose of each bill was to outline a 'solution frame'. For example, federal failed bills 
often (26/44) designated a problem in a section referred to as 'findings'. For California 
bills, problems were more often labeled by 'existing law' (41/42). Georgia, in contrast to 
the other two cases under study, appeared to have very little wording to distinguish the 
problem frame from the solution frame. There was use of 'findings' for a few Georgia 
bills (5/12), but overall, many of the bills failed to identify the 'problem definition' 
independently from the proposed solution of the bill. 
 From Figure 15, the second step used to find frames can be seen, in which the 
actors from each frame were filtered out of each word count. While it is clear that several 
words are common across many bills, such as 'state'/'states', it is also apparent from this 
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initial parsing, that other words are not as heavily used, such as 'unborn'. These word 
counts were color coded so as to approximate which words would represent potential 
frames or not. From the sparse usage of such terms as 'unborn' however, it can be inferred 
that the term may be highly associated with a particular frame, because it invokes specific 
images regarding (1) reproduction and (2) legitimate actors. However, like the word 
counts, without the associated narrative, drawing conclusions from these terms alone 
would be premature. Overall, this above step of a key actor count provides an important 
boundary identifying step of determining what terms are commonly used to designate 
actors. Even further, it allows for a clarification in tying commonly used terms to frames, 
an important step considering that our frames are actor-centered. An important limitation 
of this step is that the ability to distinguish all actors in a list of words is limited, due to 
some terms serving multiple functions within language, such as 'relative' (a family 
member, or a term relating concepts). There is also the fact that pronouns have the 
potential to mask points of the narrative because they reduce the actor to an even more 
generic term. 
 The third step of finding a frame relied upon several matrices in order to compare 
actor co-occurrences, actors' occurrences within bills, and actors' co-occurrences with 
terms of interest. Figure 15 below shows a matrix that pinpoints the actors contained 




Figure 15: An actors x bills matrix, for federal level failed bills. The purpose of this matrix was to 
identify which bill utilized which actors. 
From the matrices created, the narratives containing actors of interest could be 
pinpointed. 
 Overall, word counts provided an important step in the processing of the narrative 
in this data set. It made it possible to determine how actors appear in bills. Second, it 
provided insight into standard and non-standard wording of bills. While it does share 
some similarities with content analysis and 'keying' in the original form of frame analysis 
(Goffman, 1974, p. 43-44), it is hoped that this means of parsing apart the actors from the 
remainder of the narrative provides some system through which frame analysis can be 
more methodically approached in the future. It is noted that an additional aspect to be 
added in the future may be to also parse out potential verbs and adjectives in order to 
create a further detailed set of matrices to approach the narrative. 
4.2.1 An overview of the contents of federal level bills 
 The federal level legislation provided its own set of challenges. For example, the 
keying to identify statements indicating potential problem statements was not uniform 
across all bills. As mentioned above, twenty-six out of forty-four bills contained the term 
'findings', a term that would clearly identify what was determined to be the problem to be 
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solved. In order to navigate around this issue, it was decided that the purpose statement 
also could serve as the means to determine the problem frame. This was supplemented by 
the narrative found with the 'findings' key, as available. Another issue was the fact that 
there was only a single passed bill, thereby limiting the potential for within-level 
comparisons. Given that this was expected, it was only possible to disseminate what 
frames were potentially in play within the legislation and look at the changes from a 
historical perspective. 
 
Figure 16: Federal timeline of bills. The blue highlighted bill is the only passed bill at this level. 
 Figure 16 above shows the time line of federal level bills collected for this study. 
As can be seen from both this figure and the Chapter 3 outline of data, the number of 
passed bills at this level is limited to one, FCSRCA. For clarification purposes, the data in 
the following sections will be ordered in the manner below, as exemplified by Table 3. 
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The quotes listed in the 'statements of frame' section of the table, will be ordered 
according to the numbering of the quadrants. 
Table 3: Organization of data 
bill purpose Actor Scope  
 1 2  
3 4  
Statements of frame Quotes, listed by quadrant 
 Figure 16 above shows the time line of federal level bills collected for this study.  
4.2.1.1 Federal Successful Bill: FCSRCA 
 Comparison of all the bills cannot be completed without an understanding of them 
within their individual subsets. Given that much of the critique regarding policy has been 
aimed at the federal level, the frames at this level are of primary interest. The limited 
number of successfully passed federal bills limits what can be said about whether frames 
affect the ability of a piece of legislation to be passed. However, it may provide some 
information about the context of ARTs at this level and how they tend to be presented. 
 The first bill examined for frames was the only passed bill at the federal level, 
FCSRCA. The structure of this particular bill has no keyword to designate a separate 
problem statement from its solution statement, so it was concluded that the problem 
statement was implicit within the statement of the purpose of the bill. FCSRCA states 
that its purpose is “to provide for reporting of pregnancy success rates of assisted 
reproductive technology programs and for the certification of embryo laboratories”. 
Given that the approach of this study was based primarily upon the actors' representation 
within the frame, it is important to note that the primary actor of this problem statement is 
'embryo laboratories', as is noted in Error! Reference source not found., below. 
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Table 4: FCSRCA frame 
Fertility Clinic 
Success Rate and 
Certification Act of 
1992 (FCSRCA) 
Stated Purpose Actor Scope  
“to provide for 
reporting of pregnancy 
success rates of 
assisted reproductive 
technology programs 
and for the 
certification of embryo 
laboratories” 
Embryo laboratories 
[target of action];  
practitioners of medicine 
[excluded from action 
upon]; consumers 
[implicit] 
Unclear definitions of ART 
procedure success rates and 
inconsistent or unclear 
procedures taken by fertility 
clinics in the completion of an 
ART cycle, EXCEPT for the 





organizations, 'the state', 
accreditation organizations 
Secretary: Development of (1) a 
model certification program and 
(2) a measure of success rates 
for embryo lab-associated ART 
programs 
 
'the State' & accreditation 
organizations: the 
implementation of a modified 
certification program; collection 
of proscribed data; submission 
of data and certification reports 
to the CDC 
 
consumer & professional 
organizations: source of 
consultation for the development 
of (1) a model certification 
program and (2) a measure of 
success rates for ARTs 
Solution 
Definition 
Statements of frame 1:  
“to provide for reporting of pregnancy success rates of assisted reproductive technology programs 
and for the certification of embryo laboratories” 
 
“In developing the certification program, the Secretary [or the State] may not establish any 
regulation, standard, or requirement which has the effect of exercising supervision or control over 
the practice of medicine in assisted reproductive technology programs.” 
 
“(a) CONSULTATION- In developing the definition under subsection (b), the Secretary shall 
consult with appropriate consumer and professional organizations with expertise in using, 
providing, and evaluating professional services and embryo laboratories associated with assisted 
reproductive technologies.” 
2:  
“to provide for reporting of pregnancy success rates of assisted reproductive technology programs 
and for the certification of embryo laboratories” 
STANDARDS- The certification program shall include the following standards developed by the 
Secretary:  
A standard to assure consistent performance of procedures by each embryo laboratory certified 
under the certification program or by an approved accreditation organization in a State which has 
not adopted the certification program.  
A standard for a quality assurance and a quality control program to assure valid, reliable, and 
reproduceable procedures in the laboratory.  
A standard for the maintenance of records (on a program by program basis) on laboratory tests 
and procedures performed, including the scientific basis of, and the methodology used for, the 
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Table 4: FCSRCA frame 
tests, procedures, and preparation of any standards or controls, criteria for acceptable and 
unacceptable outcomes, criteria for sample rejection, and procedures for safe sample disposal.  
A standard for the maintenance of written records on personnel and facilities necessary for 
proper and effective operation of the laboratory, schedules of preventive maintenance, function 
verification for equipment, and the release of such records to the State upon demand....” 
3:  
“the Secretary shall, in consultation with the organizations referenced in subsection (c), define 
pregnancy success rates and shall make public any proposed definition in such manner as to 
facilitate comment from any person (including any Federal or other public agency) during its 
development.” 
 
“the Secretary shall consult with appropriate consumer and professional organizations with 
expertise in using, providing, and evaluating professional services and embryo laboratories 
associated with the assisted reproductive technology programs.” 
 
“A State may qualify to adopt the certification program if the State has submitted an application to 
the Secretary to adopt such program and the Secretary has approved the application.” 
“A State which has adopted the certification program may use accreditation organizations 
approved under section 4 to inspect and certify embryo laboratories” 
4:  
“Such an application shall include--  
assurances satisfactory to the State that the embryo laboratory will be operated in accordance with 
the standards under subsection (d),  
a report to the State identifying the assisted reproductive technology programs with which the 
laboratory is associated, and...” 
 
“The certification program shall include the following standards developed by the Secretary:  
A standard to assure consistent performance of procedures by each embryo laboratory certified 
under the certification program or by an approved accreditation organization in a State which has 
not adopted the certification program.  
A standard for a quality assurance and a quality control program to assure valid, reliable, and 
reproduceable procedures in the laboratory.  
A standard for the maintenance of records (on a program by program basis) on laboratory tests and 
procedures performed, including the scientific basis of, and the methodology used for, the tests, 
procedures, and preparation of any standards or controls, criteria for acceptable and unacceptable 
outcomes, criteria for sample rejection, and procedures for safe sample disposal.  
A standard for the maintenance of written records on personnel and facilities necessary for proper 
and effective operation of the laboratory, schedules of preventive maintenance, function verification 
for equipment, and the release of such records to the State upon demand.  
A standard for the use of such personnel who meet such qualifications as the Secretary may 
develop.” 
However, a further reading of narrative of the bill reveals references to other actors that 
can be directly tied to the problem statement, thereby providing further context. For 
example, the mandate for the creation of a model certification program states explicitly 
that the Secretary and the state,  
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“In developing the certification program...may not establish any regulation, standard, or 
requirement which has the effect of exercising supervision or control over the practice of medicine 
in assisted reproductive technology programs.” 
In stating that the practice of medicine may not be infringed upon, the U.S. Congress is 
clearly excluding the consideration of a potential actor as part of the problem, i.e. those 
that 'practice medicine'. Even further, it indicates that despite the tie between the practice 
of medicine in ART programs and the embryo clinics of interest, only some of the actors 
in the entity referred to as 'fertility clinics', are under scrutiny: 'embryo laboratories'. This 
statement further excludes the attached body of ART programs from sanctions, i.e. the 
monitoring and certification that is being applied to embryo laboratories. An even less 
explicit actor of this activity are consumers of the fertility clinic. Within the bill, they are 
mentioned a mere two times, both as a term to describe other organizations that may be 
'consulted' in the development of a model certification program. An important point of 
note regarding these three actors in this bill is the fact that, while they all may play a part 
in how the problem is defined, their roles are significantly different. The mentioning of 
the embryo clinics as the explicit actor clearly identifies them as the means of solving the 
perceived problem (Rochefort & Cobb, 1994, p. 23). The expression that sanctions could 
not be extended to those that practice medicine in assisted reproductive technology 
implies something not only about the practitioners, but also about the embryo 
laboratories. From Ingram and Schneider’s social construction of actors matrix, it can be 
hypothesized that both entities practitioners and laboratories may be perceived as 
'contenders' in the policy arena, i.e. actors considered to be stronger but also undeserving 
of benefits. In the language of Schneider and Ingram's social construction framework, 
these actors are considered to be contenders (1997, p. 116-120), because of their power 
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within the policy area as well as the fact that they are not necessarily positively 
constructed. As such, it is clear that the distinction is made between 'embryo labs' and 
'practice of medicine' as the point on which to apply burdens. Regarding the consumer of 
the fertility clinic, it is not quite clear in which quadrant they reside with regard to the 
Schneider & Ingram social construction of actors matrix, of which a model of can be seen 
in Figure 19 of Appendix C. On the one hand, it appears that they are a dependent, given 
that, from the language of the bill, the primary function of this legislation is to correct for 
an information asymmetry through publication of information on fertility clinics. On the 
other, they also are given the opportunity to structure the certification process, thereby 
creating a more costly policy structure, according to the framework (p. 112, 123). 
 The second part of the frame is the solution definition. The most prominent, 
explicit actor is the Secretary of Health and Human Services, acting through the Centers 
for Disease Control (CDC). However, it also important to note that the implementation is 
carried out through 'the state' and accreditation organizations. Also important in the 
development process are the professional and consumer organizations, which are 
designated as consultants for the development of the program. Again, their role within the 
solution becomes an important aspect of understanding the solution frame. As stated by 
the bill, the Secretary is the primary actor for development and delivery of the model 
certification program, as well as the actor to whom reports are due regarding the data 
collection aspects of the bill. However, the Secretary defers adoption and implementation 
of the programs, as well as immediate data collection and management of the certification 
programs, to 'the state' or accreditation programs. Moreover, states can choose not to 
become an actor in this particular bill, seemingly resulting in their inclusion in the 
 
 85
solution definition being more rhetorical and not creating action on the part of the state. 
Similarly, the professional and consumer organizations are also voluntary participants to 
the process, but they are given 'authority' in the sense that they enter into the development 
process as experts on how the model certification program should function. Even further, 
there are the embryo laboratories, which are saddled with the burden of certification and 
observation. 
 Overall, as mentioned before, the embryo laboratories appear to function as 
contenders in the sense described in Ingram and Schneider’s matrix of actors, which can 
be seen in Figure 19. By this, I mean that they are an extension of the fertility clinic, as 
are the medical practitioners. Given the relationship between the different actors, it is 
then necessary to look at the scope, in order to understand how the social construction 
plays out. In this particular bill, the scope of inclusion of each actor is different. The 
Secretary exists in a broad scope of action, but constrained in that action by actors on 
which he may not act. As such, given that his function is more as a tool than a socially 
constructed actor, it is necessary to look at how the constraints to action affect the other 
actors of the bill. Given that the medical practitioner is both not being acted upon and 
receiving the option to manage (through consultation) the burden that is placed on it, it 
appears to function also as a contender, primarily through the fact that it is exempted 
from action and called upon to 'self-manage' through consultation. The embryo 
laboratories also function as contenders, in the sense that they are an extension of the 
practice of medicine, and therefore tied directly to those creating the rules. Even further, 
however, is the fact that little direction action against the embryo laboratories for not 
obtaining certification, is expressed within the wording of the bill. Given that the primary 
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loss of not obtaining certification would be being listed as being 'not certified', there is 
only slight incentive but no requirement to adhere to the newly created rules. Without 
further examples of passed bills to compare these actors, these constructions are merely 
implied through the set up of the bill, but not conclusive. 
 Given that there are no other passed bills for points of comparison, little can be 
said regarding the frames' effect on the ability of the bill to be passed. However, 
regarding the existence of frames themselves, it seems as if there is evidence of a more 
traditional frame encompassing 'doctors' and 'consumers/couples'. The doctor frame is 
'more visible', in the sense that there is a provision to not impinge upon the practice of 
medicine in ARTs and the requirement that the Secretary consult with 
“appropriate...professional organizations with expertise in using, providing, and 
evaluating professional services and embryo laboratories associated with the assisted 
reproductive technology programs.” The consumer frame used within the bill primarily 
falls within the problem definition and the implicit indications that consumers are the 
actor for whom action is being taken. Non-traditional frames are not present at all. 
 An important note to make at this point is that the 'society'/'state' frame appears to 
have no standing in this form of narrative. Given that the federal government and 'the 
state' are inherent actors in this bill, the government frame becomes illogical. 
Additionally, the embryo clinic, while it appears to have received a burden, also seems to 
function as an extension of the doctor frame. The following bills will be necessary to 
confirm such a pairing, but from this limited analysis, this appears to be the case. 
4.2.1.2 Federal Failed Bills 
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 The forty-four federal failed bills provided additional insight into the structure 
and composition of bill frames, as well as providing further insight into which actors 
tended to receive problem definitions on their behalf, which actors were constructed as 
'problematic' and which actors tended to result in constraints to government action. A 
small selection of the failed federal bills can be seen in Table 5, below. 
Table 5: Examples of frames for two federally failed bills 
HR 1852 Stated Purpose Actor Scope  
“To assure equitable 
treatment of fertility 
and impotence in 
health care coverage 
under group health 
plans, health 
insurance coverage, 
and health plans 
under the Federal 
employees' health 
benefits program.” 
Health insurance issuers 
[acted upon]; Federal 
employees [action on 
behalf of] 
Inequality on the part of health insurers, 




Health insurance issuers, 
actors of ERISA, actors of 
the Public Health Service 
Act 
Assuring that policies covering 
impotence treatment also cover infertility 
treatment 
 
Does not allow for constraints to be 
placed upon the general practices of 
insurance companies, such as placing 
restrictions on restricting which drugs 






“To assure equitable treatment of fertility and impotence in health care coverage under group health plans, 
health insurance coverage, and health plans under the Federal employees' health benefits program.” 
2: 
“(a) IN GENERAL- A group health plan, and a health insurance issuer offering group health insurance 
coverage, that provides for coverage of impotency medications such as viagra shall also provide coverage 
of fertility treatments.” 
3: 
“(b) INDIVIDUAL HEALTH INSURANCE- (1) Part B of title XXVII of the Public Health Service Act is 
amended by inserting after section 2752 the following new section: 
`SEC. 2753. EQUITY IN FERTILITY COVERAGE. 
`(a) IN GENERAL- The provisions of section 2707 (other than subsection (c)) shall apply 
to health insurance coverage offered by a health insurance issuer in the individual market 
in the same manner as it applies to health insurance coverage offered by a health insurance 
issuer in connection with a group health plan in the small or large group market. 
`(b) NOTICE- A health insurance issuer under this part shall comply with the notice 
requirement under section 714(c) of the Employee Retirement Income Security Act of 1974 
with respect to the requirements referred to in subsection (a) as if such section applied to 
such issuer and such issuer were a group health plan.'. 
(2) Section 2762(b)(2) of such Act (42 U.S.C. 300gg-62(b)(2)) is amended by striking 
`section 2751' and inserting `sections 2751 and 2753'. 
(c) FEHBP- Section 8902 of title 5, United States Code, is amended by adding at the end 
the following the following new subsection: 
`(p) A contract may not be made or a plan approved which does not comply with the 




Table 5: Examples of frames for two federally failed bills 
“`(a) IN GENERAL- The provisions of section 2707 (other than subsection (c)) shall apply to health 
insurance coverage offered by a health insurance issuer in the individual market in the same manner as it 
applies to health insurance coverage offered by a health insurance issuer in connection with a group health 
plan in the small or large group market. 
`(b) NOTICE- A health insurance issuer under this part shall comply with the notice 
requirement under section 714(c) of the Employee Retirement Income Security Act of 1974 
with respect to the requirements referred to in subsection (a) as if such section applied to 
such issuer and such issuer were a group health plan.'” 
HR 3940 Stated Purpose Actor Scope  




Embryo laboratories Insufficient availability of information 
regarding the selection of embryo clinics 
Problem 
Definition 
American Fertility Society 




embryo labs; Secretary of 
HHS; the states; 
accreditation organizations 
Consultation with AFS, CoAP and 
consumer organizations, the development 
of a model certification program based 
upon standards set by the Secretary of 
HHS,to be carried out by the states. It is 
also to be monitored by (1) an accepted 
accreditation organization approved by 
the Secretary of HHS or (2) a state AND 
the Secretary of HHS. The states are 
required to qualify to administer a 
program through application to the 
Secretary of HHS for approval. The 
penalty for failure to maintain 
certification standards is the revocation 






“To provide for the certification of embryo laboratories.” 
2: 
“IN GENERAL- Not later than 2 years after the date of the enactment of this Act, the Secretary shall 
develop a model program for the certification of embryo laboratories to be carried out by the States.” 
3: 
“CONSULTATION- In developing the certification program under subsection (a), the Secretary shall 
consult with the American Fertility Society, the College of American Pathologists, and appropriate 
organizations representing consumers of embryo laboratory services.” 
 
“PUBLICATION- The Secretary shall, in consultation with appropriate private organizations involved 
with embryo laboratories, not later than 3 years after the date of the enactment of this Act and annually 
thereafter publish and distribute to the States and the public information showing pregnancy success rates, 
as defined by the Secretary under subsection (e)(2), achieved by each in vitro fertilization program in 
association with embryo laboratories in the United States. Such information shall prominently disclose 
which States have implemented the certification program of the Secretary and which laboratories have been 
certified under such program.” 
4: 
“PUBLICATION- The Secretary shall, in consultation with appropriate private organizations involved 
with embryo laboratories, not later than 3 years after the date of the enactment of this Act and annually 
thereafter publish and distribute to the States and the public information showing pregnancy success rates, 
as defined by the Secretary under subsection (e)(2), achieved by each in vitro fertilization program in 
association with embryo laboratories in the United States. Such information shall prominently disclose 
which States have implemented the certification program of the Secretary and which laboratories have been 
certified under such program.” 
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Table 5: Examples of frames for two federally failed bills 
 
“CERTIFICATION BY STATES- A State may qualify to administer the certification program established 
by the Secretary under section 2(a) within the State if the State has an application to the Secretary to take 
such action approved. Such an application shall include--” 
 
“ADMINISTRATION- A certification program in a State shall be administered by the State and shall 
provide for the certification of embryo laboratories by the State or by an accreditation organization 
approved by the State.” 
 
“ a) IN GENERAL- A certification issued by a State or an accredition organization for an embryo 
laboratory shall be revoked or suspended if the State or organization finds, on the basis of inspections and 
after reasonable notice and opportunity for hearing to the owner or operator of the laboratory, that the 
owner or operator or any employee of the laboratory--  
◦ has been guilty of misrepresentation in obtaining the certification,  
◦ has failed to comply with any standards applicable to the certification, or  
◦ has refused a request of the State or accreditation organization for permission to inspect the laboratory, 
its operations, and records.  
• EFFECT- If the certification of an embryo laboratory is revoked or suspended, the certification of 
the laboratory shall continue in effect for 60 days after the laboratory receives notice of the 
revocation or suspension. If the certification of an embryo laboratory is revoked or suspended, the 
laboratory may apply for recertification after one year after the date of the withdrawal or 
revocation.” 
 
With the federal level bills, the lack of availability of contrasting 'passed' bills resulted in 
no point of comparison to determine whether the frames in use were different than those 
passed. Undoubtedly, at this level, having a broader selection of legislation would have 
clarified the results immensely. That being said, given the results of just this level of bills, 
some interesting results regarding legislative frames become apparent. For one, the 
concept of a 'women' frame and 'society' frame, do not hold up well in the context of 
legislation. This may be because the terms are highly generalized, such that the terms 
would inevitably be used in some form. The society frame is also so close to the 
'government' frame, that distinguishing actions on the part of 'society' or 'the public' is 
drowned out by action being taken in general. Both of these frames could possibly benefit 
from further adjustments to identify whether there are additional actors terms that could 
be used to identify these frames or whether they would benefit from the addition of verbs 
and adjectives. However, the overall legislation presented at this level did present some 
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indications of variation of frames that could potentially affect the success of those frames 
in passage. 
 For the problem definition aspect of the frame, the bills typically identified 
couples and/or consumers as important actors in the bills. The occurrence of 'couple' as a 
term occurred in thirteen of the forty-four bills. Sometimes, these individuals were 
identified as 'the infertile', a term that, from some discourse perspectives, has been 
considered a term indicating dependency (Farquhar, 1996, p. 83). It is important to note 
that 'couples' were rarely targeted in the solution of the frame. The form that they were 
targeted was primarily for the purpose of denying coverage of IVF. For example, a bill 
addressing veterans' benefits only targeted couples in the sense that it excluded the use of 
IVF as a potential health plan covered treatment for infertility.  
(1) The Secretary may-- 
`(A) provide to an eligible veteran (and, if necessary, the veteran's spouse) qualifying 
procreative services, and 
`(B) subject to paragraph (2) of this subsection, reimburse an eligible 
veteran for qualifying adoption expenses incurred by the veteran... 
`(4) For the purposes of paragraph (1) of this subsection, the term `qualifying 
procreative services' means procreative services that are reasonable and necessary to 
overcome the effects of a service-connected disability described in paragraph (3) of 
this subsection, but such term does not include-- 
`(A) procedures to conceive a child using gametes of an individual other than 
the veteran or the veteran's spouse; `(B) procedures to conceive a child through 
in vitro fertilization; or 




Therefore, for all intents and purposes, the couple appears to remain a dependent 
population. Other populations' inclusion in the problem definition of the bills varied. 
 Given the limitations of the approach to these pieces of legislation, the solution 
definition appeared to have the most interesting results regarding the hypotheses 
proposed by this study. For one, one common actor/ tool often featured is the Secretary of 
Health and Human Services (HHS). Also featured in similar positions were the Secretary 
of Veterans' Affairs and the Comptroller General. For the most part, with the exception of 
the three bills that appear functionally similar to FCSRCA, the function of these 
individuals was often to define terms under which to give benefits like ART treatment for 
infertility (Secretary of HHS) or affirm it (Secretary of Veterans' Affairs). Another 
example of a frequent actor of the solution definition was physicians, who often had the 
standing of 'expert' within the wording of the bills, as expected. This often took the form 
of a requirement for verification in order to access some service: 
 “(5) For purposes of this subsection-- `(A) the term `infertility' means--(i) the inability to 
conceive a pregnancy after 12 months of regular sexual relations without contraception or to carry 
a pregnancy to a live birth; or (ii) the presence of a demonstrated condition determined by 2 
physicians (at least 1 of whom specializes in infertility) to cause infertility;”.(HR 1418 IH) 
 
(1) The term `infertility treatment services' means, with respect to an individual entitled to benefits 
by reason of section 226(b), diagnosis and treatment (described in paragraph (2)) by a physician 
(as defined in subsection (r)(1)). (HR 2758) 
 
`(ii) the procedure (including any retrieval incident thereto) is performed at medical facilities that 
conform to the standards of the American Society for Reproductive Medicine, the Society for 
Assisted Reproductive Technology, the American College of Obstetricians and Gynecologists, or 
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any other similar nationally-recognized organization, or a Federal agency that promulgates 
standards for infertility procedures; (HR 1246) 
 
Similarly, professional organizations also served to fulfill the role as 'expert', particularly 
as points of consultation for the government official or office tasked with implementing 
the legislation. With regard to the implementation of action, many of the failed pieces of 
legislation clearly exemplified the traditional frames, which were hypothesized to support 
passage of legislation. For some bills, such as those preceding FCSRCA on the issue of 
embryo laboratory certification, a significant amount of intrusion by the government into 
the practice of medicine and the function of the fertility clinic may have contributed to 
the failure of these pieces. For example, in FCSRCA, an explicit limitation exists for the 
Secretary of HHS: 
SECRETARY- In developing the certification program, the Secretary may not establish any 
regulation, standard, or requirement which has the effect of exercising supervision or control over 
the practice of medicine in assisted reproductive technology programs. (P.Law 102-493) 
In contrast, the three bills addressing the same topic and with similar construction of the 
problem (HR 3940, HR 5110 & HR 756), appear to have no explicitly worded 
limitations. Even further, a point of interest may be the exact means through which the 
Secretary could exact penalties in these bills. For example, all three of the failed, similar 
bills allowed for the Secretary, the state or both, to exact fees in the certification process: 
FEES- The Secretary and a State may each require payment of fees for the issuance and renewal of 
certificates in such amount as they may determine is necessary to carry out their respective 
responsibilities under this Act. (HR 3940) 
 
FEES- The Secretary shall require payment of fees for the issuance and renewal of certificates in 
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such amount as the Secretary may establish to carry out this Act based on the volume and scope of 
the services being performed by the embryo laboratories. (HR 5110) 
 
FEES- The Secretary shall require payment of fees for the issuance and renewal of certificates in 
such amount as the Secretary may establish to carry out this Act based on the volume and scope of 
the services being performed by the embryo laboratories. (HR 756) 
FCSRCA did not allow this to be the case, a potential example of an aspect of a solution 
definition that could be considered burdensome to the privileged actor of the traditional 
frame. In the remaining bills, because there is no clear bill for comparison, the ability to 
attribute frame to their failure is limited. 
 Overall, the general conclusions to be drawn from the frames found in the failed 
legislation solution definitions appeared to represent three different ways that possibly 
could prevent their passage, according to the previously presented 'traditional frame': (1) 
prevention of access to IVF [burdensome on the 'infertile couple'], (2) the placement of a 
burden upon physicians, or (3) the exclusion of privileged actors from their own 
management system. An additional important note is that, out of the forty-four of bills for 
analysis, only five appeared to have any non-traditional frames (i.e. society frames, 
women frames, or children frames): HR 2861, HR 3350, S 1726, S 707, and HR1161. All 
five of these bills were directly addressed to the issue of “infant health” or “women's 
health”, thereby seemingly removing them from having a fully traditional frame. 
However, according to the coding by actors, a different story is told. In fact, by that 
coding, HR 1161 contains many of the traditional frame actors, as well as all of the 
'society'/'government' actors, while using a limited number of the child and female actors. 
This may indicate either (a) that the actor association with each frame is a weak one or 
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(b) that no frames exist within legislation. Given the lack of a point of comparison, in the 
form of successfully passed bills, either one is difficult to conclude. 
4.2.2 An overview of the contents of the California level bills 
 
Figure 17: A time line of California bills. The blue highlighted bills are passed bills 
 The next sample set examined was California legislation. The legislation from 
California, as compared to the federal level legislation, required significant sifting 
through the narrative in order to understand which actors were being addressed for the 
problem and solution definitions. While forty out of forty-two of the bills had a clear key 
term to designate what the defined problem was ('existing law'), the density of the 
narrative complicated the distillation of the important actors and actions from general 
defining terms. The one bill that did not use the 'existing law' term was a resolution and 
therefore had a different structure. Some important structures that made the California 
data set significantly different from both the federal data set and the Georgia data set is 
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the fact that while one version of a California bill might contain one of the ART terms 
searched for, not all iterations necessarily contained it. Given that this study looked 
primarily at the final version of all bills, this significantly trimmed the number of bills 
examined for frames of interest. Of the 42 bills collected, only 27 of them contained the 
original search terms. Another point of interest that makes this subset different from the 
other two is that the passage of the legislative body did not necessarily result in it being 
signed into law. While this had the potential to happen in any of these subsets, neither 
Georgia nor the federal level legislative bodies passed any legislation that did not get 
signed into law, whereas in California four of the 27 bills that passed the legislative body 
failed to become signed into law. Given that the primary interest of this study was 
whether the bill could manage passage through the legislative body, these bills were 
counted among the 'passed' bills. However, this explains why there may be proposed 
legislation that failed to pass, but has similar or the exact same requirements as a 'passed' 
version that predates it. 
4.2.2.1 California Passed Bills 
 On the surface, the passed bills in California appeared to contradict the 
hypotheses completely. For one, while they did appear to draw heavily upon the 
traditional frames of 'physician', 'couple', and 'family', the bills did not appear to apply 
solutions to the social constructions as would have been expected. For example, some 
bills implement clear penalties for transgressions by powerful actors. An instance of this 
is bill AB 2513, which implements a definitive civil penalty of a fine if it is found that a 
physician or surgeon is found to have conducted themselves unprofessionally: 
This bill would require a physician and surgeon who removes sperm or ova from a patient to 
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obtain a prescribed written consent from the patient before the sperm or ova are used for a purpose 
other than reimplantation in the same patient or implantation in the spouse of the patient. The bill 
would provide that violation of the requirement constitutes unprofessional conduct. The bill would 
provide that the misdemeanor provision does not apply to a person who violates the requirement. 
This bill would require a physician and surgeon who fails to obtain the required consent a 2nd time 
to be assessed a civil penalty of not less than $1,000 and not more than $5,000, plus court costs, to 
be paid to the individual whose required consent was not obtained. (AB 2513) 
However, without further analysis of the success of this action, it is not possible to 
determine whether this action is enforceable or is primarily rhetoric aimed at placating a 
dependent set of actors. This could be argued to be the case given that some of the bills 
that permit penalties for such powerful groups managed to get passed through the 
legislature but then failed to become law. Other bills clearly utilize non-traditional 
frames, even when couched with traditional frames of physician and infertile couple. For 
example: 
(b) (1) No later than January 1, 2002, the department, after consultation with the appropriate 
national medical specialty societies, shall develop a standardized written summary in laymen's 
language and in a language understood by the patient or oocyte donor regarding health and 
consumer issues relating to ART and oocyte donation. The summary shall be printed and made 
available by the board to physicians and surgeons and shall include, but not be limited to, the 
following disclosures: 
A) The potential risks to both the mother and the fetus posed by the drugs, medications, and 
hormones used in ART.  
B) The potential risks of implanting multiple embryos, including multiple births.  
C) The potential risks to both the mother and the fetus from multiple births.  
D) The potential risks of oocyte donation, including the risk of decreased fertility and the risks 
associated with using the drugs, medications, and hormones prescribed for ovarian stimulation 
during the oocyte donation process.  
 
 97
Even further, there is a significant amount of intervention by government bodies on 
behalf of different actors and even the public. Some actors, such as the couple or 
consumers, are still constructed in a similar manner to how they are constructed in the 
federal level bill. However, the presence of additional actors and social constructions in 
these bills, such as 'child', provide evidence that other frames orientations exist within 
legislation and also have the potential to be passed. The passage of legislation penalizing 
physicians and other medical professionals for transgressions appears to be more 
acceptable, but examples such as passed bill SB 674, provide a contradiction to the 
acceptability of such legislation because, while they state the following, they also fail to 
become law: 
(1) Existing law provides for the licensure and regulation of various healing arts practitioners and 
requires certain of those practitioners to use particular designations following their names in 
specified instances. Existing law provides that it is unlawful for healing arts licensees to 
disseminate or cause to be disseminated any form of public communication, as defined, containing 
a false, fraudulent, misleading, or deceptive statement, claim, or image to induce the rendering of 
services or the furnishing of products relating to a professional practice or business for which he or 
she is licensed. Existing law authorizes advertising by these healing arts licensees to include 
certain general information. A violation of these provisions is a misdemeanor. 
Whether this action is rhetoric or even intended to target other professional groups 
outside of those powerful groups providing ARTs comes into question. However, it does 
provide some explanation as to why the types of regulation vary so drastically around the 
country. 
 Overall, the social constructions within the California passed legislation include 
more actors in addition to providing different constructions for them. The social 
construction of infertile couples appears to remain the same, i.e. they are dependent 
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actors to whom offering the benefits of political action may or may not be optimal. 
However, there are additional dependents within this case that were not present in the 
federal failed case, primarily children, but also women, as the example above shows. 
Another example of an alternative frame appears in the laws mandating testing 
precautions on behalf of a gamete/embryo recipient with regard to testing and informed 
consent. However, there are also bills in which constraints are applied to these new 
actors' participation. For example, the laws relating to oocyte donation require that the 
donors undergo counseling and informed consent before undergoing the procedure and 
are informed that compensation for egg donation is not always provided. For example, 
the wording of AB 1317 is as follows: 
125325. (a) The person or entity posting an advertisement seeking oocyte donation associated with 
the delivery of fertility treatment that includes assisted oocyte production and a financial payment 
or compensation of any kind, shall include the following notice in a clear and conspicuous 
manner: 
"Egg donation involves a screening process. Not all  potential egg donors are selected. Not 
all selected egg donors receive the monetary amounts or compensation advertised. As with any 
medical procedure, there may be risks associated with human egg donation. Before an egg donor 
agrees to begin the egg donation process, and signs a legally binding contract, she is required to 
receive specific information on the known risks of egg donation. Consultation with your  doctor  
prior  to  entering  into  a  donor  contract  is  advised." 
While the informed consent and counseling aspects of this bill are for the benefit of the 
donor, they also act as a constraint on their participation in this transaction, reducing their 
agency. By Schneider and Ingrams' framework, these new actors could be considered to 




4.2.2.2 California Failed Bills 
 The failed bills in California, unlike the passed bills, appear to have slightly less 
variation of frame. While the number of failed bills presented here is a much smaller 
number as a result of excluding bills not addressing ARTs within their body, it becomes 
apparent that the failed bills do not have quite the same amount of variation in actors as 
in the passed bills. For example, within the six California failed bills examined for 
frames, the primary actors in these bills are physicians, insurers and the 'infertile'. Also 
featured were donors and researchers. An interestingly missing frame, which appeared 
heavily in passed bills, is the child frame. Similarly, the woman frame does not appear to 
feature as heavily. However, regarding language and construction of the featured actors, 
there appears to be little difference between passed and failed legislation. Passed bills do 
place some constraints upon actors that have real enforcement mechanisms, but this is 
also found in failed legislation. The only difference between passed and failed is the 
representation of insurance actors, who appear to represent a greater fraction of the actors 
targeted in failed bills than in successful bills. However, there are also significantly fewer 
pieces of failed legislation, which means that the possibility that there will be one bill that 
does or does not contain one actor over another increases. 
 Regarding the frames that were presented in this subset, the primary actor for 
whom policy action was being taken appeared to be consumers. This is the case for two 
bills focusing on insurance coverage and one on the structure of advertising. The failed 
legislation addressing advertising primarily focuses on physicians. Gamete donation does 
not appear to target a particular group, instead imposing penalties on anyone making the 
attempt to sell or buy human tissue. As such, the social construction of each of these 
actors would appear to also be contenders. While the generic terminology to describe 
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actors within the gamete donation bill may make it appear that these actors would be 
classified under the deviant construction, a closer look at the text of the legislation 
appears to limit the punishment to only civil action in the form of a fine, similar to those 
applied to physicians in both the passed bills and failed bills of California legislation. An 
example can be seen below. 
This bill would provide that any person who clones a human cell, or purchases or sells an ova, zygote, 
embryo, or fetus, for the purpose of cloning a human being, shall be punished by a 
 
criminal    fine    ,  by  imprisonment  in  a  county  jail  for 
 
not  exceeding  one  year,  or  by  both  a  fine  and  imprisonment (AB 1251) 
This may also be because the issue is considered to be tied directly to medicine, given that the 
billcontains a clause relating to professional conduct, as in the example below: 
It would make a violation an act of unprofessional conduct under the Medical Practice Act. The bill 
would also require the revocation of the local business license of any business that violates this 
provision. By creating new crimes, this bill would impose a state-mandated local program. 
 Overall, it can be seen that the construction of actors within both California failed 
and passed bills radically differed from the hypothesized relationship between actors and 
actions. While the social constructions are similar to those found in the federal level bills, 
their influence over the ability of bills to get passed is not evident at all. Another 
distinguishing factor of California bills is the inclusion of several non-traditional frames, 
even though they were couched within a more traditional frame such as family. More 
generally, California bills exemplify the limitations of frame on the ability to get bills 




4.2.3 An overview of the contents of the Georgia level bills 
 
Figure 18: Time line of Georgia Bills. The passed bills are highlighted in blue. 
 Of the legislation examined for this study, Georgia had the smallest subset over 
that shortest period of time. As can be seen from the time line above, a majority of 
legislation has occurred after 2005, with three bills occurring before 2005. As can be 
seen, the only ones that managed to pass occurred in 2007 and 2009. As mentioned 
earlier in this section, Georgia bills presented an interesting challenge for analysis. For 
one, Georgia bills appeared to have no key term identifying the present state of policy 
and the goal to be accomplished by new policy. This is similar to the status of 
approximately half of the pieces of federal level legislation. Therefore, the purpose 




4.2.3.1 Georgia Passed Bills 
 As can be seen in the Figure 18 time line, both of the passed bills occurred after 
2005. Even further, it can be seen that one of the passed pieces of legislation is a 
resolution rather than a bill and therefore functions in a different manner than the other. 
Of the passed legislation, the first was passed for the purpose of establishing a committee 
“on Rights Relating to Reproductive and Genetic Technology”. The composition of this 
committee provides a clear example of what concepts are closely associated with ARTs, 
as can be seen in the excerpt below: 
...the Senate Study Committee on Rights Relating to Reproductive and Genetic Technology to be 
composed of seven members of the Senate. The chairpersons of the Senate Judiciary Committee, 
Senate Health and Human Services Committee, and Senate Science and Technology Committee 
shall each be a member, and the other four members shall be appointed by the Lieutenant 
Governor. (SR 280) 
It is clear from this that the primary conceptual associations with ARTs are health and 
science. Given this to be the case, it is clear that the constructions that can potentially be 
applied to this area are potentially perceived to be limited. The other piece of legislation 
dealt with the adoption of embryos (HB 338). From the structure of HB 338, it is clear 
that the child frame is an important aspect of this bill, despite the fact that the bill's 
underlying structure is derived from a more traditional frame. An even more interesting 
aspect of this frame is its general recognition of the embryo as an actor with its own 
interests, as opposed to an object, as is found in many of the other bills utilizing the term. 
This can be seen in such statements as the one below: 
(5)   'Recipient  intended  parent'  means  a  person  or  persons  who  receive  a  relinquished  
24embryo  and  who  accepts  full  legal  rights  and  responsibilities  for  such  embryo  and  any  
25child  that may be  born  as  a  result of  embryo  transfer. (HB 388) 
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Given this case, it is clear that keying, in the Goffman sense, has occurred because the 
entity has undergone a transformation from an object to an actor, in some sense. Even 
further, this bill heavily utilizes the child frame and subsumes the traditional frame of 
family through its language, by emphasizing the embryo and the potential future child to 
be born of that embryo, while removing the distinguishing factors of a more traditional 
frame like 'family', which would be expected to emphasize parenthood and parent-child 
relationships. Alternatively, it also does not utilize a 'couple'/'consumer' frame at all, 
instead placing an emphasis upon the embryo/child guardianship. In effect, this bill is an 
example of utilizing terms to address an alternative frame. 
4.2.3.2 Georgia Failed Bills 
 As can be seen from the time line in Figure 18, the number of failed bills in 
Georgia far outnumber the passed bills. The primary actors of interest within these bills 
consist of couples, insurers, and physicians, similarly to the previous subsets. However, 
Georgia failed bills utilize the child frame far more heavily that previous subsets. For 
instance, in one failed bill, the term 'unborn' is used: presumably to reference that the 
entity in question is an actor only limited by its lack of birth. This example from HB 
1358, can be seen below: 
Inheritance rights shall not flow  to the in vitro human embryo as a legal person unless the  
1in vitro human embryo develops into a fetus and is born in a live birth or at any other time  
2when  rights  attach  to  an  unborn  child  in  accordance  with  law.   As  a  legal  person,  the  in  
3vitro  human  embryo  that  is  born  in  a  live  birth  as  a  result of  embryo  adoption  to  
another  
4couple  shall not retain  its  inheritance  rights  from  the  biological parents." (HB 1358) 
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The heavier use of the child frame may be an example of frames causing the failure of 
legislation, though it can be seen in both passed and failed Georgia bills, that this 
particular frame is more favored. Regarding the other actors, 'physician' is used in half of 
the bills, in which it acts as primarily a source of authority with regard to the 'couple' and 
other actors within. For example, in HB 1073, the physician is the authority through 
which a commissioning couple may enter into a surrogacy contract, and makes 
arrangements for embryos in the case of unforeseen circumstances such as divorce. 
However, as the authority in the ART transaction, the physician also appears to be given 
the burden of 'safekeeping' of embryos and other parties involved, as can be seen in the 
wording of HB 1358, below: 
Any physician  or medical facility that causes  fertilization  of  a  human  ovum  in vitro shall  
1be  directly responsible  for the  safekeeping  of  the  in  vitro  human  embryo. (HB 1358) 
4.2.4 Comparisons between frames and conclusions 
 Across all bills, it becomes apparent that some frames are more easily teased out 
than others. A primary example of an easily distinguished frame would be the 'child' 
frame, which was apparent in both California and Georgia legislation. Other frames, such 
as 'society', were not as easily distilled. It is not clear whether this was the case because 
'society' frames are assumed to occur with any state action, or because the instrument 
with which to identify the frame requires refinement. Similarly, the 'women' frame also 
proved difficult to distill from the legislation presented here. In part, it could also be 
argued that the frames were constrained by the overarching metanarrative of 'health', 
which would automatically place some actors in positions of prominence, while limiting 
or excluding others. 
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 Through this exercise of distilling frames from the many subsets of narrative, a 
few concepts hopefully have become apparent. For one, physicians and other health 
professionals continue to dominate this particular policy arena. This limits the potential 
policy options, as shown previously by Harris (2010). Their heavy involvement over their 
own management, as shown by the frequent use of the individual physician or the 
professional organization representing physicians, provides evidence that they act as 
contenders, according to the Schneider and Ingram social construction classification. 
Even further, it becomes apparent that while it has been argued that their political power 
has waned with the advent of managed care, it is clear that as a group they are still 
perceived favorably enough to act as a trusted expert in activities related to the practice of 
medicine. 
 It is also important to note the emphasis placed upon the consumer/couple as a 
dominant actor to receive benefits, in the form of increased access to the treatment 
through mandates on insurers, or through increased access to information through 
application of certification and screening processes. However, despite the application of 
legislation on their behalf, it does not appear that they carry much political power, which 
is why they have been designated here as being a socially constructed 'dependent' group. 
Even further, some of the legislation that has been formulated on their behalf appears to 
be primarily rhetorical, for example, the mandate upon embryo laboratories certification 
found in FCSRCA (1992). 
 The other remaining actors' role in the framing of legislation relating to this issue 
provide an interesting contrast between the cases under study, for example the emphasis 
on the child frame as the dominant alternative frame in Georgia, whereas the dominant 
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California alternative frame was more heavily focused upon women or the public. 
However, what is clear from the small sample set presented here is that the use of 
alternative frames is limited, and requires further study as to what may determine the 






5.1 Contribution to theory 
 Overall, it is believed that this study has shown the existence of frames within 
legislation. It is hoped that future study will attempt to provide further means through 
which to more systematically approach the study of frames, particularly within 
legislation. While this study only examined those bills that directly reference the topic of 
interest, it is believed that a broader selection of bills could be used to refine the methods 
of systematic frame analysis, for the purpose of use with large data sets. Moreover, the 
examination of multiple iterations of policy could also be of interest in understanding the 
process of frame development. This multiple iterations method could also shed further 
light on the development of ART-related policy, particularly in clarifying the appearance 
and cutting of ART terms from different iterations of bills. 
 Regarding the contributions to the literature, it is believed that this study brings 
multiple aspects of frame analysis to the forefront. First, the attempt to parse out the 
social construction of actors as a means of developing the frame itself provided a 
different way of viewing the actors and their activities within legislation. This is in 
contrast to some of the publications of the MAGEEQ project, which used frame analysis 
for the purpose of evaluating the means by which gender issues were incorporated in 
European Union policy (Verloo, 2004; Lombardo & Meier, 2006), and developed a frame 
based off of four concepts: the diagnosis of what's wrong, attribution of causality to 
whom, the prognosis of what should be done, and the call for an actor to do something 
(Verloo, 2004). Using this initial frame, it was the intent of this study to utilize the social 
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constructions of actors, per the definitions provided by Ingram and Schneider in Design 
for Democracy, to determine the frames of legislation (1997). The purpose of uniting 
these two frameworks for the examination of legislation was to capture the interaction 
between the proposed problem and solution within legislation, thus attempting to distill 
both explicit and implicit actors within legislation. 
 Even further, it was the purpose of this paper to extend previous work on applying 
CAQDAS to frame analysis. The attempt to use a process of distilling word counts was 
only partially successful in describing the narrative of the legislation. It is believed that 
this process could be further improved by further distilling the word counts into other 
grammatical features, and running a matrix analysis across the actors along with these 
additional grammatical features. This could potentially provide further systematization to 
the process of frame prediction and discovery, thus guiding the frame analysis method 
towards a more empirical analytic process. 
5.2 Limitations and contribution to ART policy literature 
 Overall, while it may appear that the data set of this study was far from small, it is 
the belief of the author that it would further benefit from a larger selection of legislation 
in future study, so as to better clarify whether the lack of frames such as those relating to 
women and children at the federal level, or women at the state of Georgia level, is a result 
of the frame not occurring or a limiting factor of the overall metanarrative. Similarly, an 
analysis of the multiple iterations of legislation could also be beneficial in better 
understanding the role, existence and persistence of frames within legislation. 
 Additionally, it is believed that this study provided some clarification of the social 
constructions around different ART actors. While it is limited in the conclusions that can 
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be drawn, it is clear that most of the social constructions are persistent in each of the 
cases studied, despite the fact that they are implemented slightly differently. While some 
social constructions are non-existent in certain cases, such as women and children at the 
federal level, this may be due to jurisdictional issues as much as a lack of mobilization of 
such frames. 
5.3 Policy implications 
 The overarching policy implications tie primarily back to the concept of 
mobilization in social movement theory. It is perceived here that, at the federal level, 
there is little mobilization of non-traditional frames. This may be a function of the 
previously observed fragmentation of actors, as presented by Goggin and Orth (2004). 
However, it could also be argued that this is the result of structural factors such as 
federalism and power distribution. Given the observation that there is persistence of some 
social constructions and frames at all levels, it would appear to indicate that some 
organization may occur beyond just historical structuring. Even further, given the 
historical power balance, as presented in the historical analysis of Chapter 1, the 
development of such a structure should be neither surprising nor its persistence 
unexpected. Without the mobilization of an alternative metanarrative, particularly with 
regard to reproduction, the ability to 'change course' with regard to policy would 
seemingly be difficult, thereby resulting in the current regulatory scheme found in the 




APPENDIX A: TABLES OF REPORTS 
Table 6: EAB Report Recommendations 
Major Ethical Issues  
Moral status of the Embryo “'Profound respect...but....not...full legal and moral rights 
attributed to persons.” 
“Embryo loss associated with attempts to assist otherwise 
infertile couples bear children of their own...may be regarded 
as ethically acceptable from an ethical standpoint, under 
certain conditions (emphasis own)” 
 Safety of mother and offspring “it is concerned, as well, about the physical and mental 
health of the children born following such a procedure and 
about their legal status. Many women have told the Board 
that in order to bear a 
child of their own they will submit to whatever risks are 
involved....Department should not interfere with such 
reproductive decisions, it has a legitimate interest in 
developing and disseminating information regarding safety 
and health so that fully informed choices about reproduction 
can be made.” 
Adverse effects of technological intervention “...broad prohibition of research involving human in vitro 
fertilization is neither justified nor wise. Among the 
developments warned against by some who testified before 
the Board, a few ( e.g. , the 
cloning of human beings and the creation of animal/human 
hybrids) are of uncertain or remote risk.” 
 
“Other abuses may be avoided by the use of good judgment 
based upon accurate information of the type collected by the 
Board and now being disseminated in this report.” 
Federal funding “The Board concluded that it should not advise the 
Department on the level of Federal support, if any, of such 
research; but it concluded that Federal support, if decided 
upon after due consideration of all that is at issue, would be 
acceptable from an ethical standpoint.” 
Overall Report Conclusions  
Support of in vitro fertilization/ embryo transfer research to 
better understand the fertilization process 
More data would be beneficial to draw additional 
conclusions from regarding the rate of abnormal embryo 
creation and further experimentation in animal models  
Ethically acceptable to conduct research involving human in 
vitro fertilization 
With 2 caveats and 5 sub-caveats: 
(a) human research without embryo transfer involves: (1) 
research that complies with all provisions governing research 
with human subjects; (2) research is designed to establish 
safety and efficacy and obtain acquire information for that 
purpose that is not otherwise attainable; (3) gametes are 
obtained from informed persons on their use and that have 
consented to that used; (4) embryos will not be held beyond 
normal implantation period; (5) advisement of the public will 
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Table 6: EAB Report Recommendations 
Major Ethical Issues  
occur in the discovery of a higher than normal risk of 
abnormal offspring production 
(b)research involving the transfer of gametes through IVF 
only be conducted with married couples 
Ethically acceptable for the department to conduct or 
support IVF research, but chooses not to address the level, if 
any, funding 
Assuming the caveats of conclusions 2 are met 
 
 
Table 7: OTA 1988 Report Recommendations 
Policy issue Potential congressional action Policy options 
Should the Federal Government 
improve collection of data on 
reproductive health? 
“The Federal Government has an 
interest in collecting 
data in three areas of infertility: factors 
contributing to infertility, its 
prevalence, and the outcome of certain 
treatments.” 
 
“Option I: Take no action.” 
“Option Z: Appropriate funds for the 
Secretary of Health and Human 
Services to make grants to State public 
health departments for the establishment 
of a national surveillance system on 
chlamydial infection.” 
“Option 3: Direct the Secretary of 
Health and Human Services to enhance 
the collection of data on infertility.” 
“Option 4: Establish a systematic 
method for registering 
the birth of IVF babies and for 
following 
the development and health of these 
infants.” 
Should efforts toward prevention of 
infertility be enhanced? 
“The Federal Government supports no 
identifiable activities expressly directed 
toward prevention of infertility. It 
supports several activities allied with 
prevention of infertility, such as NCHS 
collection of descriptive data about 
infertile couples, contraceptive research 
funded by NIH and the Agency for 
International Development, and 
programs of the Centers for Disease 
Control that aim to prevent sexually 
transmitted diseases.” 
“Option 1: Take no action.” 
“Option 2: Amend the Public Health 
Service Act to extend the program of 
grants for prevention and control of 
sexually transmitted diseases to include 
prevention of infertility secondary to 
sexually transmitted diseases.” 
“Option 3: Evaluate Federal efforts to 
prevent infertility.” 
“Option 4: Establish a demonstration 
project for identification of risks for 
infertility.” 
“Option 5: Enhance education in 
reproductive health.” 
Should the Federal Government ensure 
that consumers of selected infertility 
services have the information to make 
informed choices? 
“Congress generally does not 
regulate medical practice, with the 
exception of drawing broad criteria 
for care delivered at Veterans’ 
“Option 1: Take no action.” 
“Option 2: Encourage the use of a 
consensus review or conference on the 
use of IVF, gamete intrafallopian 
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Table 7: OTA 1988 Report Recommendations 
Policy issue Potential congressional action Policy options 
Administration hospitals or 
reimbursed by Federal insurance 
programs. Nor are medical 
techniques subject to consumer 
protection legislation, with the 
notable exception of Food and Drug 
Administration regulations for 
testing drugs and devices, and for 
regulating advertising of their 
indications and efficacy. Rather, 
quality assurance and consumer 
protection issues are left to State 
legislatures, professional societies, 
consumer groups, and word-of-
mouth.” 
transfer, and other innovative 
treatments for infertility.” 
“Option 3: Extend consumer protection 
laws to selected infertility services.” 
Preexisting mechanisms for gaining 
access to infertility diagnostic and 
treatment services adequate? 
Currently, those who can afford to 
pay for infertility services out-of-
pocket have the greatest access. To 
consider use of newer medical 
technologies, infertile individuals 
need to be able to pay anywhere 
from several hundred dollars to 
more than $22,000. Individuals with 
some private insurance coverage 
generally can expect to have a large 
portion of their expenses covered 
during the diagnostic phase, with 
considerable variability of coverage 
for infertility treatments.” 
Option 1: Take no action. 
Option 2: Direct the Health Care 
Financing Administration of the 
Department of Health and Human 
Services to review and report on the 
extent of existing coverage for 
infertility diagnosis and treatment 
services under the Medicaid and 
Medicare Programs 
Option 3: Amend the existing Federal 
Medicaid Program to add a new 
reimbursement category for services 
related to the diagnosis and treatment 
of infertility. 
Option 4: Amend Title 5 of the U.S. 
Code to provide that any carrier offering 
obstetrical benefits under the health 
benefits program for Federal 
employees shall also provide benefits 
for medical procedures to overcome 
infertility, including procedures to 
achieve pregnancy and to carry 
pregnancy to term. 
Option 5: Facilitate adoption, a social 
alternative to infertility treatment. 
Should the Veterans’ Administration 
provide infertility diagnosis and 
treatment? 
For the VA to provide care to a 
veteran, at least four conditions 
must be met: the veteran must 
have a disability, the VA care must 
be for that disability,the care must 
be necessary, and the care must 
constitute hospital care (including 
Option I: Take no action. 
Option 2: Direct the Administrator of 
the Veterans’ Administration to 
interpret disability to include the 
inability to procreate. 
Option 3: Amend Title 38 of the U.S. 
Code to specify that infertility 
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Table 7: OTA 1988 Report Recommendations 
Policy issue Potential congressional action Policy options 
medical treatments). These 
provisions mean that veterans 
currently obtain only limited 
treatment for infertility from the 
VA. 
treatments including but not limited to 
IVF, gamete intrafal]opian transfer, 
and artificial insemination may be 
provided by the Veterans’ 
Administration 
Should the transfer of human gametes 
and embryos be regulated? 
Sperm are sold by commercial 
sperm banks throughout the United 
States and have been for many 
years. 
 
Donation of unfertilized ova is 
today occurring at a number of 
infertility clinics. A few have begun 
to pay women to undergo hormone 
stimulation and ovum retrieval, 
sometimes in the course of 
voluntary sterilization by tubal 
ligation. Ovum banking using 
frozen ova has yet to become 
available, but considerable research 
is under way to make this feasible 
 
Embryos that remain after IVF 
procedures are not yet sold, as 
clinics and hospitals have chosen 
instead to give parents the choice of 
having them frozen, destroyed, or 
donated. 
Option 1: Take no action. 
Option 2: Mandate national standards 
for protection of paid ovum donors. 
Option 3: Mandate national standards 
for protection of recipients and 
offspring. 
Option 4: Ban commercial sales of 
embryos. 
Should anyone accepting or transferring 
human gametes keep nonidentifying 
genetic records on behalf of the 
potential child? 
Donation of human gametes is 
usually accompanied by an oral 
patient history including important 
genetic information that can become a 
formal written record. Such information 
is routinely obtained by those who 
operate sperm banks as they screen 
donors. Currently, however, the 
type of information that is collected 
and the ways in which it is 
maintained and transferred vary 
greatly. This variation is 
particularly significant 
because the predictive value of 
genetic history may increase in 
coming years. 
Option 1: Take no action. 
Option 2: Mandate that operators of 
sperm, ova, and embryo repositories, or 
anyone who transfers these materials, 
maintain written records 
detailing the non-identifying genetic 
history of all gamete donors and that 
this information be available to the 
recipients of gametes or embryos 
and the eventual offspring. 
Should commercialized surrogate 
motherhood be regulated by the Federal 
Surrogate motherhood is an 
infrequent but increasingly 
Option 1: Take no action. 
Option 2: Review developments in State 
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Table 7: OTA 1988 Report Recommendations 
Policy issue Potential congressional action Policy options 
Government? popular arrangement used by 
infertile couples, singles, and 
homosexuals as an alternative 
to adoption and perhaps infertility 
treatment in their efforts to form a 
family. Surrogacy arrangements 
are based upon principles of 
contract and family law, and 
therefore are largely within 
the traditional domain of State 
legislative activity. 
law related 
to surrogate motherhood. 
Option 3: Facilitate development of 
State legislation 
related to surrogate motherhood 
Option 4: Facilitate interstate 
cooperation and harmonization 
of State laws. 
Option 5: Mandate national standards 
for surrogate 
motherhood arrangements or 
commercial 
intermediaries 
Option 6: Facilitate international 
agreements concerning 
transnational surrogacy arrangements. 
Option 7: Ban commercialized 
surrogate motherhood. 
Do some areas of reproductive research 
require additional support? 
Federal support of human 
reproductive research 
is concentrated in two agencies of 
the Public 
Health Service: NIH (in particular, 
the National 
Institute of Child Health and 
Human Development 
and the National Institute of 
Environmental Health 
Sciences) and CDC (in particular, 
the National Institute 
for Occupational Safety and Health 
and the 
National Center for Health 
Statistics). 
Option 1: Take no action. 
Option Z: Expand Federal support for 
research in male infertility. 
Option 3: Expand Federal support for 
research on the psychology of 
participants in assisted conception. 
Option 4: Direct the Secretary of Health 
and Human Services to review, solely 
for scientific merit, research involving 
human sperm, eggs, and early embryos. 
Option 5: Mandate the appointment of 
an Ethics Advisory Board within the 
Department of Health and Human 
Services. 
Option 6: Direct the Secretary of Health 
and Human Services to implement (and 
update as needed) the 1979 
recommendations of the Ethics 
Advisory Board. 
Option 7: Direct the congressional 
Biomedical Ethics Board to develop 
guidelines for federally funded research 
with human sperm, eggs, and embryos. 
 
Table 8: PCB Report Recommendations (specifically regarding ARTs) 
General conclusions  
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Table 8: PCB Report Recommendations (specifically regarding ARTs) 
A.1. Institutional governance a) There is minimal direct governmental regulation of the practice 
of assisted reproduction and  
b)extensive, voluntary professional self-regulation of the practice of 
assisted reproduction. 
A.2. Substantive areas of 
concern 
a) There is no comprehensive mechanism for data collection, 
monitoring, or oversight of the effects of ARTs on children or 
gestational mothers, 
b) there is no uniform law of access, 
c) there is no oversight of novel practices once moved into clinical 
practice, 
d) there is no uniform system of public review and deliberation 
regarding human or social significance of ARTs 
E. Commerce There is no comprehensive mechanism for regulation of commerce 




APPENDIX B: LIST OF SEARCH TERMS 
List of Search terms used to find ART bills 
• in vitro fertilization/invitro fertilization 
• IVF 
• assisted reproduction 
• assisted reproductive medicine 
• assisted reproductive technology 
• medically assisted reproduction 
• infertility treatment 
• fertility treatment 
• human reproductive technologies 
• gamete intrafallopian transfer 
• zygote intrafallopian transfer 
• artificial insemination 
 
EXLUDED TERMS 
• infertility [alone] 
• fertility [alone] 
• infertility drugs [not in conjunction with other terms] 
• reproductive HARM 
• reproductive health/care [alone] 
• reproductive toxicity 
• interpregnancy care 
• fertility drugs 
• fertility preservation 
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APPENDIX C: FRAMES & SOCIAL CONSTRUCTIONS 
Table 9: Frames 





feminist • Changes female role 
• alters value of female 
body 
• creates incentive to 
'loan out' one's body 
• allows for the 
(re?)construction of 
the female body as 











• Alters value of child 
• There is a lack of 
representation of the 
child in the process, 
outside of the parent 
• alters value of 
embryo 
• creates the possibility 
of abortion 
• increases the health 








• Collect data on  
additional animal 
models 
• Require informed 
consent 
• Collect data on the 
resultant children 
of IVF 
• Evaluate the 
psychological 
wellbeing of both 
child and parents 
• Create rules on the 
number of 






woman • Little provision of 
'sufficient' drug 
testing 
• representation of 
woman is as 
'desperate 
dependent' 







• Collect longitudinal 
data on fertility 
treatments and 
users 














society • Long term fertility 
impact 
• Creates a need for 
new legal definitions 
• Provides new 





• Collect longitudinal 
IVF birth data 
• Create legal 
clarification of 
'familyhood' 
• create rules on the 








Table 9: Frames 
 Position Diagnosis Attribution of 
Causality 
Prognosis Proposition 
• Differential access/ 
economic costs 
(Creation of a 
disparity between 
haves and have-nots 
with regard to 
reproductive access) 
• Potential 'misuse' 
(eugenics, sex-
selection, cloning) 




• 'Market' for human 
parts (gametes) and 
bodies (surrogacy) 
• The potential for an 
increase in disabled 
babies 
• The potential for 
unclear genetic 
lineages (siblings 
that have grown up 
with different 
'parents') 









• create clear rules 
on the use(s) of 
PGD 
• create limits on age 
access and use of 
IVF 
• institute strict rules 
on cloning 
• collect clear genetic 




religion • Circumvents nature/ 
God's will 
• 'Defeating' the 
purpose of 
'procreation' 
• Creates the 
possibility for the 
destruction of 
embryos 
'doctors' • Ban IVF use legislators 
socio-
technological 
• Allows for too much 
technological 
intervention 









• Insufficient access 
• High cost 






Table 9: Frames 
 Position Diagnosis Attribution of 
Causality 
Prognosis Proposition 
• Inaccurate success 
rates 
• Telling the child their 
parentage 
• Positive versus 
negative right to 
genetic reproduction 
insurance to cover 
access to IVF 
treatments 




'live birth rates' 
• Otherwise create 
rules making the 





Physician • Too much 
intervention by the 
government 
• Sufficient governance 
at the professional 
level 
Government • Maintain 
professional 
autonomy 













Table 10: List of actors distilled from all bills 
1 : administrator 31 : donor 61 : organization
2 : adult 32 : embryo (2) 62 : owner
3 : agency 33 : employee 63 : parent
4 : agent 34 : employer 64 : participant
5 : applicant 35 : entity 65 : partner
6 : attorney 36 : family 66 : patient
7 : beneficiary 37 : female 67 : people
8 : board 38 : fetus 68 : person
9 : body 39 : government 69 : personnel
10 : business 40 : group 70 : petitioner
11 : center (2) 41 : guardian 71 : physician
12 : child 42 : gynecologist 72 : policyholder
13 : citizen 43 : holder 73 : population
14 : client 44 : hospital 74 : product
15 : clinic 45 : human 75 : professional (2)
16 : commissioner 46 : husband 76 : program
17 : committee 47 : individual 77 : public
18 : community 48 : institute 78 : recipient
19 : company 49 : institutions 79 : representative
20 : consumer 50 : insurance 80 : school
21 : contractor 51 : insurer 81 : secretary (2)
22 : coordinator 52 : juvenile 82 : society
23 : corporation 53 : laboratory 83 : spouse
24 : counsel 54 : life 84 : stakeholder
25 : county 55 : member 85 : state (2)
26 : couple 56 : mother 86 : surgeon
27 : court 57 : nonprofit 87 : unborn
28 : department 58 : obstetrician 88 : woman
29 : director 59 : office 89 : workers

























Table 11: Nvivo stop terms 
stop words 
if s into on as 
will such no or these 
and that in with  
not the for was  
but Their by to  
and Then be they  





APPENDIX D: BILLS 
Table 12: The bills 
Federal HR 1931: `Childless Veterans Assistance Act of 1989'. 1989 
HR 1199: no title 1989 
HR 5110: `Fertility Clinic Success Rate and Certification Act' 1990 
HR 1161: `Women's Health Equity Act of 1991'. 1991 
HR 3940: `Fertility Clinic Success Rate and Certification Act of 1991' 1991 
HR 756: `Fertility Clinic Success Rate and Certification Act'. 1991 
HR 4773`Fertility Clinic Success Rate and Certification Act of 1992'. 1992 
S 1757: `Health Security Act'. 1993 
HR 568: `Contraception and Infertility Research Centers Act of 1993'. 1993 
S 168: Affordable Health Care for All Americans Act’’. 1995 
HR 2774: no title 1999 
HR 2706: `Family Building Act of 1999'. 1999 
HR 4532: `Equity in Fertility Coverage Act of 2000'. 2000 
S 2160: `Fair Access to Infertility Treatment and Hope Act of 2000'. 2000 
S 874: `Fair Access to Infertility Treatment and Hope Act of 2001'. 2001 
HR 2608: `Cloning Prohibition Act of 2001'. 2001 
HR 2172: `Cloning Prohibition Act of 2001'. 2001 
HR 1246: no title 2001 
HR 389: `Family Building Act of 2001'. 2001 
S 303: `Human Cloning Ban and Stem Cell Research Protection Act of 2003'. 2003 
S 1726: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2003 
HR 3350: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2003 
HR 3026: no title 2003 
HR 3014: `Family Building Act of 2003'. 2003 
HR 1852: `Equity in Fertility Coverage Act of 2003'. 2003 
HR 969: `Medicare Infertility Coverage Act of 2003'. 2003 
HR 801: `Cloning Prohibition Act of 2003'. 2003 
HR 4872: `Retinoblastoma Awareness and Prevention Act of 2004'. 2004 
S 707: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2005 
S 876: `Human Cloning Ban and Stem Cell Research Protection Act of 2005'. 2005 
HR 2861: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2005 
HR 2759: `Equity in Fertility Coverage Act of 2005'. 2005 
Hr 2758: `Medicare Infertility Coverage Act of 2005'. 2005 
HR 2574: ‘‘Respect for Life Embryonic Stem Cell Act of 2005’’. 2005 
HR 1822: `Human Cloning Ban and Stem Cell Research Protection Act of 2005'. 2005 
HR 1418: `Infertility Coverage for Federal Employees, Military Personnel, and their Families Act'. 2005 
HR 735: `Family Building Act of 2005'. 2005 
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Table 12: The bills 
S 363: `Hope Offered through Principled, Ethically-Sound Stem Cell Research Act' 2007 
S 812: `Human Cloning Ban and Stem Cell Research Protection Act of 2007'. 2007 
HR 2892: `Family Building Act of 2007'. 2007 
HRes 322: not title 2007 
HR 1424: `Paul Wellstone Mental Health and Addiction Equity Act of 2008'. 2008 
HR 493: `Genetic Information Nondiscrimination Act of 2008'. 2008 
S 1258: `Family Building Act of 2009'. 2009 
HR 697: `Family Building Act of 2009'. 2009 
California SB 1780: Health insurance: infertility treatment coverage. 1994 
AB 1101: Health care coverage: contraceptive drugs: family planning: reproductive health. 1995 
SB 1363: Personal rights: human tissue. 1995 
SB 1964: Discrimination in employment and 
housing. 
1996 
SB 1555: Sperm, ova, or embryos: use and implantation 
without authorization. 
1996 
AB 2513: Physicians and surgeons: assisted reproduction 1996 
SB 1349: Committee on Business and Professions. Vocations: 
Pharmacy Law: sanitizers. 
1997 
AB 1251: Human cloning. 1997 
AB 441: Tissue donors: sperm donors. 1997 
AB 764: Food and drug inspections. 1997 
AB 589: Health care coverage: clinical practice guidelines. 1998 
AB 2040: Parent and child: assistive reproductive technologies. 2000 
SB 1630: Assisted reproductive technology. 2000 
AB 525: Health benefits: reproductive health care. 2000 
AB 1826: coverage: infertility treatment. 2002 
SB 1272: Stem cells: human tissue: research. 2002 
SB 1557: Human cloning. 2002 
SJR 38: Stem cell research. 2002 
AB 1996 2002 
SB 1230 2002 
SB 133: Human cloning. 2003 
AB 267: Cloning: humans. 2003 
SB 771: Human cells: embryo registry: egg cell donation. 2003 
AB 2380: Parent and child relationships. 2004 
SB 18: Reproductive health and research. 2004 
AB 2512: Fetal pain prevention. 2006 
SB 1260: Reproductive health and research. 2006 
SB 1325: Adoption. 2006 
SB 1704: Health care benefits. 2006 
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Table 12: The bills 
SB 313: Adoption. 2007 
SB 443: Tissue donors: sperm donors. 2007 
SB 1726: Adoption. 2008 
SB 1184: Public Health 2008 
AB 941: Adoption. 2009 
AB 1317: Assisted oocyte production: advertisement: 
information. 
2009 
AB 1397: Tissue donation. 2009 
AB 1543: Medicare supplement coverage. 2009 
SB 674: Healing arts. 2009 
SB 1150: Healing arts. 2010 
AB 1487: Tissue donation. 2010 
AB 2020: Family law. 2010 
AB 2426: Surrogacy facilitators. 2010 
Georgia HB 1073 1996 
SB 451 1998 
HB 1012 2003 
SB 537 2006 
SR 280 2007 
HB 1384 2008 
HB 1358 2008 
SB 330 2009 
SB 204 2009 
SB 169 2009 
HR 5 2009 
HB 489 2009 
HB 351 2009 
HB 1 2009 
SR 156 2009 
HB 338 2009 
HB 228 2009 
 
Table 13: Time line 
Federal Human Embryo Transfer 1985 
Alternative Reproductive Technologies: Implications for Children and Families 1987 
Federal Employee Family-Building Act of 1987 1987 
Consumer Protection Issues Involving In Vitro Fertilization Clinics 1988 
Federal Employee Family-Building Act of 1987 1988 
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Table 13: Time line 
Medical and Social Choices for Infertile Couples and the Federal Role in Prevention and Treatment 1988 
HR 1931: `Childless Veterans Assistance Act of 1989'. 1989 
HR 1199: no title 1989 
HR 5110: `Fertility Clinic Success Rate and Certification Act' 1990 
HR 1161: `Women's Health Equity Act of 1991'. 1991 
HR 3940: `Fertility Clinic Success Rate and Certification Act of 1991' 1991 
HR 756: `Fertility Clinic Success Rate and Certification Act'. 1991 
Fertility Clinic Services 1992 
HR 4773`Fertility Clinic Success Rate and Certification Act of 1992'. 1992 
S 1757: `Health Security Act'. 1993 
HR 568: `Contraception and Infertility Research Centers Act of 1993'. 1993 
S 168: Affordable Health Care for All Americans Act’’. 1995 
HR 2774: no title 1999 
HR 2706: `Family Building Act of 1999'. 1999 
HR 4532: `Equity in Fertility Coverage Act of 2000'. 2000 
S 2160: `Fair Access to Infertility Treatment and Hope Act of 2000'. 2000 
S 874: `Fair Access to Infertility Treatment and Hope Act of 2001'. 2001 
HR 2608: `Cloning Prohibition Act of 2001'. 2001 
HR 2172: `Cloning Prohibition Act of 2001'. 2001 
HR 1246: no title 2001 
HR 389: `Family Building Act of 2001'. 2001 
S 303: `Human Cloning Ban and Stem Cell Research Protection Act of 2003'. 2003 
S 1726: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2003 
HR 3350: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2003 
HR 3026: no title 2003 
HR 3014: `Family Building Act of 2003'. 2003 
HR 1852: `Equity in Fertility Coverage Act of 2003'. 2003 
HR 969: `Medicare Infertility Coverage Act of 2003'. 2003 
HR 801: `Cloning Prohibition Act of 2003'. 2003 
HR 4872: `Retinoblastoma Awareness and Prevention Act of 2004'. 2004 
S 707: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2005 
S 876: `Human Cloning Ban and Stem Cell Research Protection Act of 2005'. 2005 
HR 2861: ‘‘Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act’’ 2005 
HR 2759: `Equity in Fertility Coverage Act of 2005'. 2005 
Hr 2758: `Medicare Infertility Coverage Act of 2005'. 2005 
HR 2574: ‘‘Respect for Life Embryonic Stem Cell Act of 2005’’. 2005 
HR 1822: `Human Cloning Ban and Stem Cell Research Protection Act of 2005'. 2005 
HR 1418: `Infertility Coverage for Federal Employees, Military Personnel, and their Families Act'. 2005 
HR 735: `Family Building Act of 2005'. 2005 
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Table 13: Time line 
S 363: `Hope Offered through Principled, Ethically-Sound Stem Cell Research Act' 2007 
S 812: `Human Cloning Ban and Stem Cell Research Protection Act of 2007'. 2007 
HR 2892: `Family Building Act of 2007'. 2007 
HRes 322: not title 2007 
HR 1424: `Paul Wellstone Mental Health and Addiction Equity Act of 2008'. 2008 
HR 493: `Genetic Information Nondiscrimination Act of 2008'. 2008 
S 1258: `Family Building Act of 2009'. 2009 
HR 697: `Family Building Act of 2009'. 2009 
California SB 1780: Health insurance: infertility treatment coverage. 1994 
AB 1101: Health care coverage: contraceptive drugs: family planning: reproductive health. 1995 
SB 1363: Personal rights: human tissue. 1995 
SB 1964: Discrimination in employment and 
housing. 
1996 
SB 1555: Sperm, ova, or embryos: use and implantation 
without authorization. 
1996 
AB 2513: Physicians and surgeons: assisted reproduction 1996 
SB 1349: Committee on Business and Professions. Vocations: 
Pharmacy Law: sanitizers. 
1997 
AB 1251: Human cloning. 1997 
AB 441: Tissue donors: sperm donors. 1997 
AB 764: Food and drug inspections. 1997 
AB 589: Health care coverage: clinical practice guidelines. 1998 
AB 2040: Parent and child: assistive reproductive technologies. 2000 
SB 1630: Assisted reproductive technology. 2000 
AB 525: Health benefits: reproductive health care. 2000 
AB 1826: coverage: infertility treatment. 2002 
SB 1272: Stem cells: human tissue: research. 2002 
SB 1557: Human cloning. 2002 
SJR 38: Stem cell research. 2002 
AB 1996 2002 
SB 1230 2002 
SB 133: Human cloning. 2003 
AB 267: Cloning: humans. 2003 
SB 771: Human cells: embryo registry: egg cell donation. 2003 
AB 2380: Parent and child relationships. 2004 
SB 18: Reproductive health and research. 2004 
AB 2512: Fetal pain prevention. 2006 
SB 1260: Reproductive health and research. 2006 
SB 1325: Adoption. 2006 
SB 1704: Health care benefits. 2006 
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Table 13: Time line 
SB 313: Adoption. 2007 
SB 443: Tissue donors: sperm donors. 2007 
SB 1726: Adoption. 2008 
SB 1184: Public Health 2008 
AB 941: Adoption. 2009 
AB 1317: Assisted oocyte production: advertisement: 
information. 
2009 
AB 1397: Tissue donation. 2009 
AB 1543: Medicare supplement coverage. 2009 
SB 674: Healing arts. 2009 
SB 1150: Healing arts. 2010 
AB 1487: Tissue donation. 2010 
AB 2020: Family law. 2010 
AB 2426: Surrogacy facilitators. 2010 
Georgia HB 1073 1996 
SB 451 1998 
HB 1012 2003 
SB 537 2006 
SR 280 2007 
HB 1384 2008 
HB 1358 2008 
SB 330 2009 
SB 204 2009 
SB 169 2009 
HR 5 2009 
HB 489 2009 
HB 351 2009 
HB 1 2009 
HB 338 2009 
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